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Background: Fatigue is one of the most common symptoms of neurological 
conditions. Although the literature suggests different approaches to treatment of this 
pervasive symptom, there is not a single, agreed comprehensive and well-supported 
approach to manage fatigue. There is strong evidence (Mathiowetz, Finlayson, 
Matuska, Chen, & Luo, 2005; Mathiowetz, Matuska, Finlayson, Luo, & Chen, 2007) 
that the face-to-face fatigue self-management program designed by Packer et al 
(1995) is effective in improving fatigue in people with MS. However, in Australia 
and many other developed and developing countries this program is not available for 
those people who have difficulty accessing services due to geographical location, 
transportation problems, work commitments or who lack confidence to participate in 
face-to-face programs. Equity of access is an important issue not only for this 
particular program but also for any self-management program in Australia (and 
internationally) which has a large rural and remote population. Evidence highlights 
the need for self-management programs to be delivered in different formats to ensure 
equity of access. One of the suggested ways is delivering the programs online. There 
is sufficient evidence that people with a disability have access to the internet. Thus, 
this project was designed to refine and further develop a pre-designed online fatigue 
self-management (online FSM) program and to evaluate it in a sample of adults with 
chronic neurological condition through a randomised controlled trial (RCT). Further, 
the study intended to explore who and how people with fatigue improve in their 
health outcomes.  
Methodology and Results: The aims of the project were fulfilled through four 
studies: 1) a pilot study; 2) a randomised controlled trial of the online FSM program; 
3) a comparison with the face-to-face FSM program; and 4) exploration of predictors 
of improvement.   
During the pilot study, three pilot tests were conducted for the purposes of formative 
evaluation and to make necessary changes to improve the program. During the third 
pilot test, the effectiveness of the online FSM was also tested using a pre-test post-
test design on a sample of individuals with multiple sclerosis, Parkinson’s disease or 
post-polio syndrome. The pilot study resulted in a standardised 7-week online FSM 
program mimicking its face-to-face version. Participants were offered fatigue self-






management skills through structured activities, sharing information and 
experiences, expressing their ideas or feelings and offering advice and support to one 
another. The participants in the third pilot study improved significantly on the 
Fatigue Impact Scale (p<.05) and showed a trend toward significance shown on the 
Personal Wellbeing Index (p=.08).  
The RCT, the second study, included 95 participants who were randomised into one 
of three groups: an online FSM, an information-only FSM (info FSM) and a control 
group. The groups were compared at three time points (pre-test, post-test and at 3-
months follow-up) on Fatigue Impact Scale, Activity Card Sort and Personal 
Wellbeing Index (FIS, ACS and PWI). Sores on Generalized Self-efficacy (GSE), 
Duke Social Support Index (SSI) and Depression, Anxiety and Stress Scale (DASS) 
were also used as covariates. The results showed that although both the online and 
information-only FSM groups improved over time on the FIS and ACS (p < .05), 
they were not significantly different from the control group or from each other at any 
time point. The low power in all analyses when comparing the groups revealed that a 
larger sample size is required to detect possible differences between the online FSM 
and control groups.  Results of the secondary analysis on a combined group (online 
FSM group plus info FSM groups) showed that the online FSM and info FSM group 
complemented each other. The combined group showed significant differences when 
compared to the control group. This further suggests that the need for a larger sample 
size.  
The literature suggests incorporating face-to-face interventions as one of the 
experimental conditions when testing the effectiveness of an online program. 
Therefore, in the third study, a face-to-face group was used as a non-randomized 
comparison group. As the online FSM program was designed to provide service for 
people who do not have access to the face-to-face program, randomisation of the 
participants to four groups (face-to-face FSM, online FSM, info FSM and control 
groups) was not feasible; restricting the inclusion criteria to participants who had 
access to both the face-to-face and online programs would have excluded the very 
people for whom the program was designed. Thus, this study compared a sample of 
20 participants in a face-to-face FSM program with each of the three other groups 
(online FSM, info FSM and control groups) using a nonequivalent pre-test post-test 






study. The findings showed that after controlling for the baseline data these 
participants had better scores on the FIS than the control group at post-test while 
these results were not seen in comparison to the online and info FSM groups. The 
results of this study on the face-to-face FSM program in comparison with online 
FSM program suggest that the online and info FSM program were successfully 
mimicking its face-to-face version. Further, the differences in some outcome 
measures and some clinical and demographic characteristics clearly demonstrated 
that the participants with access to the face-to-face program were significantly 
different than those in the RCT study. The participants who volunteered for 
participation in the online FSM program had lower activity levels and higher fatigue 
levels than the participants who had access to the face-to-face program. It appears 
that the two versions of the program provide access to significantly different 
participants. 
The fourth study aimed to indicate predictors of improvement on the FIS, ACS and 
PWI. Regression analyses were performed to find whether baseline demographic, 
clinical characteristics and/or changes in clinical characteristics from pre-test to 
follow-up were predictors for positive health outcomes. In this study, 92 participants 
with complete data set (pre-test, post-test and follow-up) were included. In parallel to 
the results emerging in systematic reviews (Nolte, Elsworth, Sinclair, & Osborne, 
2007; S. Taylor, 2005; Warsi, Wang, LaValley, Avorn, & Solomon, 2004), younger 
people with more severe baseline scores appear to be more likely to make clinically 
significant improvements in their health outcomes. Improvement in mood and self-
efficacy of people with fatigue were found to be predictors of better results for 
fatigue. Another interesting finding of this study was that improvement in self-
efficacy and stress helps people with neurological conditions to improve in their 
fatigue regardless of their activity level at baseline.  
Conclusion: While fatigue is a common problem for people with fatigue secondary 
to neurological conditions, this online FSM program is the first of its kind to be 
implemented. The primary purpose of the fatigue self-management program is to 
help the participants improve their everyday performance and quality of life by 
incorporating ‘energy conservation techniques’ and self-management principles into 
their own life. Through the application of the fatigue self-management program, 






occupational therapists and other health professionals expect that the participants will 
learn the self-management skills, make corresponding behaviour changes and 
experience a reduction in the effect of fatigue on their lives. New knowledge gained 
from this study can further support the idea of providing other self-management 
programs online.  The results of this study also add to the growing body of evidence 
emerging regarding how information technology may assist with improving health 
outcomes related to chronic conditions. Further, some predictors of improvement in 
health outcomes in this group of people were determined. The findings provide some 
evidence of the potential benefits of online fatigue self-management program for 
people with chronic neurological conditions. Online interventions like the online 
FSM program represent an important strategy for bridging the gap in service for 
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1.1 STATEMENT OF THE PROBLEM AND SIGNIFICANCE OF 
STUDY 
Chronic disease contributes to over 70% of the disease burden in Australia.  This is 
expected to increase to 80% by 2020 (2006). Chronic conditions are the main source 
of disability and the principal cause of health care expenditure in Australia 
(Aupperle, Beatty, Shelton Fde, & Gontkovsky, 2002). The Australian Better Health 
Initiative aims to reduce this cost to the individual, their family and the community 
by refocusing health systems to meet the needs of Australians with chronic 
conditions. The need for a change in the health care system seems to be more critical 
when the cost of chronic conditions is taken into consideration. The direct cost of the 
chronic conditions for the health care system (e.g. physician visits, hospitalisation) 
and the indirect cost (e.g. personal care, domestic care, unemployment) put burden 
on the society. For example, in 2005 total real financial costs of multiple sclerosis 
(MS) were estimated at $601m with the annual cost per person with MS estimated to 
be $37,333;  $30 for every Australian.   
Meeting health care needs of the growing population of people with chronic 
conditions is a problem faced by both developed and developing countries. However, 
traditional health care systems are primarily focused on prevention and control of 
acute illnesses leading to less emphasis, historically, on management of chronic 
disease, illness and/or disability. One strategy to bridge this gap between the persons’ 
needs and the capacity of social and health services and to decrease the costs is the 
implementation of self-management programs for the individuals with chronic 
conditions and self-management support by health professionals (K. R. Lorig & 
Holman, 2003). Self-management programs provide people with chronic conditions 
with information, problem-solving skills and strategies to manage life with a chronic 
condition. This includes not only management of the symptoms but also the 
emotional consequences of living with a chronic condition and their day to day roles 
and responsibilities. There is also evidence that self-management programs are cost 
effective (Daniëlle, Manuela, Johannes, Emiel, & Johan, 2006; Gallefoss & Bakke, 





1999; Groessl & Cronan, 2000; K. R. Lorig et al., 2002; Wheeler, Janz, & Dodge, 
2003). 
The Australian Government and the United Kingdom (UK) Department of Health 
both have a strong commitment to self-management of chronic conditions 
(Department of Health, 2002; South Australia Department of Human Services, 
2004). Research  suggests that an emphasis on chronic disease self-management can 
reduce general practitioner visits, hospitalisation rates and improve health outcomes 
(K. R. Lorig et al., 1999). Self-management programs have also been successful in 
reducing the morbidity of chronic conditions. Evidence in Australia highlights the 
need for self-management programs to reach the right people, particularly those who 
have difficulty accessing services due to geographical location, ethnicity, language 
barriers, limited literacy levels, or those who lack the confidence to be partners in 
their own care (South Australia Department of Human Services, 2004). Online 
interventions have been shown to be successful in transferring information to 
individuals with chronic conditions; therefore online self-management interventions 
may be a reasonable way to bridge the gap between needs of individuals with chronic 
conditions and traditional health services. However, the role of the internet in self-
management of chronic conditions has received little attention in the literature.  
Fatigue is one of the most common and debilitating symptoms experienced by people 
with chronic conditions. Fatigue secondary to chronic illness is a subjective 
experience associated with physiological and psychosocial manifestations. It is one 
of the most troublesome symptoms for people with neurological conditions, 
including multiple sclerosis, Parkinson’s disease, and post-polio syndrome.  Between 
50 and 95% of these individuals report fatigue and mostly name it as their worst or 
one of their worst symptoms (Fisk, Pontefract, Ritvo, Archibald, & Murray, 1994; 
Kraft, Freal, & Coryell, 1986; Krupp, Alvarez, LaRocca, & Scheinberg, 1988). 
Fatigue has a known impact on quality of life and health status (Amato et al., 2001; 
Benedict et al., 2005; Benito-Leon, Morales, Rivera-Navarro, & Mitchell, 2003; 
Janardhan & Bakshi, 2002; Jonsson, Dock, & Ravnborg, 1996; Stuifbergen, 2006; 
Wollin et al., 2007). It results in major life changes. For example while 87% of 
Australians with MS are of working age (15-64 years), fatigue is reported as a central 





cause of MS persons being unable to maintain full-time employment (Black , Grant , 
Lapsley , & Rawson, 1994; Jongbloed, 1998). 
Therefore, the literature has called for rigorous research to treat fatigue. Management 
of fatigue includes pharmacological and non-pharmacological interventions. 
Pharmacological interventions have undergone randomised control studies (Canadian 
MS Research Group, 1987; Krupp et al., 1995; Weinshenker, Penman, Bass, Ebers, 
& Rice, 1992). Systematic reviews show that most pharmacological interventions 
result in severe side-effects and risk becoming refractory to treatment (Brañas, 
Jordan, Fry-Smith, Burls, & Hyde, 2000; Solari, Uitdehaag, Giuliani, Pucci, E. et al., 
2008). The literature also suggests a range of non-pharmacological interventions to 
manage fatigue from cooling therapy to cognitive behavioural therapy, yoga, 
exercise and so on. One of the only standardised treatments well supported by the 
literature is Managing fatigue: A six week course for energy conservation (T. L. 
Packer, Brink, & Sauriol, 1995). This group 6-week program is the most well 
developed and commonly used fatigue self-management program internationally. 
The efficacy of the fatigue management program has been tested by several 
independent researchers (Mathiowetz et al., 2005; Mathiowetz, Matuska, & Murphy, 
2001; Sauter, Zebenholzer, Hisakawa, Zeitlhofer, & Vass, 2008). Although the 
results have shown the efficacy of the fatigue self-management program, most 
Australians can not access it because the program is being offered in limited 
metropolitan areas. Those who live in rural and remote areas, or who have 
transportation difficulties, or are confined to the house due to disability or work full 
time are also denied access the face-to-face version of the program. Therefore, this 
research project examined the effectiveness of a newly developed online version of 
the program - a novel way to manage fatigue secondary to multiple sclerosis and 
other chronic conditions. If this program is effective, people with MS in Australia 
will have available an evidence-based intervention, accessible to people who face 
transportation barriers, the tyranny of distance or an inability to attend at set times. 
Hence, this study employed an RCT to evaluate the efficacy of an online self-
management group intervention and compare it with an online information-only 
fatigue self-management group and a control group in a sample of adults with 
chronic neurological conditions. The literature suggests incorporating face-to-face 





treatment interventions as one of the experimental conditions when testing the 
efficacy of an online program (Ritterband et al., 2003). Therefore, a face-to-face 
comparison was also included in this research. Although there are many systematic 
reviews on the efficacy of self-management programs, there is a scarcity of literature 
on who and how people improve in their health outcomes, and what should be done 
for people with different levels of activity to help them reduce their fatigue.  
Subsequently, this study also applied a secondary analysis approach to re-evaluate 
the data collected in the main part of study in order to facilitate a better 
understanding of the relationships between quality of life, fatigue and activity 
participation and social support, self-efficacy, mood, and their role in chronic disease 
management. 
1.2  OVERVIEW OF THE THESIS 
This thesis is organised in seven chapters. The first two chapters are the introduction 
and literature review. The development process and formative evaluation of the 
online fatigue self-management program is presented in Chapter 3. This chapter also 
includes the results of a preliminary effectiveness evaluation in preparation for the 
RCT. In Chapter 4 the RCT is used to evaluate the efficacy of the online fatigue self-
management program in comparison with information-only and control groups. 
Chapter 5 compares the participants in the face-to-face group with those of the online 
fatigue self-management, information-only fatigue self-management and control 
groups. In Chapter 6, predictors of improvement for the participants are explored. 
Chapters 2 to 6 also include discussions related to the study. An overview and 
conclusion of the results of the four studies is summarised in Chapter 7 (Figure 1).  
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1.3 OVERVIEW OF THE PROJECT  
1.3.1 STUDY 1: A PILOT TEST OF AN ONLINE FATIGUE SELF-
MANAGEMENT PROGRAM 
The online fatigue self-management program was based on the face-to-face protocol 
developed by Packer et al. (1995). The prototype for the online FSM program was 
designed during the AussieNet Project funded by Lotterywest. While the researcher 
was involved in all stages of the AussieNet project, it was not part of this PhD study. 
Once the initial protocol was developed, formative evaluation was undertaken 
(Objective 1 of this PhD). The formative evaluation included three pilot tests. The 





collected information during and after each pilot test was used to further improve the 
protocol.  
The third pilot test of formative evaluation provided the opportunity to undertake a 
small, preliminary efficacy study (Objective 2) using a single group pre-test, post-test 
design. This resulted in a standardised program to be tested in the RCT study of this 
PhD project.  
1.3.2 STUDY 2: A RANDOMISED CONTROLLED TRIAL OF AN ONLINE 
FATIGUE SELF-MANAGEMENT PROGRAM FOR ADULTS WITH 
CHRONIC NEUROLOGICAL CONDITIONS 
The main objectives of this study were to evaluate the efficacy of the online fatigue 
self-management program (Objective 3) and then to compare it with an information-
only fatigue self-management group and a control group in a sample of adults with 
chronic neurological conditions (Objective 4). The primary outcomes were fatigue, 
quality of life and activity participation.  
1.3.3 STUDY 3: COMPARISON OF THE FACE-TO-FACE FATIGUE SELF-
MANAGEMENT PROGRAM WITH OTHER VERSIONS OF THE 
PROGRAM 
As the online FSM program was designed to provide service for the people who do 
not have access to the face-to-face program, randomisation of the participants to four 
groups (face-to-face FSM, online FSM, info FSM and control groups) was not 
feasible because restricting the inclusion criteria to participants who had access to 
both the face-to-face and online programs would have excluded the very people for 
whom the program was designed.  Subsequently, a nonequivalent pre-test post-test 
control study of the face-to-face fatigue self-management program was designed to 
evaluate the efficacy of the face-to-face fatigue self-management program (Objective 
5) and compare it with the online fatigue self-management, information-only fatigue 
self-management and control groups in a sample of adults with chronic neurological 
conditions (Objective 6).  





1.3.4 STUDY 4: PREDICTORS OF IMPROVEMENT FOR ADULTS WITH 
FATIGUE SECONDARY TO CHRONIC NEUROLOGICAL 
CONDITIONS 
A secondary analysis was conducted on all complete data sets in order to re-evaluate 
all data collected from the fatigue self-management programs (RCT and face-to-face 
studies). Regression analysis, which is a powerful statistical approach for explaining 
and predicting quantifiable clinical outcomes (Portney & Watkins, 2008), was used 
to be able to predict outcomes and characteristics which are crucial to effective 
fatigue self-management programs. The aim of this study was to answer three 
clinical questions: What clinical and demographic characteristics predict the 
likelihood of improvement in people with fatigue? (Objective 7); What changes in 
clinical characteristics predict the likelihood of improvement people with fatigue? 
(Objective 8); and What are the predictors of improvement in fatigue for people with 
different baseline activity levels? (Objective 9). Data was collected at all time points 
in order to undertake the planned secondary analysis. 
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2 LITERATURE REVIEW 
2.1 INTRODUCTION 
This chapter provides background information needed to understand current 
literature on self-management programs and fatigue in neurological conditions. The 
literature on self-management is broad, ranging from self-management models to 
efficacy of self-management programs. Likewise, research reporting on different 
aspects of fatigue and its management is also extensive, including many 
characteristics of fatigue, its impact on the person’s life and its management. 
Therefore, the literature outlined in this chapter is divided into two main parts: Part 
1) chronic conditions, self-management and internet interventions, and Part 2) 
fatigue in neurological conditions. The first part includes prevalence and impact of 
chronic conditions, management of chronic conditions, definitions and models of 
self-management programs. This part also reviews the theoretical framework and 
important components of self-management programs, followed by an overview of 
who benefits most from self-management programs and how. Barriers to provide 
self-management programs are also reviewed. Then, online interventions, their 
advantages and disadvantages and effectiveness and access to the internet by people 
with chronic conditions are highlighted. The second part of this chapter reviews the 
definitions, prevalence, types, causes and correlates of fatigue. It also reviews how 
fatigue is related to depression and activity and how it impacts on psychological and 
physical aspects of life and then, how fatigue can be managed, again with emphasis 
on self-management.  
2.2 PART 1: CHRONIC CONDITIONS, SELF-MANAGEMENT 
AND THE INTERNET INTERVENTIONS 
2.2.1 PREVALENCE AND IMPACT OF CHRONIC CONDITIONS  
Management of persons with chronic conditions is a long-standing challenge for 
health care organisations. A chronic health condition is “any condition that presents 
itself for longer than six months, involves slow changes and may be controlled but is 
often not curable” (The Royal Australian Colledge of General Practitioners, 2004, 
p.3). The World Health Organization (WHO) estimates that 41 million people will 





die from chronic conditions in the year 2015, 20% of which will occur in high 
income countries, including Australia.  Based on the results of a study in 2004-05, 
over three quarters of Australian people living in private dwellings had at least one 
chronic condition (WHO, 2005). The proportion of the population with at least one 
condition increased with age. Almost 100% of people aged 65 years and over were 
living with at least one chronic condition (Australian Bureau of Statistics, 2004-
2005).  
The impact of a chronic condition/s on the individual and community is immense. 
Although often not immediately life-threatening, chronic conditions place a 
substantial burden on the health, economic status, and quality of life of individuals, 
families and communities. In Australia, chronic conditions contribute to around 80% 
of the total burden of disease and health problems as measured by disability-adjusted 
life years (DALYs) (National Health Priority Action Council, 2006, p.3).  
The financial costs for chronic conditions are also high. For example, in 2005 while 
only 14900 people across Australia were reported to have multiple sclerosis 
(prevalence of .08%) the total financial cost to the health care system was $601 
million (Access Economics Pty Limited, 2005). The cost of arthritis is similarly very 
high. The reported cost for arthritis  (16.5% of the population, which was equal to 3.1 
million people in 2001) was $8.96 billion (Access Economics Pty Limited, 2001). 
The Australian Better Health Initiative (Department of Health, 2006) aims to reduce 
this cost to the individual, their family and the community by refocusing health 
systems to meet the needs of Australians with chronic conditions.  
2.2.2 THE CURRENT CONTEXT FOR THE MANAGEMENT OF CHRONIC 
CONDITIONS   
The WHO recommends overcoming the high impact of chronic conditions by using 
accurate information, scientific knowledge and effective interventions (World Health 
Organization, 2005). Because of the nature of chronic conditions, management varies 
over time, with treatments adjusted according to changes in the person’s symptoms 
and fluctuations as the condition progresses. A client-centred approach, with persons 
contributing to and driving the management process, gives the opportunity to the 





individuals to live with their chronic condition with the least negative impact on their 
lives and consequently on their community.  
One suggested strategy is the implementation of self-management programs for 
people with chronic conditions and self-management support by health professionals. 
Research shows that people with effective self-management skills make better use of 
health care professionals’ time (Barlow, Turner, & Wright, 2000; K. R. Lorig et al., 
1999). People live with their chronic condition on a daily basis over a long period of 
time therefore their ideas and behaviours are important. Changing attitude and 
behaviour can influence the way people manage their condition (The Royal 
Australian Colledge of General Practitioners, 2004). Consequently, persons with the 
chronic condition play an integral role in the management of the condition 
(Bodenheimer, Lorig, Holman, & Grumbach, 2002).  
Given the current crisis in health care systems and the burden of chronic disease, the 
focus on self-management in health policy is not surprising. The WHO Global 
Strategy on Diet, Physical Activity and Health recommends “promoting incentive-
based approaches to encourage prevention and control of chronic diseases” all over 
the world (World Health Organization, 2006, p. 53).  
The current health system in Australia is based on acute care principles. There is a 
major difference between acute care and chronic disease management. With acute 
care, the treatment aims at returning the person to normal life while in chronic 
disease management, the person’s life is irreversibly changed and neither the disease 
nor are its consequences static (Holman & Lorig, 2000). For chronic disease 
management, health care systems need to have the capability to respond to a unique 
person’s choices and preferences, accommodate differences in a person’s 
preferences, and also encourage shared decision making (Briere, 2001). Currently, 
the acute health care systems are known to be insufficient and ineffective in 
responding to the growing population of people with chronic conditions (Briere, 
2001). 
The importance of changing care for people with chronic conditions has also been 
reflected in different countries’ health policies. In the US, the Chronic Care Model 
recognises self-management as one of the major components for treating chronic 





conditions (Bodenheimer, Wagner, & Grumbach, 2002). Another example of a 
specific focus on self-management internationally is the Expert Patients Programme 
in the UK which aims to develope the confidence and motivation of the person to use 
their skills, information, and professional services to take effective control over 
living with a chronic condition (Kennedy, Gately, & Rogers, 2004).  
In Australia, at the policy level, self-management is identified as one of the four key 
action areas along with prevention across the continuum, strengthening early 
detection and early treatment, and integration and continuity of prevention and care 
(National Health Priority Action Council, 2006). In 2006-2007, self-management 
programs were funded as a part of the Promoting good health, prevention and early 
intervention package by the Australian Government. The budget for this package is 
$250 million over 5 years.  
2.2.3 DEFINITION OF SELF-MANAGEMENT  
Defining self-management requires an examination of the premises on which an 
acceptable definition is based. It is also necessary to understand the tasks and skills 
required for people to self-manage a chronic condition. Self-management programs 
are based on the premise that while the health professional is an expert on the 
disease/condition, persons with chronic conditions are the experts on living with the 
condition (Bodenheimer, Lorig et al., 2002). In most cases, health professionals 
cannot accurately set the goals themselves. Individuals with chronic conditions know 
their needs and can provide information and preferences that are complementary to 
the health professional knowledge. In general, the person with the chronic condition 
provides the individual information and the health professional the general 
information, and both are necessary for effective management (Holman & Lorig, 
2000).  
According to Corbin & Strauss (1988) there are three sets of tasks and skills required 
for self-management of chronic conditions. The first task is the medical management 
of the condition, such as taking medication, adhering to a diet, or taking a tablet. The 
second set of tasks is maintaining, changing and creating new meaningful behaviours 
or life roles. The third set of tasks is to deal with the emotional sequelae of having a 
chronic condition. As emotions such as anger, fear and frustration are commonly 





experienced by people living with chronic conditions, learning to manage these 
emotions is part of the work required to manage the condition (K. R. Lorig & 
Holman, 2003). The skills needed for performing the tasks include problem solving, 
decision-making, finding and utilising resources, forming partnership with health 
professionals and taking action (Bodenheimer, Lorig et al., 2002).  
Therefore, self-management is a dynamic multi-dimensional concept which is about 
personalised living, people choosing how to manage their condition(s), optimal 
living with the condition and its outcome is to promote health and well being (C. 
Foster, Brown, Killen, & Brearley, 2007). Self-management is related specifically to 
living with a long term condition: “The individual’s ability to manage the symptoms, 
treatment, physical and psychosocial consequences and lifestyle changes inherent in 
living with a long term disorder” (Department of Health, 2005, p.6). 
2.2.4 MODELS OF SELF-MANAGEMENT  
Recognition of the current burden of chronic conditions on the individual and the 
society has resulted in increasing interest and investment in examining self-
management support models in order to meet the needs of people with chronic 
conditions. The literature identifies two major types of self-management support: the 
compliance based or medical model and the collaborative model, also known as 
empowerment (Bodenheimer, Lorig et al., 2002; Bodenheimer, Wagner et al., 2002; 
Jordan & Osborne, 2007; Koch, Jenkin, & Kralik, 2004). The former which appears 
to be more common in ‘real life’ clinical settings (Holmström & Rosenqvist, 2005) is  
a model where persons receive professional support and direction and follow the 
given instructions to self-manage aspects of their condition. A number of 
disadvantages are known for the ‘compliance based’ medical approach. This model 
represents a barrier to the uptake of self-management as the continued socialisation 
of people with chronic conditions into the medical approach encourages continued 
dependence on professionals (R. M. Anderson, Funnell, Barr, Dedrick, & Davis, 
1991). In the compliance based approach, the main concept is adherence to the 
prescription of the health professionals, based on the professionals’ identification of 
problems. In this model, it is thought that not only the persons bring little to the table 
besides their condition (Bodenheimer, Lorig et al., 2002) but also they may be 
blamed by the professionals for their shortcomings. This approach largely ignores the 





‘self’ in self-management (Koch et al., 2004) and conflicts with the foundations of 
self-care and self-management for people living with chronic disease (Department of 
Health, 2005). Therefore, the compliance based model is no longer viable in light of 
current policy changes in Australia (National Health Priority Action Council, 2006). 
 The other type of self-management support relies on a collaborative relationship 
between health-care professionals and persons with chronic conditions. The 
collaborative model has been proposed as an approach which enables the link 
between persons’ needs and health care systems (K. R. Lorig, 2003). This method of 
delivery of care represents a greater shift in control, from the health-care professional 
to the person (Department of Health, 2005). Programs based on this approach see the 
individuals as central in managing their condition, and the collaborative partnership 
between persons and providers is the means for achieving effective care (K. R. Lorig, 
Sobel, Ritter, Laurent, & Hobbs, 2001). In a collaborative model, persons accept 
responsibility to manage their own conditions and are encouraged to solve their own 
problems with information, but not prescriptions, from professionals (Bodenheimer, 
Lorig et al., 2002). In this model the persons seek, and are actively involved in a 
relationship with health professionals. This close relationship facilitates making 
choices by the persons in levels of support they receive. Although the level of 
support requested may vary subject to the illness trajectory and the individual’s 
circumstances, Koch et al. (2004) suggest that self-management is related to decision 
making and personal accountability. In this approach, people with conditions have 
expertise of similar importance to the expertise of professionals. While professionals 
are experts about diseases, persons are experts about their own lives. Although the 
collaborative model of care is not the dominant approach in primary care practices, 
its effectiveness at managing chronic conditions is documented broadly in the 
literature.  
2.2.5 SELF-MANAGEMENT PROGRAMS  
2.2.5.1 THE ROLE OF SELF-EFFICACY IN SELF-MANAGEMENT PROGRAMS 
As self-efficacy beliefs and expectations strongly influence individual’s choices, 
decisions, behaviours, and persistence (Brekke, Hjortdahl, & Kvien, 2003), many 
argue that a good self-management program should  rest on a theoretical basis of 





changing self-efficacy (Burckhardt, 2005).  Self-efficacy is defined as the confidence 
or belief that an individual has in their ability to execute a particular cognition or 
behaviour (Bandura, 1997a). Self-efficacy is a part of self-regulatory processes 
through which individuals shape environmental and interpersonal resources and 
behaviour toward a desired end (Bandura, 1997b). The concept of self-efficacy is the 
central tenet of Bandura’s social learning theory (Bandura, 1997b). This theory 
emphasises the underpinning role of personal mastery in the psychological and 
behavioural processes leading to behavioural change (Maddux, 1995). Based on 
Bandura’s theory, efficacy beliefs have a potent influence in self-knowledge and 
beliefs of self-determination and they direct human behaviour on a fundamental level 
(Bandura, 1997b). Bandura (1997b) argues that self-efficacy provides an explanation 
for one common mechanism through which people exercise influence over their own 
motivation and behaviour. Self-efficacy theory proposes that confidence in personal 
ability to carry out a behaviour (i.e. self-efficacy) influences the direction, intensity, 
and persistence of that behaviour (Bandura, 1997a).  
Evidence for the importance of measuring self-efficacy in a self-management 
intervention can be extrapolated from the literature that shows a relationship between 
self-efficacy and quality of life (Han, Lee, Lee, & Park, 2003; Robinson-Smith, 
Johnston, & Allen, 2000). Moreover, Amir, Roziner, Knoll and Neufeld (1999) 
examined the influence of social support and mastery (measured by locus of control 
and self-efficacy) mediating between disease severity and quality of life (QoL) in a 
sample of 89 people with epilepsy. Ninety percent of the variance of the quality of 
life was explained by a combination of disease severity, self-efficacy in epilepsy, 
social support, and locus of control. Mastery was found to mediate the correlation 
between disease severity and quality of life, and social support was found to act as a 
mediator between disease severity and mastery. They concluded that self-efficacy 
and social support act as mediators between disease severity and quality of life in 
epilepsy. There is also evidence for association of multiple sclerosis (MS) quality of 
life and self-efficacy. A study indicated that base-line and change in self-efficacy for 
function and control (MS Self-efficacy scale) were predictors of changes in physical 
and psychological components of quality of life in the 29-item Multiple Sclerosis 
Impact Scale in people with MS (Motl & Snook, 2008). The authors have 





emphasised that identifying educational and rehabilitation methods for increasing 
self-efficacy may maximise positive outcomes in treatment of MS symptoms. 
There are a great number of studies with different settings/population showing 
improved self-efficacy as an outcome of self-management interventions. For 
example, an RCT with long-term follow-up showed significant improvements in self-
efficacy and health management behaviours following participation in a tailored 
general chronic disease self-management program and these results were sustained 
for over 3 years (K. R. Lorig et al., 1999). This relationship is also seen in 
participants with different living situations. A study on an under-serviced, poor, rural 
population in US also showed improvement in self-efficacy and self-management 
behaviour in people with chronic disease (K. Farrell, Wicks, & Martin, 2004). 
Disease specific studies report improvement in self-efficacy, as well.  An example is 
an RCT study by Girdler (2004) on efficacy of self-management intervention for 
adults with age-related vision loss. Participants showed significant improvement in 
generalised self-efficacy at post-test and follow-up (both p < .0001) compared to 
those who received usual care.  
2.2.5.2 IMPORTANT COMPONENTS OF SELF-MANAGEMENT PROGRAMS 
While the reviews have reported the relative efficacy of self-management programs 
in chronic conditions, there are still unknowns when explaining the factors needed to 
be included in a program to be called a ‘self-management program’. Some authors of 
systematic reviews criticised studies on self-management interventions for not fully 
describing the content of the interventions and providing little information about 
their intervention background and suggest that this problem could be overcome by 
publishing protocols to ensure consistency of content and allow accurate 
interpretation of the intervention and explaining how they are effective (S. A. Brown, 
1999; Norris, Engelgau, & Narayan, 2001).  Notable is the independent development 
of different interventions with little regard to building on previous research. An 
exception to this is the work within some research groups (for example see the work 
of Glasgow, 1995, Wing and Anhin, 1996, Wing and Epstein 1988) where more 
systematic development has occurred for interventions for self-management of 
diabetes. This led to the current position where aside from acknowledgement that 





didactic interventions is insufficient there is little consensus over what components 
are most effective in self-management interventions.  
However, some studies have highlighted some important components of the self-
management program. Barlow and colleagues (2002) stated that for self-management 
to be effective, it needs to encompass the “ability to monitor one’s condition and to 
affect the cognitive, behavioural and emotional responses necessary to maintain a 
satisfactory quality of life” (p. 190). This definition implies that a well-designed self-
management intervention not only includes personal symptom management but also 
improves the daily occupations and the psychosocial life of the individual. The 
literature also suggests that effective interventions should be delivered in 
collaboration with  individuals and their families and enable them to take an active 
role in their care, improve their knowledge and self-management skills (Holman & 
Lorig, 2000; Von Korff, Glasgow, & Sharpe, 2002). Further, a meta-analysis  
suggested that interventions that use face-to-face delivery, cognitive reframing or 
include exercise content are more likely to improve Glycaemic control (as a health 
outcome) than other approaches (Ellis et al., 2004).  
The literature gives contradictory results on the effects of different components of 
self-management programs. While Norris (2002) suggest that interventions with 
greater contact time are associated with greater change in glycosylated haemoglobin 
(as a health outcome), Brown (1992) found that length of program was not associated 
with outcome. 
In a meta-regression, Warsi et al. (2004) considered characteristics specific to the 
educational program: the duration of education, number of educational sessions or 
education contacts, background of facilitators (e.g. medicine, nursing, social work, 
health education), setting of the educational program (inpatient versus outpatient), 
educational format (group versus individual), method of the education (written, 
audiotape, telephone, or face-to-face) and use of a formal syllabus. They found that 
the only program characteristic associated with improved outcomes was face-to-face 
education. This suggests that for any controlled trial study on effectiveness of online 
self-management intervention, the results should be compared with face-to-face 
intervention. Chodosh et al. (2005) attempted to find components of self-





management programs which are most responsible for benefits. They hypothesised 
the following five elements to be essential for a successful self-management 
program: 1) Tailoring: providing a disease specific program 2) Having a group 
setting 3) Giving individual feedback 4) Having a psychological emphasis in the 
program 5) Providing the program by the participants’ medical providers. However, 
despite their aim, they reported that the existing data does not provide enough 
information to determine which elements of the programs are most responsible for 
benefits. However, Mühlhauser and Berger (2002) argue that this attempt to dissect 
the programs into single components and to evaluate them separately is not suitable 
for self-management interventions which are complex interventions. “Complex 
interventions in health care comprise a number of separate elements which seem 
essential to the proper functioning of the intervention although the ‘active ingredient’ 
of the intervention that is effective is difficult to specify” (Medical Research Council, 
2000 , p.1). Therefore, it is difficult to isolate the ‘ingredients’ to determine which of 
them is responsible for the outcome (Duncan, Paley, & Eva, 2007). 
2.2.5.3  EFFICACY OF SELF-MANAGEMENT PROGRAMS 
Evidence based on RCTs shows self-management to be useful in maintaining and 
improving individuals’ quality of life, health behaviours and health status, while 
lowering health care utilisation through improved self-management skills, self-
efficacy, and better communication between individuals and health providers (For 
example Adams et al., 2003; Barlow et al., 2000; Bruce, Lorig, Laurent, & Ritter, 
2005; Ghosh, 1998; K. R. Lorig, Ritter et al., 2001; K. R. Lorig et al., 1999). 
However, several systematic reviews of the literature have explored the efficacy of 
these programs more thoroughly, shedding new light on the weight of evidence. 
Self-management interventions have been shown to have long-term effects on 
participants’ quality of life (K. R. Lorig & Holman, 1989; K. R. Lorig, Ritter, 
Laurent, & Fries, 2004). A systematic review (Gibson et al., 2003) has assessed the 
effects of asthma self-management programs on adults’ quality of life. They have 
included thirty six trials. Quality of life was assessed in ten studies, six of which 
provided mean total scores. Overall there was a significant improvement in total 
quality of life score for those participants receiving self-management intervention 
(standard mean difference 29, confidence interval .11 to .47). Recently Foster, 





Taylor, Eldridge, Ramsay, & Griffiths (2007) reported a systematic review of lay-led 
self-management programs for people with chronic conditions. They included 
seventeen trials involving 7442 participants. The authors concluded that lay self-
management education programs may lead to small short-term improvement in 
people’s self-efficacy, self-rated health, cognitive symptom management and 
frequency of aerobic exercise. Although the review showed there is not sufficient 
evidence to suggest that such programs improve health quality of life, they have 
emphasised that the studies were heterogeneous in conditions, outcomes collected 
and effects. Steed, Cooke and Newman (2003) systematically reviewed studies on 
self-management and psychological intervention for people with diabetes and 
specifically focused on depression, anxiety, adjustment and quality of life as outcome 
measures for these studies. Reviewing 36 articles, they did not detect detrimental 
effects following any type of intervention. Depression was particularly improved 
following psychological interventions whilst quality of life improved more following 
self-management interventions. It is of note that beneficial effects of self-
management interventions were less clear in the long term. The authors also reported 
that while most randomised controlled trials indicated no benefits for anxiety, pre-
post trials reported improvements in this symptom.  
It is also important to note that there is a growing evidence of significant association 
between social support and quality of life (S. Cohen, 1988). Change in social support 
is reported to be a significant predictor of changes in health-related quality of life in 
heart failure, rheumatic arthritis, spinal cord injury and other chronic conditions 
(Bennett et al., 2001; Hampton, 2001; Han et al., 2003; Minnock, Fitzgerald, & 
Bresnihan, 2003). A qualitative study in Australia  showed social contact and 
comparison to be the strongest and most common perceived benefits of self-
management for people with stroke (Catalano, Dickson, Kendall, Kuipers, & Posner, 
2003).  
Some systematic reviews have concentrated on medical outcomes of self-
management programs. Warsi et al. (2004) report results of a systematic review 
evaluating the efficacy of interventions containing self-management education 
components that had a concurrent control group and evaluated clinical outcomes. 
They excluded the outcomes of knowledge, compliance, self-efficacy, satisfaction, 





quality of life and/or depression. They also expelled studies involving physical or 
psychosocial therapies such as exercise and group therapy. They concluded that self-
management education programs resulted in small to moderate effects for people 
with diabetes and asthma but not for arthritis. Another systematic review (Chodosh et 
al., 2005) also showed that pooled effects of the self-management programs were 
statistically significant but clinically small for pain and function outcomes for 
osteoarthritis. The systematic review was focused on chronic self-management 
programs for older adults with diabetes mellitus, hypertension and osteoarthritis. A 
random-effects meta-analysis was conducted and revealed a statistically and 
clinically significant pooled effect size of -.36 (95% CI, -.52 to .21) for hemoglobin 
A1c’ which is equivalent of the reduction in hemoglobin A1c level of about .81%. 
Decrease in systolic blood pressure by 5 mm Hg (effect size, -.39) and decreased 
diastolic blood pressure by 4.3 mm Hg (effect size -.51) was reported (Chodosh et 
al., 2005).  
A systematic review on self-management studies on chronic obstructive pulmonary 
disease (COPD) by Monninkhof et al. (2003) found no improvements for hospital 
admissions, emergency room visits, days lost from work and lung function. They 
also pointed out that there are many limitations in published literature such as using 
inappropriate outcome measures and that the programs mostly focus on symptom 
management and not on improving self-management skills or behavioural change. 
Conversely, research reveals a positive effect of self-management programs on costs 
associated with COPD. In a study of the economic benefits of person with COPD in 
Canada, researchers estimated that providing chronic persons with education on self-
management as well as ongoing supervision by a case manager would yield a savings 
of over C$2000 per persons per year (Bourbeau et al., 2006). 
The literature on self-management has predominantly focused on chronic conditions 
like arthritis, diabetes, and respiratory disorders (Chodosh et al., 2005; Cicutto & 
Brooks, 2006; Kralik, Koch, Price, & Howard, 2004; Monninkhof et al., 2003; Norris 
et al., 2001; Norris, Nichols et al., 2002; Siebenhofer, Berghold, & Sawicki, 2004; 
Willems, 2006). Very few studies have been conducted on the efficacy of self-
management for people with neurological conditions. For instance, only four out of 





146 articles on self-management for chronic conditions which were reviewed  by 
Barlow et al. (2002) specifically addressed neurological problems. 
Although systematic reviews and meta-analyses provide the highest level of evidence 
for effectiveness of programs (Portney & Watkins, 2008), if the theory behind the 
programs and the difference between trials designed to determine efficacy and those 
focusing on implementation  are not taken into consideration, the results would not 
allow for adequate appraisal (Mühlhauser & Berger, 2002). Self-management 
programs are considered complex intervention. When evaluating a complex 
intervention, the heterogeneity in their goals, methods and target populations should 
be accurately considered. Lenz, Steckelberg, Richter, & Mühlhauser (2007) 
conducted a methodological review on systematic reviews for complex interventions 
and used diabetes and hypertension self-management as examples. They included 14 
reviews. Their review on comparable topics identified different publications of the 
same program which were classified differently within and between reviews. They 
concluded that methods of current systematic reviews are not fully equipped to 
appraise person education and self-management programs. Also they considered that 
since these programs are complex and heterogeneous, consideration of aggregated 
evidence in necessary. 
2.2.5.4 WHO BENEFITS MOST FROM SELF-MANAGEMENT PROGRAMS AND HOW 
Although self-management programs are being used world-wide, there is little 
known about the characteristics of the participants who may benefit most from these 
programs. Structured reviews are limited partly by the difficulty in interpreting the 
included trials. In a paper reviewing asthma self-management, participants suitable 
for guided self-management are mentioned as the individuals with moderate or 
severe asthma, variable disease, history of emergency room visits owning to asthma, 
bad perception of the severity of the disease and good cooperation (Lahdensuo, 
1999).  However, the authors did not provide any proof for their opinion.  
The literature suggests that a person’s willingness to adopt the self-management 
approach is one example of a personal characteristic that determines effectiveness 
(Prochaska & DiClemente, 1992; Prochaska, DiClemente, & Norcross, 1992). That 
is, when people are not really convinced that self-management can be beneficial, 





they may adhere to it as long as they are in the program, but they will be prone to 
relapse. This participant characteristic of willingness to adopt a certain new 
behaviour is conceptualised as ‘readiness to change’ (Dijkstra, Vlaeyen, Rijnen, & 
Nielson, 2001; McConnaughy, Eileen, Prochaska, & Velicer, 1983; Prochaska & 
Norcoss, 2001). Research shows significant difference in clinical improvement 
between participants in self-management program depending on their levels of 
readiness to change in pain and diabetes program (Peterson & Hughes, 2002). A 
motivational model for pain self-management goes one step further and suggests the 
perceived importance and self-efficacy influence an intermediary factor, readiness to 
change. They also called for further study to test whether readiness to change 
predicts engagement in self-management behaviours (Jensen, Nielson, & Kerns, 
2003).  
While several important variables like educational level, disease duration, disease 
severity, social supports, medication effects and the level of self-efficacy may 
contribute to the success of an educational program, Warsi et al (2004) reported  that 
needed data was under reported in the literature. Nolte, Elsworth, Sinclair, and 
Osborne (2007) conducted  large study on 1341 Australian individuals with a wide 
range of chronic conditions who attended self-management courses. They conducted 
a subgroup analysis to explore baseline differences by stratifying the sample by age, 
gender and level of education. The authors concluded that younger women were 
more likely to benefit from self-management interventions across most heiQ scales 
but they had lower baseline scores than older women  (Richard H. Osborne, 
Elsworth, & Whitfield, 2007). There were no significant differences for people 
across educational levels.  
Only a few studies have specifically explored what people do to help themselves, 
what enables them to do so, and how this can be supported.  Foster et al. (2007) 
published a Cochrane Library systematic review and explored how people help 
themselves following a cancer diagnosis. They concluded that as self-management is 
poorly defined and lacks a theoretical framework, it is not yet possible to draw a 
conclusion on how self-management programs work. 





2.2.5.5 BARRIERS FOR SELF-MANAGEMENT PROGRAMS 
Despite the importance and effectiveness of self-management programs for people 
with chronic conditions, these programs have been underused for several reasons. 
First, in some countries like the US, because there is no reimbursement, the programs 
are largely given outside the mainstream of the health care system (Kaplan & Davis, 
1986). Second, a large number of people with chronic conditions cannot or will not 
attend group education programs for reasons including severity of disability, limited 
access to transportation or living in a rural or remote area (Jerant, Friederichs-
Fitzwater, & Moore, 2005). Third, logistics problems such as scheduling could 
render it difficult to run the program (K. R. Lorig et al., 2004). Currently, most face-
to-face courses are being run during the day. There is a view that this excludes 
people in the workforce who might benefit from the self-management programs. 
Consideration of running courses online or face-to-face programs at different times 
of the day to suit those in employment has been recommended (Kennedy et al., 
2004). 
The same barriers, more or less, exist in Australia. Recruitment of a sufficient 
number of participants able and interested to take part in the programs is known as 
one of the barriers integrating self-management programs into the Australian health 
care system (Jordan & Osborne, 2007). One of the major limitations of using 
community-based, face-to-face interventions is that participants must have their own 
transportation or the program providers must offer it. In Australia, being able to drive 
or to use public transportation is a major barrier to accessing community programs 
for many people with disabilities, including people with neurological conditions. For 
example, only 61% of people with MS live in major cities (Simmons, Hendrie, 
McDonald, Tribe, & Vowels, 2004). This means most people who need the programs 
can not attend. Workforce issues and referral issues are also barriers to self-
management programs (Jordan & Osborne, 2007). Collectively, these findings 
highlight the importance of different formats of service delivery in overcoming 
barriers to accessing self-management support (Nour, Laforest, Ggnac, & Gauvin, 
2005).  





2.2.6 ONLINE INTERVENTIONS 
According to Jordan & Osborne (2007) delivery of programs at a local level is one of 
the factors essential for advancing chronic disease self-management programs in 
Australia. Internet self-management interventions may provide a new format of 
delivery for people who are traditionally marginalised as a result of geographical 
location, severity of disability or employment.  
Optimism for the potential positive impact of online delivery is attributable to several 
advantages of the internet over other self-management intervention methods. These 
may act to reduce the barriers and increase access to self-management programs. 
Delivery of self-management programs using internet technology has the potential to 
reach a larger number of people with chronic conditions and reduce the burden of the 
condition on their life. The internet constitutes a widely available and affordable 
multimedia instructional medium that can help overcome some of the barriers to 
delivering effective self-management program (Devineni & Blanchard, 2005).  
There are many other attractive features to online interventions. Madara (1997) 
argues that a community “is more easily found, chosen, or started online” (p.23). 
Online interventions require access to computer hardware and technical assistance 
but they are not limited by a local community’s size, geography, or social services. 
Online interventions can deliver, customise and record all the program sessions and 
provide the person an opportunity to communicate with health professionals and with 
other people with chronic condition. The interactive nature of the internet, combined 
with the potential to store large volumes of information, provides a unique 
opportunity to offer high-quality interactive online interventions (Ritterband et al., 
2003). The internet is available 24 hours per day, and can provide connection 
between clients and their health professionals. Web browser interfaces are easy to 
use, the person has only to click a mouse button to interact with the program and 
different programs utilise the same familiar looking screen layout. The information 
content of the Web page can be personalised for individual persons using data from 
their electronic record (Stoop, Rietb, & Berga, 2004). Displaying photographs and 
video clips in a Web browser does not need additional expensive hardware and 
quality person hand-outs containing text and graphics can be generated 
inexpensively. Conversely printed, education booklets are costly to produce and 





update. Relaying information, enabling informed decision-making, promoting health 
behaviours, promoting peer information exchange, an emotional support, promoting 
self-care managing demand for health services and equity are assumed benefits of 
online interventions (E. Murray, Burns, Tai, Lai, & Nazareth, 2005; Ritterband et al., 
2003; Stoop et al., 2004).  
There are several disadvantages in using online interventions. Computers may never 
replace the human touch associated with traditional doctor-person communication 
but multimedia computer-based information resources can play an increasing part in 
the cost-effective delivery of health care resources. False or misleading information, 
privacy and malpractice are the potential negative consequences (Evers, Cummins, 
Prochaska, & Prochaska, 2005; E. Murray et al., 2005) and are also known as 
disadvantages for online interventions. Although the internet has the potential to 
affect health-related behaviours, it is important to note that internet users generally 
need to have familiarity with web navigation and the English language to 
successfully obtain useful information online. One can argue that this ‘high-tech’ 
approach is only suitable for well-educated individuals from affluent communities 
(Birru & Steinman, 2004). However, the literature suggests some fairly simple 
modifications when designing websites to overcome most navigation and language 
barriers for low-literate users (Zarcadoolas, Blanco, Boyer, & Pleasant, 2002). 
Online programs could be made available in public libraries, community centres, 
work places, hospital out-patient and family practice waiting areas. 
Considering both the advantages and disadvantages of online interventions, there is a 
need to find out if online interventions can deliver self-management programs 
successfully.  
2.2.6.1 EFFICACY OF ONLINE INTERVENTIONS 
The literature shows that potentially there are several benefits in using online 
interventions. However, to meet this potential, online interventions must demonstrate 
feasibility and efficacy through rigorous scientific testing. There is growing evidence 
for significant effectiveness of online education. Wantland, Portillo, Holzemer, 
Slaughter, & McGhee (2004) conducted a meta-analysis to compare online 
interventions and non-online interventions.  They reviewed 22 studies with data from 





11,754 participants in both online and non-online interventions. The results showed 
an improvement in outcomes for individuals using online interventions to achieve the 
specified knowledge and/or behaviour change for the studied outcome variables 
(Wantland et al., 2004). The outcomes included increased exercise time, increased 
knowledge of nutritional status, increased knowledge of asthma treatment, and 
increased participation in healthcare, slower health decline, improved body shape 
perception, and 18-month weight loss maintenance.  
While the literature on effectiveness of online interventions for chronic condition 
non-specific programs is promising, there are also effectiveness studies on online 
interventions specifically designed for people with chronic conditions. A randomised 
controlled trial evaluating the effectiveness of a back pain e-mail discussion group on 
580 people, showed improvement in health distress and health care utilisation in 
participants compared to controls after one year (K. R. Lorig et al., 2002). Another 
example of successful use of computers in intervention is a randomised controlled 
trial for testing a computerised system which provided for 204 HIV-positive 
individuals with information and decision support. The results showed that the 
system can improve a person’s quality of life and promote more efficient use of 
health care (Gustafson et al., 1999). A study by McKay, King, Eakin, Seeley and 
Glasgow (2001)  showed that an online intervention improved physical activity 
moderately and the authors concluded that “greater attention should be focused on 
methods to sustain involvement with internet intervention health promotion programs 
over time” (p.1333). Also, the effect of the internet on perceived social support has 
been reported in an experimental  trial by Barrera et al. (2002).  They stated that a 3-
month internet-based support intervention could improve perception of social support 
in people with diabetes. 
Murray, Burns, See Tai, Lai, & Nazareth (2005) further evaluated the effectiveness 
of online interventions for people with chronic conditions. Twenty four RCTs 
involving 3739 participants were included in this Cochrane Library systematic 
review. The definition of online interventions was operationalised in this article as 
“any package that required the user to interact directly with any form of computer, 
and contained health information plus at least one of peer support, decision support 
or behaviour change support and was not defined by the authors of the paper as a 





decision aid or computerised cognitive behavioural therapy” (p.3). Online 
interventions were found to have largely positive effects, tending to improve user 
knowledge and perceived social support. The reviewers suggested that these positive 
effects of online interventions may extend to improved clinical outcomes. While the 
importance of the self-management approach for chronic conditions was pointed out 
in this article, having a self-management approach was not considered as one of the 
inclusion criteria for the type of interventions reviewed. Although tested online 
interventions were attended by people with a wide range of chronic conditions from 
headaches, posttraumatic stress and pathological grief, panic disorder, to diabetes 
management, AIDS, asthma and cancer, none of the studies reviewed were 
developed for managing symptoms in neurological conditions including fatigue.  
Although both the effectiveness of online interventions and the problems in 
delivering the self-management programs are well recognised, there are few studies 
reporting self-management programs for adults delivered using the internet. 
Effectiveness of one internet-based self-management program for people with 
chronic conditions was tested in an RCT (K. R.  Lorig, Ritter, Laurent, & Plant, 
2006). The program consisted of password-protected, interactive web-based English-
language instruction, web-based bulletin board discussion groups and a book, Living 
a healthy Life with Chronic Conditions (K. R. Lorig, Ritter et al., 2001). The book 
was to be referred to by the participants at various times in the program. The course 
was taught in an interactive manner designed to enhance self-efficacy.  One other 
example of an online self-management program, a pilot study on the effectiveness of 
internet-based support for dyspnea self-management in people with chronic 
pulmonary disease, has been published. The results showed significant improvement 
in both self-efficacy and activities of daily living (both p < .01) (Nguyen, Carrieri-
Kohlman, Rankin, Slaughter, & Stulbarg, 2005). Furthermore, a recent systematic 
review of internet-based self-management interventions for youth with health 
conditions showed that there is great promise on using the internet as a mode of 
delivery for self-management programs (Stinson, Wilson, Gill, Yamada, & Holt, 
2008). 
Kerr, Murray, Stevenson, Gore, and Nazareth (2006) conducted a qualitative study to 
determine the criteria used by people with chronic conditions and their caregivers for 





assessing the quality of online interventions. They prepared criteria for the online 
interventions relating to information content, presentation, interactive components 
and trustworthiness. However, the online interventions which were assessed in this 
study were mostly person education web sites and not self-management 
interventions.  
It appears that online self-management programs have potential as effective 
alternatives to face-to-face programs, thereby expanding the availability and 
diversity of communities from which individuals can choose. These practices also 
could help efforts to eliminate disparities in health that exist because of inequities in 
people’s access to resources (Powell, Glover, Probst, & Laditka, 2005).  
2.2.6.2 ACCESS TO INTERNET BY PEOPLE WITH CHRONIC CONDITIONS 
Recent research in the US shows that 51% of the adults with a disability or chronic 
condition use the Internet compared with 74% of those who report no disability or 
chronic conditions (Pew Internet & Americal Life Project, 2007). The study showed 
that once online, internet users with chronic conditions perform activities at the same 
rate as other users. Eighty-six percent of internet users with chronic conditions report 
that they search for health information online, compared with 79% of internet users 
who report no chronic conditions. Furthermore, the majority (75%) of individuals 
with chronic conditions or disability reported that their last health information search 
had an impact on their health care (Pew Internet & Americal Life Project, 2007). 
While there is literature available on use of technology by people with physical 
disabilities, there is no evidence why they do not use it even if it is available to them. 
One reason may be their limitation in using the computer. An Australian study on 
people with physical disability (Pell, Gillies, & Carss, 1999) showed that only 13% 
of the participants were aware of the assistive hardware or software and the cost was 
the major reason given as to why these devices were not used.  
The feasibility of conducting an online intervention in Australia has been examined. 
The Multi-Purpose Household Survey (MPHS) for 2006-07 showed that nearly 
three-quarters (73% or 6 million) of Australian households have access to a 
computer, and 5 million of these have Internet access. This is a five-fold increase in 





the number of household Internet connections in ten years. The survey also found 
that the Internet is used daily by half (50%) of all Australians over the age of 15, and 
almost all (91%) use it at least weekly. In 2003 46% of farms used the Internet as 
part of their business operations, an increase of three percentage points from the 
previous year. These figures are even higher in urban areas (Australian Bureau of 
Statistics, 2005). A great number of people with disabilities take advantage of this 
tool, too. In 2003, just under half (48%) of people aged 15 years or over with a 
disability (excluding persons with a disfigurement or deformity without any 
limitations), reported having used a computer in the previous 12 months (Australian 
Bureau of Statistics, 2002-2003). For the same period, almost 2 in 5 (39%) had 
accessed the internet. Therefore, based on Australian information, there is strong 
evidence that many individuals with chronic conditions have the ability to access the 
Internet. 
2.3 PART 2: FATIGUE IN NEUROLOGICAL CONDITIONS  
2.3.1 FATIGUE DEFINITION, PREVALENCE AND PATTERNS 
Fatigue is a common symptom experienced by virtually everyone during the course 
of their lives. Depending on the definition and the methods used to quantify fatigue, 
the prevalence of extreme fatigue may vary between 7% and 45% (Lewis & 
Wessely, 1992). It is possibly also the most common symptom to be found across all 
medical conditions (Abhijit.  Chaudhuri & Behan, 2004). For ease of presentation, 
extreme fatigue is referred to as ‘fatigue’ in this thesis.  
Fatigue secondary to chronic conditions is different from fatigue experienced by 
people without chronic conditions (Aaronson et al., 1999). Fatigue secondary to 
chronic conditions is associated with physiological and psychological manifestations 
which are not relieved by rest, sleep or positioning (Aaronson et al., 1999; Dittner, 
Wessely, & Brown, 2004; Swain, 2000) while an acute or ‘normal’ fatigue as a 
consequence of physical or mental efforts can be relieved by this way (Ream & 
Richardson, 1996). In chronic conditions fatigue is defined as “an overwhelming 
sustained sense of exhaustion and deceased capacity for physical and mental work at 
usual level” (North American Nursing Diagnosis Association, 2001, p.3).  





Fatigue is a common symptom in most of chronic neurological conditions such as 
MS, Parkinson’s disease (PD), post-polio syndrome (PPS), stroke and traumatic 
brain injury. Between 75 and 95% of individuals with MS report fatigue, with 50 to 
60% naming it as their worst or one of their worst symptoms (Fisk et al., 1994; Kraft 
et al., 1986; Krupp et al., 1988). Fatigue also occurs in 59 – 89% of individuals with 
PPS, which is probably the major and most disabling symptom in this chronic 
condition (Berlly, Strauser, & Hall, 1991; T. L. Packer, Sauriol, & Brouwer, 1994; 
Schanke et al., 2002). Two national surveys in the US showed that 91% of  polio 
survivors reported post-polio syndrome (PPS), a delayed syndrome characterised by 
excessive fatigue, with 41% reporting fatigue as significantly interfering with 
performing or completing tasks, and 25% reporting fatigue as interfering with their 
activities of daily living (Parsons 1989, as cited in Richard L. Bruno, Creange, & 
Frick, 1998). People with PD frequently report fatigue as well. A prevalence study 
by J. Friedman & Friedman (1993) using the modified version of the Fatigue 
Severity Scale (FSS) showed that 67% of 58 people with PD rated their fatigue as 
different to the fatigue experiences before the onset of the disease.  The people with 
PD were more fatigued than age-matched controls. More than 50% of participants 
with PD claimed that fatigue constituted one of the three most disabling symptoms of 
the disease. The authors followed up 26 of the participants for nine years. The results 
showed that 50% of the participants still were affected by fatigue, explaining it as 
one of the most disabling symptoms of their condition (Friedman, 2001). In another 
prevalence study of 245 people with PD, only 43% of the participants were 
experiencing fatigue; however, the reliability and validity of the fatigue scale used 
for the study was not discussed (Karlsen, Larsen, Tandberg, & Jørgensen, 1999). 
These clearly show the high prevalence of fatigue in people with chronic conditions 
compared with the prevalence of 7% to 45% in the population assessed as being 
without chronic conditions (Lewis & Wessely, 1992). Fatigue is also reported by 
more than half of people with stroke (Ingles, Eskes, & Phillips, 1999; Leegaard, 
1983) and is a common symptom of brain disease following the acute stages of brain 
injury (LaChapelle & Finlayson, 1998). Fatigue is the third most prevalent symptom 
of post concussion syndrome following headaches and dizziness (Middleboe, 
Andersen, Birket-Smith, & Friis, 1992).  





Research on fatigue in PD and PPS is still new; it is about 15 years since the first 
studies on PD fatigue by van Hilton et al (1993) were published. The number of 
studies on PPS fatigue is also limited. In contrast, study on individuals with MS has 
been an area of interest by researchers and clinicians for many years. Research on 
fatigue in MS commenced about 25 years ago therefore there is extensive evidence 
around fatigue in MS.  
The pattern of fatigue is very similar across diagnoses; it  can be easily triggered and 
is not relieved by rest, sleep, or positioning (Dittner et al., 2004; Swain, 2000). It 
occurs daily, worsens as the day progresses, can last up to 24 hours per day and has a 
lengthy recovery time (Fisk et al., 1994; Karlsen et al., 1999; Krupp et al., 1988; 
Lou, Kearns, Oken, Sexton, & Nutt, 2001; Schanke et al., 2002). This pattern can be 
seen in most neurological conditions including MS, PD and PPS (Abe, Takanashi, & 
Yanagihara, 2000; Richard L. Bruno et al., 1998; Friedman & Friedman, 1993; T. L. 
Packer, Martins, Krefting, & Brouwer, 1991). The only distinctive feature of fatigue 
related to MS seems to be the heat sensitivity; ninety percent of people with MS 
report that their fatigue worsens in warmer environmental temperatures (Freal, Kraft, 
& Coryell, 1984; Kos, Kerckhofs, Nagels, D'Hooghe, & Ilsbroukx, 2008). Although 
evidence suggests that MS fatigue may pre-date the onset of other symptoms (Bakshi 
et al., 1999), qualitative studies of the experience of fatigue report a close 
relationship between fatigue and exacerbation of other symptoms(Stuifbergen & 
Rogers, 1997; Yorkston, Klasner, & Swanson, 2001) including physical, cognitive, 
and emotional symptoms. 
2.3.2 TYPES OF FATIGUE  
The literature categorises fatigue in different ways. Fatigue, based on its origin, can 
be known as a primary symptom or as secondary to another symptom in a chronic 
condition. Fatigue may be the result from centrally mediated processes characterised 
by the disease, such as demyelination and axonal loss in the central nervous system 
or immune reactions or secondary to other variables. Both primary and secondary 
types of fatigue may occur simultaneously with each impacting on the other. Fatigue 
and depression also interact. Depression as a result of primary fatigue may cause 
decrease in activity level. This lower level of activity may in turn increase secondary 
fatigability as a result of deconditioning (Kos et al., 2008). 





The clinical approach to fatigue is to categorise it into two types: central and 
peripheral. Peripheral fatigue is a sense of exhaustion caused by repeated use of 
muscles. It can be due to disorders in muscle and neuromuscular junction and is 
frequently observed in neurological diseases as myasthenia gravis or Guilain-Barre 
syndrome (Merkies, Schmitz, Samijn, van der Meche, & van Doorn, 1999) as well as 
immunological diseases such as rheumatoid arthritis (Swain, 2000). This objective 
reduction in motor power is measureable by testing the rate of decline in peak force 
generated during maximum voluntary muscle contraction. Peripheral fatigue is a 
distinctive topographic pattern of myopathic weakness. Central fatigue is 
characterised by a feeling of constant exhaustion. People with central fatigue have 
difficulty with initiating or maintaining any voluntary physical or even mental 
activity (A. Chaudhuri & Behan, 2000; Hoehn & Yahr, 1967). This subjective sense 
of fatigue is essentially perceived at the level of the central nervous system (CNS) 
(Abhijit.  Chaudhuri & Behan, 2004). Both central and peripheral fatigue occur in 
PD, MS and PPS (R. L. Bruno, 1993; Friedman & Friedman, 1993; Karlsen et al., 
1999; Krupp & Pollina, 1996). 
Adding a time component to fatigue, it can be defined as acute fatigue or chronic 
fatigue. Acute fatigue is when fatigue exists for 6 weeks or less and chronic fatigue 
presents more than 50% of the time for more than 6 weeks (Bethoux, 2006). 
Fatigue has different dimensions: physical and mental (psychological and cognitive). 
Physical fatigue may happen after minimal physical effort and worsens as the day 
progresses. Mental fatigue is frequently reported in people with MS in the cognitive 
domains of memory, learning, attention, and information processing (Krupp & 
Pollina, 1996). In comparison, no impairments in verbal memory or enhanced 
cortical function has been seen in people with PPS but they show important deficits 
in attention and information processing speed (R. L. Bruno, 1993). Word-finding 
difficulty and anomia are examples of task-specific mental fatigue seen in persons 
with PPS (R. L. Bruno, 2000). Physical and mental fatigue are known as two 
independent symptoms in PD, too (Lou et al., 2001). Physical effort is reported after 
physical exertion and mental fatigue is reported after mental effort. Apathy is a 
characteristic symptom of people with PD (Isella et al., 2002). Therefore, although 





there are differences in fatigue dimensions between diagnoses, the overall pattern is 
similar in neurological conditions. 
2.3.3 CAUSES OF FATIGUE 
Despite its prevalence and pervasive nature, the cause of fatigue is unclear. Fatigue 
includes a complex interaction between biological, psychological and behavioural 
processes (Swain, 2000). There are several hypotheses for the origin of fatigue in 
MS: 1) an increased number and volume of lesions in the white matter 2) diffused 
axonal damage 3) progression in brain atrophy (Kos et al., 2008).  
The first two hypotheses have been rejected by research. Bakshi et al. assessed 
fatigue in 71 individuals with MS and categorised them into MS-fatigue and MS-
non-fatigue groups. The results of the study did not show significant correlation 
between fatigue severity and regional or global MRI plaque load or atrophy assessed 
by conventional sequences. No significant differences were noted in any MRI 
measures between MS-fatigue and MS non-fatigue groups. (Bakshi et al., 1999; 
Codella et al., 2002). Another study investigated whether the extent of cerebral grey 
matter (GM) pathology was associated with the presence and severity of MS-fatigue. 
Fatigued and non-fatigued participants (14 participants in each group) did not differ 
in terms of grey matter pathology of the cerebral cortex of the frontal lobe and basal 
ganglia. The authors concluded that structural grey matter pathology is not a major 
contributing factor to the development of fatigue in persons with MS.  
There is a hypothesis that the correlation of lesion load in brain and fatigue might be 
influenced by concomitant symptoms of MS like depression and physical disability. 
In a mixed method study (Colombo et al., 2000), fatigue was assessed by an 
interview and scored by the Fatigue Severity Scale (FSS). Two groups of MS 
participants, those with (n = 15) and those without (n = 15) fatigue, were matched for 
sex, age, disease duration, and scores on the Expanded Disability Status Scale score, 
Pyramidal Functional System score, and depression score. A significant association 
was found between the person scores on the FSS and the burden of MRI lesions (r = 
.5; p < .005). Significantly higher parietal lobe (p < .05), internal capsule (p < .05), 
and periventricular trigone (p < .05) lesion loads were found in persons with fatigue 
compared with the group without fatigue. This study also supported the third theory 





of a central nervous system origin of fatigue in people with MS (Colombo et al., 
2000). The study showed that in non-disabled non-depressed persons with MS, 
pathophysiological process of demyelination and axonal loss caused higher fatigue 
levels (Colombo et al., 2000). A longitudinal study including 134 people with MS 
suggested that fatigue predicts brain atrophy as opposed to being a consequence of 
the demyelination process (Marrie, Fisher, Miller, Lee, & Rudick, 2005).  
Several hypotheses have been proposed for cause of fatigue in PD: 1) altered 
activation of the hypothalamic-pituitary-adrenal system due to prolonged stress; 2) 
inflammatory processes; and 3) dysfunction in the basal ganglia and striato-thalamo-
cortical loop caused by change in neurotransmitters (Fumihito YoshiiHirohide 
TakahashiRyuya KumazawaSatoko, 2006). Degeneration of the axon sprouts can 
explain the new muscle weakness and fatigue in polio survivors, but what causes the 
degeneration in the first place remains a mystery (Halstead, 1998). In PPS, it seems 
that poliovirus-induced damage to the brain activating system is responsible for 
decreasing cortical activation, impairing attention and generating the symptoms of 
post-polio fatigue (R. L. Bruno, 1995). 
While both primary pathological mechanisms and secondary contributory factors on 
fatigue are extensively explored, research suggests that the etiology of fatigue is 
multi-factorial (Smith & Hale, 2007) and the nature of fatigue in MS, at least, 
appears to be more complex than other conditions (Smith & Hale, 2007).  
2.3.4 IMPACT OF FATIGUE ON DAILY LIFE 
There is evidence for reduced activity participation level and negative emotional 
consequences as a result of secondary fatigue in chronic neurological conditions. The 
impact of fatigue was mostly studied in the 1980-1990s. Krupp et al. interviewed 32 
people with MS and compared them with 33 healthy adults matched by age and sex. 
The MS participants suggested that MS fatigue was more severe and had more 
disabling impact on activities of daily living than fatigue experienced by the 
comparison group (Krupp et al., 1988). Their results were consistent with the results 
from Freal et al.’s (1984) study in which 309 individuals with MS were evaluated. 
Results of this study revealed that fatigue interfered with activities of daily living. 
Fatigue was worse for 83% after ‘vigorous exercise’ and for 64% after ‘moderate 





exercise’ although 15% reported that moderate exercise helped to reduce fatigue. But 
a study shows that the fatigue perceived during a physical or cognitive activity does 
not correlate with an objective reduction of observed performance (Parmenter, 
Denney, & Lynch, 2003). 
Packer, Sauriol and Brouwer (1994) used the FSS and the Human Activity Profile 
(HAP) to assess fatigue and activity level in people with and without chronic 
neurological conditions in comparison with a control group. Their study included 28 
people with PPS, 13 people with chronic fatigue syndrome, 9 people with MS and 11 
healthy participants. The participants with chronic conditions had significantly 
higher scores on the FSS and lower scores on the HAP compared to healthy 
participants. Their results support this hypothesis that higher fatigue may be 
correlated with decreased activity (or energy) levels.  Packer, Foster and Bouwer 
(1997) continued their research evaluating activity patterns of people with and 
without chronic fatigue syndrome. The results showed significant difference between 
the percentage of time spent by the two groups with respect to the variable of rests, 
work and productivity (work and household). The study also found that the 
participants with chronic fatigue syndrome spent less time on productivity and 
greater time in rest than the controls.  
Similar results are seen in studies on PD. People with PD who experience fatigue 
report that their fatigue prevents sustained physical activity (Hoff, Van Hilten, 
Middelkoop, & Roos, 1997). Fatigue was reported to be negatively correlated with 
self-report activities of daily living among people with  PD with FSS more than 4 
(Shulman, Taback, Bean, & Weiner, 2001). Gaber and Friedman (2003) found a 
significant inverse relationship between fatigue severity and leisure activity level, the 
frequency of vigorous physical activity and time spent performing daily tasks in 
people with PD. The results also showed that fatigue was correlated with more 
sedentary behaviour, lessened functional capacity for exercise and worse physical 
conditioning. In contrast, a study on individuals with PD showed that physical 
activity level of people with fatigue was not different from those without fatigue 
when it was measured objectively by waste-worn activity monitor (Hoff et al., 1997). 





On the other hand, evidence supports the idea that a higher level of activity can 
decrease fatigue levels. One study reported that a 4-week aerobic exercise 
intervention resulted in improvement on quality of life  and a tendency toward 
reduction in fatigue among people with MS (Mostert & Kesselring, 2002). Training 
consisted of 5×30 minute sessions per week of bicycle exercise with individualised 
intensity. Another example of negative correlation of fatigue and activity is a more 
recent study by Okan et al. (2004). Participants with MS and Expanded Disability 
Status Score less than or equal to 6.0 were randomly assigned to one of three groups 
lasting 6 months: weekly Iyengar yoga class along with home practice, weekly 
exercise class using a stationary bicycle along with home exercise, or a waiting-list 
control group. The participants in both active groups showed improvement on the 
Multi-Dimensional Fatigue Inventory, and the Short Form (SF)-36 health-related 
quality of life scores compared to the control group. This is while a cross-sectional 
study showed no relationship was between fatigue impact and spiroergometric 
parameters (Rasova, Brandejsky, Havrdova, Zalisova, & Rexova, 2005). However 
these studies only focused on structured activity rather than lifestyle activity.  
Morris et al. (2002) tested the relationship of observed fatigue and motor 
performance. It was expected that higher fatigue scores in the afternoon would 
accompany reduced motor performance as the day progressed. In the study 14 
individuals with MS and a similar number of matched controls were compared and 
no differences in gait pattern were found between morning and afternoon assessment, 
whereas fatigue scores increased in the afternoon. They concluded that the 
mechanisms for motor control and the subjective experience of fatigue were 
dissimilar (Morris et al., 2002).  
In addition to physical and activity participation limitations as a result of fatigue, 
emotional consequences are also pointed out in the literature in the literature on 
fatigue. Flenser, Ek and Soderhamn (2003) provided a thorough description of 
persons’ experience of fatigue in a qualitative study. A lowered sense of self-worth, 
feelings of shame, sorrow, and anger related to the perception of fatigue were the 
experiences that persons with MS described.  The debilitating nature of MS fatigue 
has a known impact on quality of life and health status (Amato et al., 2001; Benedict 





et al., 2005; Di Fabio, Choi, Soderberg, & Hansen, 1997; Lobentanz et al., 2004; 
Pittion-Vouyovitch et al., 2006; Stuifbergen & Rogers, 1997).  
Fatigue not only limits performance in daily life and at home but also it has a 
negative impact on work (Vercoulen et al., 1996). Changes in employment are 
increasingly associated specifically with the symptom of fatigue (Black  et al., 1994; 
National Health Priority Action Council, 2006). Fatigue is also reported as a central 
cause of MS persons being unable to maintain full-time employment (Jongbloed, 
1998). Chaudhuri and Behan reported that people with fatigue may be inactive and 
overstressed by not achieving a return to the same job (Abhijit.  Chaudhuri & Behan, 
2004). Financial pressure is another outcome of living with extreme fatigue. A study 
of 113 adults with MS who lived in urban and rural regions of Australia showed that 
fatigue was the major health variable that predicted cost of MS and its economic 
pressure (McCabe, 2003). 
2.3.5 FACTORS CORRELATED WITH FATIGUE  
Table 2.1 summarises studies regarding factors correlated with fatigue. Studies 
describing the relationship of fatigue with other variables are often limited by the use 
of cross-sectional correlation-based measures (either correlation coefficients or 
regression analyses), and therefore no conclusions can be drawn about the causality 
of the associations. Also the results are often contradictory. For example, while a 
study by K. M. Schreurs, D. T. de Ridder, & J. M. Bensing (2002) with 151 
individuals with MS showed no association between fatigue and age, gender, disease 
duration, and clinical activity , other studies found increased fatigue scores in people 
with higher age, lower educational level, longer disease duration, and progressive 
MS (Colosimo et al., 1995; Flachenecker et al., 2002; Lerdal, Celius, & Moum, 
2003). Studies on Parkinson’s disease also do not support the correlation of fatigue 







Table  2.1 Factors Correlated with Fatigue  
Fatigue correlate Result Population Reference 
Age Age significantly correlated with fatigue (r = .20, p < .01). 
 





(Lerdal et al., 2003) 
 
(Schreurs et al., 2002) 
Gender Fatigue not significantly different between females and males (p = .06). 
 





(Lerdal et al., 2003) 
 
(Karlsen et al., 1999) 
Depression Depression significantly correlated with fatigue (r = .44, p < .01). 
 
Depression significantly correlated with fatigue (r = .41, p < .01). 
 
Depression significantly correlated with fatigue (r = .45, p < .01). 
 
Depression significantly correlated with fatigue (r = .58, p < .01). 
 
General fatigue, physical and mental fatigue (beta  =  .34, .31 and .29 
respectively). The relationships persist when the effects of gender and 











(Kroencke, Lynch, & Denney, 
2000) 
(Flachenecker et al., 2002) 
 
(Schreurs et al., 2002) 
 
(Amato et al., 2001) 
 
 
(Havlikova et al., 2008) 






Table 2.1 continued 
Fatigue correlate Result Population Reference 
Type of MS Primary and secondary progressive MS people had higher fatigue  
scores than relapsing-remitting patients (F = 3.4, df = 2, 204, p = 
.012) but after controlling for age, disability level and time since 
diagnosis there was no difference between the groups.  
 
Positive relationship between fatigue and age (p < .001) among 
persons with primary progressive (when controlled for gender, level 















(Lerdal et al., 2003) 
Education Negative correlation between fatigue and education  
(r = -.15, p < .01).  
 
MS (Lerdal et al., 2003) 
Disease duration Positive correlation between fatigue and time since disease onset  
(r = .11, p < .05). 
 
The participants with fatigue and without fatigue were not 






(Lerdal et al., 2003) 
 
 
(Herlofson & Larsen, 2002) 
 






Table 2.1 continued 
Fatigue correlate Result Population Reference 
Disability level Fatigue significantly correlated with disability 
(r = .33, p<.0001). 
 
Physical fatigue was correlated with physical disability cross-
sectionally and the physical fatigue was predictor of physical 
disabilities of a year later. 
 
No correlation was found between the measures of fatigue and 
physical disability. 
 
FSS and disability level were correlated  
(rho = .43,  p= .003). But after controlling for depression, EDSS 














(Flachenecker et al., 2002; 
Kroencke et al., 2000) 
 
 








(Bakshi et al., 2000) 
 
Sleep quality Fatigue significantly correlated with disturbed sleep and abnormal 
sleep cycle (p = .003). 
 







(Attarian, Brown, Duntley, 
Carter, & Cross, 2004) 
 
 
(Taphoorn, Van Someren, & 
Snoek, 1993) 
Anxiety 33% of people with Parkinson’s disease with FSS>4 reported 
anxiety. 
PD (Shulman et al., 2001) 
 
Note. MS = Multiple Sclerosis; PD = Parkinson’s Disease.






Another example of incongruency between results of different studies is the 
association between disability and fatigue. Post hoc analyses in some studies have 
revealed that disability status was mainly responsible for the differences in fatigue 
scores between types of MS (Kroencke et al., 2000; Pittion-Vouyovitch et al., 2006; 
Schreurs et al., 2002). However, other studies show no relation between disability 
status and fatigue (Bakshi et al., 2000; van der Werf et al., 1998).  In a study of 71 
people with relapsing remitting or secondary progressive MS, Bakshi et al (2000) 
examined the relationship between disability (using the EDSS), depression 
(Hamilton depression Inventory, Beck depression inventory) and fatigue (FSS). 
Although a weak correlation was found between the level of disability and level of 
fatigue, this relationship disappeared once depression was accounted for (r = .27; p= 
.09). In this study, level of disability was recorded using EDSS which assesses only 
physical impairments. In order to assess function, the level of activity and 
participation should also be evaluated (World Health Organization, 2001).  
There is evidence that fatigue and depression are correlated. In research on people 
with PD (n=233) an association between fatigue and depression was demonstrated 
when disease severity, disease duration, levodopa dose, dementia and sleep 
medication were controlled in a multiple logistic regression analysis (odds ratio=1.2; 
B=.2, standard error=.04 and 95%confidence interval=1.1-1.3) (Karlsen et al., 1999). 
Bakshi et al (2003) also found a weak correlation between depression and fatigue 
which remained once disability was controlled. (r = .37; p=.02). A nine-year study 
(Friedman & Friedman, 2001) showed that fatigue was correlated with depression in 
people with PD. 
The literature also shows the relationship between change of fatigue and change in 
depression. In a study on 504 people with MS, increasing depression scores (using 
Zung’s Self-rating Depression Scale) were associated with increasing FSS scores (F 
= 4.55, p < .0001). In this study using regression analysis, EDSS, FSS and sleep 
quality were confirmed to be independent predictors of the mean depression score 
(R2=  .466; p < .0001) (Lobentanz et al., 2004).  
Limited research has been conducted to date to understand fatigue levels in people 
with post-polio syndrome. Berlly, Strauser and Hall (1991) surveyed 86 people with 






PPS and 20 healthy people by using the Fatigue Symptoms Questionnaire (developed 
by the authors) and the Beck Depression Inventory. The results showed that 64% of 
people with PPS had chronic fatigue and depression. 
While research to date suggests a low to high association between fatigue and 
depression, some researchers suggest this correlation may be a result of an overlap 
between fatigue and depression. However, there is evidence that even after 
controlling for this overlap, fatigue and depression are significantly correlated. A 
study on 207 individuals with relapsing-remitting, primary progressive or secondary 
progressive MS, a weak correlation between depressive mood and fatigue was found 
(r = .44; p < .001). In this study, a modified version of Self-reporting Depression 
Scale was used. This scale had a high internal consistency (Chronboch’s alpha 
score= .88) and excluded items related to fatigue (Kroencke et al., 2000). Kroencke 
et al. (2000) tested 207 individuals with clinically definite MS. The Fatigue Severity 
Scale and the Zung Self-rating Depression Scale were administered. Fatigue and 
depression were highly correlated (r = .58), even when the depression measure was 
corrected for items overlapping with fatigue and other symptoms or consequences of 
MS (r = .44). Fatigue and disability were also correlated (r = .33). Multiple 
regression revealed that both depressed mood and disability were significant 
predictors of fatigue, together accounting for approximately 23% of the variance in 
persons’ self-reported fatigue.  
A cross-sectional descriptive study on 78 people with MS showed that only some 
dimensions of fatigue are correlated with mood (Ford, Trigwell, & Johnson, 1998). 
Using the Fatigue Rating Scale (FRS) and Hospital Anxiety and Depression Scale 
(HADS) fatigue and mood were tested. Fifty eight participants scored their fatigue as 
severe. Both the mental fatigue score and the total fatigue score were positively 
correlated with depression and anxiety while there was no significant correlation 
between the physical fatigue score and depression and anxiety on the HADS.  
The relationship between fatigue and depression has also been explored by studies on 
effectiveness of depression treatments on fatigue levels. The treatment of depression 
is reported to be related to a reduction in the subjective severity of fatigue (Mohr, 
Hart, & Goldberg, 2003). Sixty persons with relapsing type of MS and moderate to 






severe depression were randomly assigned to one of three treatments for depression: 
an individual cognitive behavioural therapy arm, support group arm, and an 
antidepressant medication (sertraline) arm. The primary outcome measures were the 
Fatigue Assessment Instrument (FAI), and the Beck Depression Inventory (BDI). 
The effect of treatment on fatigue did not differ across the modalities and could 
therefore not be explained by a treatment specific mechanism. The total FAI and the 
global fatigue severity subscale were significantly reduced (p < .02). Secondary 
analyses showed that a change in global fatigue severity (a subscale of FAI) was 
associated with a change in BDI (p = .03) but change in total FAI was only 
marginally related to a change in BDI (p = .05). These relationships were due 
entirely to change in mood (p < .02) and not to change in cognitive or vegetative 
symptoms (p > .17). The authors concluded that treatment for depression is 
associated with reductions in the severity of fatigue symptoms, and that this 
relationship is due primarily to treatment related changes in mood. The strong 
evidence for the relationship between fatigue and depression shows the importance 
of considering depression level and change in depression when testing a fatigue 
management program. 
2.3.6 FATIGUE MANAGEMENT 
Management of fatigue includes pharmacotherapy and non-pharmacological 
interventions. Although effectiveness of different medications for managing fatigue 
have been reported (For example Cohen & Fisher, 1989; Kemp & Gora, 1993; T. J. 
Murray, 1985; Rosenberg & Appenzeller, 1988; Taus, Giuliani, Pucci, D'Amico, & 
Solari, 2003), systematic reviews do not confirm the results. A Cochrane Library 
systematic review showed that there is some support for using amantadine for fatigue 
in MS but the its efficacy in reducing fatigue in people with MS is poorly 
documented and there is insufficient evidence to make recommendations to guide 
prescription (Taus et al., 2003). Also, safety and efficacy of pemoline and potassium 
channel blockers is not established and primary studies have low quality (Brañas et 
al., 2000; Solari, Uitdehaag, Giuliani, Pucci, & Taus, 2008). 
A systematic review of treatment of fatigue in multiple sclerosis reviewed studies 
both from a pharmacological view and from a psychosocial/psychological 
intervention perspective (Lee, Newell, Ziegler, & Topping, 2008). Ten 






pharmacological studies were reviewed with moderate-to-high quality and showed 
statistically significant though modest impact on fatigue. The results for low–rated 
pharmacological studies were mixed with effectiveness of the interventions being 
absent to modest. Side-effects were noted as a problem in some pharmacological 
studies. The authors concluded that based on the studies reviewed there was no drug 
intervention that lead to reliable clinical decrease in fatigue in individuals with MS. 
In this study only 5 psychological/psychosocial studies (two studies on fatigue self-
management, one study on cooling therapy, one study on pulsed electromagnetic 
therapy and one study on yoga and exercise) studies were found and reviewed. The 
quality of these studies was assessed as moderate or moderate to low. The major 
criticism of these studies was use of a waiting list as control which could enhance 
positive treatment expectations in the control group. Therefore, the authors of the 
systematic review concluded that regardless of the quality of the studies, 
effectiveness of both pharmacological and non-pharmacological interventions was 
modest at best and often absent. However, grouping the studies with very different 
treatment approaches to one category (psychological/psychosocial) limits the 
strength and generalisability.  
Neill et al. (2006) reported the results of a systematic review on non-pharmacological 
interventions for fatigue in adults with MS, rheumatoid arthritis and systematic lupus 
erythemathous. The articles reviewed (n=36) were categorised into four groups: 
exercise, behavioural, nutritional and physiological. Ten different behavioural 
intervention types for fatigue were applied in 15 studies. Nine behavioural studies 
found statistically significant reduction in fatigue, but results were not always 
consistent across instruments used. The authors concluded low impact aerobic 
exercise may be effective in reducing fatigue in some adults with chronic auto-
immune conditions. A range of behavioural interventions including energy 
conservation, cognitive behavioural therapy, health education and some 
rehabilitation programs may be helpful in reducing fatigue in this group of 
population. The authors also suggested that the electromagnetic field service deserve 
further research due to promising results. However, results of this study may not be 
attributable to people with other neurological conditions and the diversity of 






interventions, designs and a broad range of instruments to measure fatigue limited 
comparison of the results.  
There are some other well-designed studies on non-pharmacological interventions for 
fatigue which were not included in the systematic reviews. In an RCT on people with 
multiple sclerosis, 51 participants with MS were randomly allocated to a 
multidisciplinary fatigue management program (MFMP) or a placebo intervention 
program (Kos, Duportail, D'Hooghe, Nagels, & Kerckhofs, 2007). The participants 
in the placebo group received the MFMP after 6 months. The MFMP showed no 
efficacy in reducing the impact of fatigue compared to the placebo group.  
A pre-post test study with people with mild to moderate MS evaluated the results of 
inpatient rehabilitation on symptomatic fatigue (Romberg, Ruutiainen, Puukka, & 
Poikkeus, 2007). The 3-week rehabilitation program included individual and group 
therapies. The participants were divided into fatigue (n=66) and non-fatigued (n=25) 
groups. The mean FSS scale score decreased by .34 points in the fatigue group while 
in the non-fatigue group it decreased by .23 points. The difference in change was 
significant between groups (p=.003) and a covariate analysis showed that this was 
strongly affected by a decrease in depression. However the long–term effect of the 
program was not evaluated.  
Energy conservation techniques are one of the behavioural interventions which have 
been taught by occupational therapists for many years to help people manage their 
fatigue (Multiple Sclerosis Council for Clinical Practice Guidelines, 1998). Energy 
conservation education involves teaching people to identify and develop 
modification to their daily activities in order to reduce fatigue. People learn to 
evaluate their energy expenditure for daily activities, determine ways of modifying 
these activities, evaluate their rest-activity ratio, use ergonomic principles to use their 
bodies more efficiently to perform tasks,  plan and balance  their daily tasks to 
manage fatigue and examine their use of adaptive equipment and community 
resources for fatigue management (Trombly & Radomski, 2002). Although there are 
many descriptions of strategies for energy conservation (Multiple Sclerosis Council 
for Clinical Practice Guidelines, 1998; Ward & Winters, 2003), there is no evidence 
for effectiveness of techniques when they are taught in an individual basis. In 






contrast, Managing fatigue: A six week course for energy conservation (T. L. Packer 
et al., 1995) is a published and standardised self-management group intervention for 
people with neurological conditions. This program is designed based on self-
management principles to be delivered in a group setting. Managing fatigue consists 
of six 2-hour sessions of highly structured classes with 7-10 participants per group. 
The primary aim of this course is “reducing disability by increasing an ability to 
participate in those self-care, productive, and leisure activities that are self-identified 
as important, meaningful, or necessary” (T. L. Packer et al., 1995, p.2).  
In examining the fatigue self-management program (T. L. Packer et al., 1995), 
Mathiowetz, Matuska and Murphy (2001) conducted a  repeated measure design 
study (n=54) which showed significantly less fatigue impact , increased self-efficacy 
and improved Quality of Life in MS clients. Mathiowetz, Finlayson, Matuska, and 
Yun Chen (2005) also carried  out a  randomised controlled trial study (n = 169). The 
results of the study showed an increase in quality of life (p < .05) and self-efficacy (p 
< .05) as well as a decrease (p < .05) in physical and social subscales of Fatigue 
Impact Scale (FIS) for persons with MS. A further study, which evaluated the effects 
of the program on fatigue impact for persons with progressive MS (n = 35), whose 
symptoms caused moderate to severe cognitive impairment, showed significant 
decrease in FIS scores after intervention and remained steady 8 weeks after course 
completion  (Vanage, Gilbertson, & Mathiowetz, 2003). Using wait list control 
groups is noted in a systematic review as the main critic for some of these studies 
(Lee et al., 2008) due to the possibility of enhanced positive treatment expectation 
events in controls. The results of Mathiowetz study (2005) were also confirmed by a 
pilot effectiveness study on group teleconference format of the fatigue self-
management program (Finlayson & Holberg, 2007). Twenty nine participants with 
MS showed significant improvement in fatigue and quality of life after participation 
in the program. Qualitative data were collected following the study to explore the 
strengths and limitations of this method of delivering of the fatigue self-management 
program. Technical issues, lack of time for sharing and lack of time to practice 
strategies were mentioned as limitations. Feedback from both the people with MS 
and the facilitators of the program showed the format to be convenient and relaxed. 






The authors raised questions about what therapists need to know to deliver telehealth 
interventions and the best strategies for preparing them for this delivery format. 
Lamb, Finlayson, Mathiowetz, & Chen (2005) continued the study to determine 
whether  there were any difference in the outcomes of individuals with multiple 
sclerosis who attended all six sessions of the Managing Fatigue program compared 
with people who missed a session and received a self-study module. The results 
showed that participants in both groups similarly benefited from the program. 
However, these participants attended 5 sessions of the course and could apply their 
gained self-management skills for the sixth sessions. A study on 32 Austrian people 
with MS also supported the results in the Mathiowetz et al studies added an 
examination of subjective sleep quality, demonstrating improvement post 
intervention that was still evident at 7-9 months follow-up (Sauter et al., 2008). 
Therefore, there is some evidence that the Managing Fatigue program is effective in 
improving fatigue, quality of life and self-efficacy in persons with fatigue secondary 
to chronic neurological conditions. 
With one exception, there is no systematic review specifically reviewing studies on 
the effect of fatigue self-management programs. The one exception is a study by 
Foster et al. (2007) which reviewed effect of self-management programs by lay-
leaders in which seven of the articles reviewed considered fatigue as one of the 
outcomes. The overall effect size for studies on 1836 participants in the interventions 
group and 1415 in the control group was 1.60 (p = .1).  
2.4 CONCLUSION 
While previous research has clearly documented the pervasive impact of chronic 
conditions on individuals and the community, meeting health care needs of the 
growing population of people with chronic conditions is a problem that most 
countries face. Traditional health care systems are primarily focused on prevention 
and control of acute illnesses leading to less emphasis, historically, on management 
of chronic disease, illness and/or disability. Further, evidence in Australia highlights 
the need for self-management programs to reach the right people, particularly those 
who have difficulty accessing services due to geographical location, transportation 
problems, work commitments or who lack the confidence to participate in face-to-






face programs. Based on the preceding review of the literature, research which 
addresses methods to overcome barriers for self-management programs is needed. 
Online interventions which are reported to be effective for different chronic 
conditions can be a practical solution for overcoming this barrier for accessing self-
management programs.  However, to date none have been reported in the literature. 
One of the most common and troublesome symptoms for people with chronic 
conditions is fatigue which has substantial negative impact on people’s lives. 
Although researchers have recently begun to investigate the different methods to 
manage fatigue for persons with chronic conditions, current evidence does not 
support effectiveness of most of them. Effectiveness of Managing Fatigue (T. L. 
Packer et al., 1995), a fatigue self-management program including skills to manage 
their activities, relationships and treatment based on their life style, is supported by 
the literature. This program is accessible in a face-to-face version and therefore only 
in metropolitan areas offering this service. Developing an online fatigue self-
management program and then testing it through an RCT, a gold standard to test 
intervention protocols, may help bridge the gap in the literature.  



















3 PILOT TEST 
3.1 INTRODUCTION 
Based on the British Medical Research Council (2000), a five-phase research process 
is required for development and evaluation of complex interventions. The pre-
clinical phase (to explore relevant theory and literature) and the modeling phase (to 
outline the perceived active components of the program in greater detail) were 
completed prior to this PhD project as was the prototype of the online program 
designed based on Managing Fatigue (T. L. Packer et al., 1995). This pilot study 
focused on the third phase of evaluation of a complex intervention i.e. exploratory 
trial. The literature emphasises the need for pilot testing of online interventions once 
they are developed in order to determine issues of feasibility, usability and efficacy 
(Eng, 1999; Ritterband et al., 2003). In health research, pilot studies are also of 
particular importance in answering questions with regards to study populations and 
sample size (G. L. Anderson & Prentice, 1999). Pilot studies are critical in 
determining the overall feasibility of a study, serving to highlight issues relating to 
implementation, methodology, and operationalisation of research concepts (Altam, 
1991; Portney, 2000). They enable the trialing of data collection measures, 
techniques and consent forms (Lancaster, Dodd, & Williamson, 2004). Therefore, 
this chapter aims to describe the final development and pilot testing of the online 
fatigue self-management program (Online FSM).  
3.2 METHODS 
3.2.1 OBJECTIVES AND STUDY DESIGN 
The online FSM was based on the face-to-face protocol developed by Packer et al. 
(1995). As noted, the prototype for the online FSM program was designed via the 
‘AussieNet Project’ funded by Lotterywest and was a separate project to this PhD 
study.  The project began with deconstruction of the face-to-face program and 
reconstruction into an online prototype; the online FSM program. The PhD study 
commenced once the prototype design was complete and pilot testing included a 
formative evaluation (to test the usability of the program) (Objective 1) and a 
preliminary efficacy study (to test the efficacy of the program and the feasibility of 
the RCT following this study) (Objective 2). Formative evaluation involves a 





comparison of program implementation with program plans, allowing for a 
reconsideration of program features. Feedback gathered via formative evaluation in 
one pilot test was used in subsequent stages to help improve the program (C. 
Mowbray, Holter, Teague, & Bybee, 2003). Also, suggestions from participants were 
solicited and aspects of the online FSM that needed improvement were identified. 
The formative evaluation included three pilot tests. During and after the pilot tests, 
feedback from users and facilitators was sought and electronic program records 
scrutinised. The collected information was used to further improve the protocol. Pilot 
Test 3 of the formative evaluation provided the opportunity to undertake a small, 
preliminary efficacy study (Objective 2) using a single group pre-test, post-test 
design. This resulted in a standardised program to be tested in the RCT phase of this 
PhD project.  
For ease of understanding, the development stage, including initial prototype design, 
is briefly described in the present chapter. The relationship between each stage of 
development, a summary of findings at each stage and the relationship between the 







Figure  3.1 The Development and Evaluation of the Online Fatigue Self-management Program (Online FSM) 
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3.2.2 PROTOTYPE DEVELOPMENT (AUSSIENET PROJECT) 
The literature suggests online programs should be founded on well-researched face-
to-face programs (Medical Research Council, 2000). As described in the literature 
review, the face-to-face Managing Fatigue program (T. L. Packer et al., 1995) has 
demonstrated effectiveness (Mathiowetz et al., 2005; Mathiowetz et al., 2007). In 
order to transform the face-to-face program to an online format, information was 
gathered via a reference group consisting of participants from previous research 
projects testing face-to-face programs, the primary author of the program (T.L. 
Packer) and experienced facilitators of the face-to-face FSM. All participants in the 
focus groups had been participants in recent self-management research projects. The 
group deconstructed the face-to-face version identifying key components of the face-
to-face program (Table 3.1 and Appendix A).  The deconstructive process included 
an open discussion of aspects of the self-management program most valued by 
participants, those that most assisted with attitude and behaviour change and those 
that should be retained. Through prompting and use of open questions and frequent 
summaries, participants came to consensus on key components. This process was led 
by an educationalist independent of the program but familiar with self-management 
programs generally. Interestingly, past participants emphasised the self-management 
format of the program (use of problems solving, discussion etc) as being key to 
success, with the content seen more as a vehicle or structure for the process.  This 
insight allowed development of a prototype and formed the basis for decision making 
in subsequent stages.   
Table  3.1 Key Components of the Fatigue Self-management Program 
Components  Participants valued 
Sharing stories Personal narratives and story telling as a basis for validation, 
support and new learning. 
Activities Trial and error as a way of testing new strategies. 
Information The chance to use/learn problem solving; to personalise and choose 
strategies to make changes based on the information provided. 
Group Interaction The opportunity to ‘give’ as well as ‘receive’ in the group. 
Health professional Facilitation by a knowledgeable health professional. 
 





In addition to the key components required, focus group recommendations also 
included technical characteristics.  It was determined that the online FSM should:  
 be easily accessible and user-friendly for participants with limited computer 
knowledge and literacy (defined as the ability to use the internet for simple searches 
and send/receive emails); 
 use asynchronous participation, such that participants could logon and remain 
online at their convenience; 
 expect a weekly commitment of approximately 2-3 hours per week, similar to 
participation in the face-to-face version (both from the facilitator and the 
participants); and 
 require individual usernames and passwords to enter the online program. 
Following deconstruction and identification of key components, the online FSM was 
reconstructed ensuring key components were embedded in the prototype.  The final 
step in producing the prototype was identification of an internet platform that met the 
technical considerations and had the potential to provide new information, enable 
communication between group members and allow completion of activities online. A 
potential platform was identified and the technical aspects of producing the prototype 
were undertaken, ready for pilot testing by participants. 
3.2.3 PILOT STUDY 
3.2.3.1 PARTICIPANTS  
Each pilot test employed a sample of convenience. This recruitment method is 
acceptable when a pilot study is used for verifying procedures (Portney 2000). The 
online program was designed for a minimum of 8 and maximum of 12 people, hence 
the pilot study used a similar group size. In order to allow for attrition (estimated at 
20%) 10-11 people were recruited for each of the pilot tests (goal of 8 per group after 
attrition).   
Potential participants contacted the researcher in response to published information: 
fatigue self-management program flyers, notices in associations’ newspapers and/or 
emails circulated by the Western Australian Multiple Sclerosis Society, Post Polio 





Network of WA, Chronic Fatigue Syndrome Association and Parkinson’s Disease 
Association. This method of recruitment was chosen to avoid a sense of coercion that 
may arise from patient/health professional relationships.  
The criteria used to recruit participants were the same as those to be used later in the 
RCT part of this study. The selection criteria included confirmed diagnosis of 
multiple sclerosis, post-polio syndrome, Chronic Fatigue Syndrome or Parkinson’s 
disease, 20 years of age or older, self-reported access to the internet three times per 
week for at least one hour, and a Fatigue Severity Scale score of 4 (the cut off score 
for extreme fatigue) or higher (Krupp, LaRocca, Muir-Nash, & Steinberg, 1989). 
Except for the diagnosis which was confirmed via a letter from participants’ 
physicians, selection criteria were addressed through a screening telephone 
interview. Potential participants were excluded based on previous participation in the 
Managing Fatigue program (Face-to-face FSM) or poor cognitive ability. In Pilot 
Test 1, the Telephone Interview for Cognitive Status (Brandt & Folstein, 1987) was 
used as  a screening test and a score below 20 was used to exclude interviewees from 
the study. In Pilot Tests 2 and 3, a score greater than 9 on the Memory Orientation 
Concentration Test (Katzman et al., 1983) was used as the cut off score for 
exclusion. Cognitive ability was considered as an exclusion criterion in order to 
consider safety of the participants. The reason for this change in explained in the 
results (section 3.3.3). People with moderate or severe cognitive impairment were 
not predicted to be able to use the internet efficiently and be able to benefit from the 
program.  
3.2.3.2 PROGRAM FIDELITY 
Fidelity is defined as the extend to which delivery of an intervention adheres to the 
protocol or program model originally developed. It assures that the treatment being 
studied is delivered in a way that accurately reflects the underlying intervention 
principles (C. T. Mowbray, Holter, Gteague, & Bybee, 2003). Attention to fidelity 
advances the study aims (Horner, Rew, & Torres, 2006) and supports the 
researcher’s conclusion about the association between the intervention and the study 
outcomes (Calsyn, 2000).  In this study, to enhance the intervention fidelity, different 
methods (training the facilitators and monitoring the intervention) were employed to 
ensure that internal validity of the study was maintained (compared with the face-to-





face FSM) and external validity was enhanced (Horner et al., 2006). Moreover, 
preparing a manual for use in a clinical trial enhances fidelity (Burgio et al., 2001). 
In a treatment manual, the intervention being tested must be described as precisely as 
possible so that program facilitators can be trained and the programs delivered in a 
consistent and reproducible manner (Luborsky & DeRubeis, 1994). The manual 
provides a detailed plan documenting each step of the program and how to 
implement it. Therefore, during the process of pilot testing of the online FSM, a 
facilitator manual was developed consisting of instructions for both technological 
and therapeutic facilitation.  
3.2.3.3 DATA COLLECTION   
Formative Evaluation: During the three pilot tests, data for the formative evaluation 
was collected in four ways: telephone interviews or focus groups (depending on 
whether the participants had access to transportation), login data and electronic 
records. Telephone interviews (at the completion of each pilot test and fortnightly 
during Pilot Test 3) and focus groups (at the completion of each pilot test) were 
conducted with participants using guided open-ended questions. This approach to the 
evaluation was used to obtain an in-depth understanding of the strengths and 
weaknesses of the intervention from the perspective of consumers (Dehar, Casswell, 
& Duignan, 1993). Feedback from facilitators was obtained through face-to-face 
interviews. Participants’ and facilitators’ directly relayed their experiences with and 
opinions of the program. The questions included exploration of technical problems in 
accessing different parts of the program, including use of interactive activities and 
participation in group discussions. The interviewer was familiar with the program but 
was not a member of the design team.  Participants in Pilot Test 3 agreed to share 
their experiences and opinions about the online FSM directly with the researcher 
through fortnightly telephone interviews. These interviews gave the design team 
opportunity to make requested changes and seek feedback concurrently with running 
the pilot test. All information from the focus groups and interviews were tape-
recorded and transcribed.  
Login data provided quantitative information both on participants’ interactions with 
each other and with the program. Participant usability of the program was examined 
by tabulating the number of ‘hits’ (different pages viewed) and ‘posts’ (contributions 





through comments, submissions, activities completed) by each participant. Tracking 
participants’ navigation in the online FSM demonstrated technical problems and 
navigation issues. Data from participants’ activities online, the amount of time they 
spent to explore different parts of the program and login errors were recorded by the 
platform. Electronic records (group discussions and completed activities) were used 
to gather information on how the participants interacted with the program, other 
participants and the facilitators.   
Efficacy Evaluation: During Pilot Test 3, pre-test (socio-demographic and outcome 
data) and post-test (outcome data) data were collected using paper-based 
measurements sent to participants’ preferred address. Socio-demographic 
information included gender, age, education, marital status, living arrangement, 
socio-economic status and first language.  The independent variable was the online 
FSM prototype described earlier.   
The outcome variables were selected based on the literature, tools previously shown 
to be effective in evaluating the face-to-face program (Mathiowetz et al., 2005; 
Mathiowetz et al., 2001) and in preparation for the RCT part of the project. All 
measures were tested to examine response burden and time for completion in order to 
test the feasibility and practicality of data collection. Given variables were tested at 
pre-test by using paper-based versions of the measurements sent by post to 
participants’ preferred addresses. This method of data collection was chosen because 
some of the participants in the face-to-face FSM part of this PhD study were not 
expected to have access to the internet to complete the questionnaires online. 
Whenever possible, Australian outcome measures or those with Australian norms 
were selected. The outcome measures used for this study are described below. 
The Personal Wellbeing Index is a measure of subjective quality of life (Cummins, 
Eckersley, Pallant, van Vugt, & Misajon, 2003). It is a self-administered tool, of 7 
items, each rated on a Likert scale of 11 points. It has strong validity (r = .78) and 
reliability (Cronbach alpha between .70 and .85) (Cummins et al., 2003). It was 
judged more suitable than the SF-36 as it was originally designed for Australian 
people and is shorter in length. Also, the SF-36 is reported to have floor and ceiling 





effects for people with MS (Freeman, Hobart, Langdon, & Thompson, 2000; Hobart, 
Freeman, Lamping, Fitzpatrick, & Thompson, 2001). 
The Fatigue Impact Scale (FIS) (Fisk et al., 1994) was used to measure the impact of 
fatigue on individuals’ lives. The FIS is a valid and reliable measurement tool 
recommended for evaluating efficacy of fatigue management interventions such as 
energy conservation education for persons with MS (Mathiowetz, 2003). The FIS has 
three subscales: cognitive, physical and psychosocial. Subjects were asked to rate the 
extent that fatigue had caused problems for them in relation to 10 items of cognitive 
functioning, 10 items of physical functioning, and 20 items of psychosocial 
functioning using a five point scale (0 = no problem, 1 = small problem, 2 = 
moderate problem, 3 = big problem and 4 = extreme problem). The maximum FIS 
score is 160 with greater scores indicating higher impact of fatigue on the 
individual’s life. It has strong psychometric properties: internal consistency (r = .93), 
a moderate correlation (r = .51) with the Sickness Impact Profile (construct validity) 
and is able to discriminate between people with MS and hypertension (discriminant 
validity) (Dittner et al., 2004). 
The Australian version of the Activity Card Sort (ACS-Aus) (T. L. Packer, Boshoff, 
& Desleigh, 2007) was used to assess participants’ current activity level by sorting 
82 activities into 4 categories (‘have not done in the last 5 years’, ‘gave up due to 
illness’, ‘beginning to do again’ and ‘do now’).  The ACS-Aus, a well known 
occupational therapy assessment, has been used successfully in another RCT testing 
a self-management program for people with vision impairment (S. J. Girdler, 2006). 
It allows participants to describe the impact that an illness or disability has had on 
their activities. As the ACS-Aus is administered face-to-face, and data collection in 
this study was undertaken via post, a pen and paper version of the ACS-Aus was 
used. The questionnaire included a checklist of the activities but the pictures from the 
ACS-Aus were not included. Scoring was undertaken according to the manual. The 
ACS-Aus has demonstrated moderate concurrent validity (r = .434), moderate 
convergent construct validity (r = .354), and strong discriminative validity (p = .000) 
(Doney & Packer, 2008). Three scores can be calculated; retained activity level, 
current activity level and previous activity level. In this study, retained activity level 
was used as one of the primary outcome measures.   





The Depression Anxiety and Stress Scale (DASS) is a self-report measure with three 
subscales: depression, anxiety and stress. Each of the three DASS subscales contains 
14 items divided into subscales of 2-5 items with similar content. Participants rate 
the extent to which they have experienced each symptom over the past week, on a 
four-point severity/frequency scale. Internal consistency (coefficient alpha) for each 
scale in a large clinical sample (n = 437) were: Depression .96; Anxiety .89; and 
Stress .93 (T. A. Brown, Chorpita, Korotitsch, & Barlow, 1997). Lovibond and 
Lovibond (1995) have demonstrated that the DASS Depression scale and the Beck 
Depression Inventory are strongly correlated (r = .81)(concurrent validity).  
The 11-item Duke Social Support Index (SSI) was used which is a standard self-
administered measure (Koenig et al., 1993). It consists of two subscales: the social 
interaction subscale with four items and the satisfaction subscale with seven items, 
which provide both a subjective evaluation of the adequacy of support received and a 
more objective evaluation of the type and number of social interactions (Goodger, 
Byles, Higganbotham, & Mishra, 1999). Goodger et al. (1999) evaluated the 
reliability and validity of the scale in a large sample of 565 Australian community 
dwelling people aged 70 years and over. They reported that the scale had good 
internal consistency (alpha = .77) and test-retest reliability (correlation of .70 to .81). 
Compared to the Multidimensional Scale of Perceived Social Scale which is 
designed for adolescents and young adults, the DSSI is a more suitable measure for 
participants who were 30 years old or over. 
The Generalised Self-efficacy Scale (GSE) (Schwarzer, 1993) was used in this 
research as self-management programs are underpinned by Bandura’s self-efficacy 
theory. The GSE is a uni-dimensional scale with a high level of internal consistency 
(alpha = .93) in the original German version. The English version of this scale has 
also been reported to have high internal consistency (alpha = .88) and test-retest 
reliability of .63 over a four month period (Barlow, Williams, & Wright, 1996). 
Essential Computer Skills Test: Because there is no standardised measure for 
measuring computer competency at a very basic level, a researcher-constructed 
measurement tool was used to examine participants’ ability to use computer. This 





tool examined typing, clicking and scrolling skills. Five simple questions were asked. 
Time to complete the test was calculated in seconds (Appendix B). 
3.2.3.4 DATA ANALYSIS  
Formative Evaluation: Audio taped focus groups and interviews were transcribed 
verbatim and views of participants and the facilitators were reviewed on an on-going 
basis.  Suggestions for change were taken into consideration either between pilot 
tests, or in the case of Pilot Test 3, during the running of the seven week program. 
Numerical data from electronic records was entered into SPSS 15.0 for Windows and 
analysed using descriptive statistics to characterise the shape, central tendency, and 
variability within login data to describe how participants accessed and used the 
program. After each pilot test, Mann-Whitney U tests were used to evaluate the data 
from electronic records between pilot tests.  
Efficacy Evaluation: Data from all outcome variables were entered into SPSS. 
Demographic characteristics were analysed using descriptive statistics. Because the 
sample was small and a sample of convenience, the Wilcoxon signed-ranks test, a 
nonparametric statistical procedure was used to test for changes over time on quality 
of life, fatigue and activity participation (Portney & Watkins, 2008). 
3.2.4 ETHICS 
Formative Evaluation: Ethics approval for the pilot study was obtained from the 
Curtin University Human Research Ethics Committee (Approval number OT-2005-
14). The focus group and telephone interviews were audio-taped. Information 
obtained as part of these discussions was treated as confidential and participants 
could not be identified after the group. At no time were people outside of the focus 
group able to identify individual responses. While other members of the group were 
reminded about confidentiality, the researcher was unable to guarantee total 
confidentiality among other members. Participants were aware of this prior to 
participation.  
An individual username and password to enter the online program were provided to 
each participant, the facilitators and the administrator. Participants were informed 
that the Curtin University IT staff responsible for providing support for the program 





had access to the program. The first name and a picture of participants were added to 
the program only if they gave verbal consent to the researcher during the telephone 
interview. Otherwise, a pseudonym and a symbol, chosen by the participants, were 
used in the online FSM (Appendix A).  The participants were ensured that complete 
confidentiality was ensured in any publications or presentations that arise from the 
research and no personal details would be published.  
Efficacy Evaluation: Ethics approval for the efficacy study was obtained from the 
same ethics committee as above (Approval number OT-2005-14). The researcher did 
not have a direct role in recruiting participants to the study. Participants interested in 
participating in the study contacted the researcher directly.  Their participation was 
voluntary and they were free to withdraw at any time. Participants were asked to give 
verbal consent during the screening interview.  Based on this consent, pre-test 
questionnaires were sent to them via post.  Return of the questionnaires was taken as 
implied consent which was clearly stated in the covering letter sent with the 
questionnaires.  
The screening interview addressing the selection criteria was conducted with each 
potential participant. At the beginning of this interview, an in-depth verbal 
explanation was given of the purpose of the study, the process of intervention and the 
use of the findings. It was emphasised that although a summary of the findings from 
the study may be published, the participants’ personal results were confidential and 
would not be divulged. Participants’ freedom to withdraw from the intervention at 
any time was highlighted. All participants were allocated an identification number. 
The ‘key’ to the identification code was stored in a locked filing cabinet separate 
from data set. All questionnaires were identified by number only.  
3.3 RESULTS 
3.3.1 FORMATIVE EVALUATION (OBJECTIVE 1) 
Demographic characteristics of the participants in the three pilot tests are presented 
in Table 3.2.  No participant was excluded based on the score on the Memory 
Orientation Concentration Test (Katzman et al., 1983). Participants came from a 
wide age range (from 26 to 77) and thus feedback allowed the program to be 
developed to suit participants with various backgrounds, life experiences and 





computer skills. For ease of presentation, an overview of flow of the participants and 
results of each pilot test are presented first. This is followed by more detailed 
explanation of how each component of the program was further developed and 
refined using the information obtained in each pilot test. 
Table  3.2 Demographic Characteristics of Participants in the Three Pilot Tests 
Participant 
characteristics 
Pilot Test 1 Pilot Test 2 Pilot Test 3 






Age Range 38-75  
Mean = 54.20± 11.71 
Range 26-77 
Mean = 50.27 ±16.16 
Range 27-66 
Mean = 47.38 ± 12.6 
Diagnosis 1 person with PD 
9 persons with MS 
1 person with PD 
3 persons with PPS 
5 Persons with MS 
1 person with MS and 
PPS 
2 persons with PD 
9 persons with MS 
Total 10 11 11 
Note. PD = Parkinson’s Disease; MS = Multiple Sclerosis,; PPS = Post Polio Syndrome. 
 
Flow of participants in the three pilot tests is shown in Table 3.3. In Pilot Test 1, 
none of the participants were able to complete the program; technical problems 
encountered included difficulty uploading the content and accessing the program.  
The web-site was hosted off-shore, as was the technical support, making 
communication between researchers and internet administrators difficult.  Loading 
content and changing settings were hampered by an eight hour time difference. 
Therefore, it was decided that the platform was not acceptable for the program. 
Although none of the participants in Pilot Test 1 completed the program, they agreed 
to give feedback to help improve the program. A focus group was conducted with 3 
participants; telephone interviews were completed with 3 other participants and the 
two facilitators of the program. At the completion of Pilot Test 1 it was concluded 
that the chosen electronic platform was not compatible with Australian systems. 





Table  3.3 Flow of Participants in the Pilot Tests and Reasons for Non-completion 
Number of participants  
Pilot Test 1 Pilot Test 2 Pilot Test 3 
Recruited 10 11 11 
Number withdrawn before start of 
program 
2 0 2 
Number not logged into the 
program  
1 5 1 
Not interested in completing the 
course for personal reasons 
1 0 1 
Not interested in completing the 
course as a consequence of 
technical problems 
6 4 0 
Active participation until end of 
the program 
0 2 7 
 
In Pilot Test 2, only two of the participants completed the program. Five did not 
complete the program as a consequence of technical problems. As most of the 
participants in this pilot test were living in rural or remote areas, a focus group was 
not possible. Telephone interviews with 6 of participants who had logged into the 
program provided suggestions for improving the program and preparing it for the 
next pilot test. A list of technical problems was prepared based on the login data, 
electronic records, telephone interviews with the participants and a focus group with 
the facilitators. Login data and electronic records provided by the platform were also 
used to improve the program. These data guided the design team to track the 
participants’ movements in the program and to find an explanation for each of the 
technological problems. Electronic records of the administrator (IT expert) and login 
data of the online FSM resulted in a more developed program to be evaluated in Pilot 
Test 3.   
Eight participants started the program in Pilot Test 3. One of the participants in the 
Pilot Test 3 decided to withdraw from the program in the fourth week. She had 
recently been diagnosed with MS and stated that participating in the program was 





upsetting her as she learned more about possible consequences of MS. The seven 
other participants remained active till the end of the program. Telephone interviews 
with the participants every fortnight during and at the end of the program provided 
the possibility to make immediate changes week to week.  
As explained, none of the participants in the Pilot Test 1 were able to complete the 
program (Table 3.3). Based on the problems in administration and local access, 
criteria were established for selection of a new platform to house the online FSM: 1) 
local control of the site; 2) researcher and facilitator access to login data and 
participant electronic records; 3) ease of navigation by participants; 4) capacity for 
interactive, online communication and ease of completion of activities without the 
need to upload or download files; and finally, 5) likelihood of WC3 compliance for 
people with disabilities.  With the added advantage of using open source coding, the 
platform called Moodle Version 1.7 (http://moodle.org; accessed 2006) originally 
developed in Australia, was judged to meet these criteria. This platform is free and 
uses open source coding. The content was uploaded to the new platform with in-built 
Moodle features used to create key components of the fatigue self-management 
program (online information, online activities, and communication facility for 
sharing stories).   
Having local control of the online program facilitated the administration thereby 
smoothing progression of the designing process. The login data and electronic 
records were easily accessible both for the administrator and for the facilitators 
during Pilot Tests 2 and 3. Availability of the three other features (ease of 
communication, completing activities and navigation) and ease of facilitation were 
also tested and are explained thoroughly in separate sections below. 
3.3.1.1 ONLINE GROUP COMMUNICATION 
The number of posts by participants is shown in Table 3.4. In Pilot Test 1, the 
interactive components of the platform proved to be complicated and restricted. Only 
4 posts occurred in the program as a result of the complexity. Consultation with the 
IT staff revealed that changing the platform was the way to solve this major problem. 





Communication was facilitated in Pilot Test 2 using ‘forums’ (an in-built feature of 
Moodle) as interactive features in the Moodle platform. Although the results of the 
interviews showed that participants were interested in group communication, the 
total number of posts by all of the participants remained limited to 42 posts over the 
seven week period (Mean = 7 per participant, Rang from 0 to 34 posts). Based on the 
interview data, it was clear that this low rate of posts was the result of difficulties in 
accessing the group communication facility.  
In Pilot Test 3, the forums were designed to be easily accessible from the front page 
of the program, and all forum discussions were posted to all participants’ email 
addresses. Participants could read and reply to the forums directly from their emails.  
Results of the interviews showed that the forums were very popular for the 
participants. The number of posts by participants in the program from Pilot Test 2 to 
Pilot Test 3 was compared. A Mann-Whitney U Test showed a trend toward 
significant improvement (p = .081) from Pilot Test 2 (Median = .5, range = 0 to 34) 










into the program 
Number of ‘Hits’ Number of ‘Posts’ 
by facilitators 
Number of ‘Posts’ by 
participants 
Number of activities 
completed online 
Pilot Test 1 7 Not recordable 12 
Total = 4 
Mean a = .57 
Median = .0 
Range = 0 - 3 
0 
Pilot Test 2 6 
Total = 1006 
Mean = 168 
Median = 70 
Range 18-573 
55 
Total = 42 
Mean = 7 
Median = .5 
Range = 0 - 34 
0 
(4 activities were completed 
offline and feedback was 
given to the  group) 
Pilot Test 3 8 
Total = 3560 
Mean = 444.75 
Median = 394.5 
Range 144-875 
85 
Total = 94 
Mean = 12.62 
Median = 12.5 
Range = 3 - 30 
Total = 78 
Mean = 9.75 
Median = 11.00 
Range = 2 - 13 
 a Mean scores are calculated per participant. 





3.3.1.2 COMPLETION OF ACTIVITIES 
Completing the activities online was not possible in Pilot Test 1. Participants had to 
complete them offline and then upload the created file to the program. This process 
proved to be too complicated to be manageable by participants with limited computer 
knowledge. Feedback from the focus groups and the telephone interviews showed 
that none of the participants were able to follow the instructions for uploading the 
files. 
In Pilot Test 2, activities were created as downloadable Microsoft Word documents 
in the online program. A hard copy was also sent in the ‘The Guidebook and 
Activities’ via mail. Participants were asked to complete the activities on the hard 
copy and give feedback to the group. Interviews with facilitators indicated that the 
feedback provided by participants was not sufficient to start any group discussion.  
In Pilot Test 3, the format of activities was changed. They were presented online in 
the format of multiple choice questions, drop down menus and short answer 
questions in the form of a ‘quiz’, another in-built feature of Moodle. Completing 
these activities required only limited computer knowledge. The activities were easy 
to complete and the instructions were clearly understandable. To further assist, a hard 
copy of the activities was included in the ‘The Guidebook and Activities’ posted to 
participants at the start of the program. Most of the participants (7 out of 8) used the 
activities online and reported them to be helpful while one participant preferred to 
use the hard copy. The mean number of activities completed online by the eight 
participants was 9.75 out of 13. During the telephone interviews, participants 
reported the usefulness of having the hard copy of the activities available at the same 
time as completing them online. Facilitators reported that their feedback to the 
completed activities started new discussions in the group. During the fortnightly 
telephone interviews, the participants reported only one technical problem in the 
activities.  The short answer questions allowed entry of only 14 characters; this was 
not suitable for some of the questions which required longer answers. This problem 
was overcome by using another feature of the Moodle platform called as ‘journal’ 
which let participants complete answers with the same facilities as a Microsoft Word 
document.  






In Pilot Test 1, four of seven participants who logged into the program needed 
considerable phone coaching to enter the site and ‘get started’. Interview data 
determined that this occurred as a result of complexity of the website address and 
unavailability of any guidance for participants. Interviews with the participants also 
showed that all had difficulty with navigation in the program - particularly if they 
had limited computer skills. Consequently, none of the participants in Pilot Test 1 
completed the program. 
As noted, prior to Pilot Test 2, ‘The Guide Book and Activities’, which explicitly 
outlined the navigation methods, was posted to the participants. An orientation week 
was also added. During the orientation week the participants had the opportunity to 
become more familiar with the program and have any technical problems resolved by 
the facilitators. As a result, only two of the participants needed additional guidance to 
start the program. The total number of hits by the six active participants during the 
seven-week course was 1006 (range from 18 to 573, Mean = 168).  Interview data 
revealed that navigation was easy for participants, particularly those with better 
computer skills. The orientation week gave participants time to become familiar with 
the program and to introduce themselves to each other. A drop in the number of 
participants logging in after the fourth day of the program showed that one week was 
too long for orientation.  
The guidebook was reviewed and more details about navigation were added. Then it 
was sent to participants prior to commencement of Pilot Test 3. During the program, 
participants were contacted fortnightly by the researcher to check for problems and 
positive components of the program. Only minor navigation difficulties were 
reported. All of the problems were immediately overcome. During the last two weeks 
of the program no technical or navigation problems were reported by participants or 
facilitators. Over the seven-week period, the mean number of ‘hits’ per participant 
was 445 (range 144 – 878) with the 8 participants registering a combined total of 
3560 ‘hits’ (Table 3.4). Mann-Whitney U Test showed a significant increase in 
number of hits by participants in Pilot Test 3 compared to Pilot Test 2 (p = .021).  
The online FSM designed with the Moodle platform was accessible and user-friendly 
for the participants. 






Interviews with the facilitators after Pilot Test 1 revealed that it was difficult to 
facilitate discussions. As the interactive feature in the program was not working 
properly, facilitation was not possible and the twelve posts by the facilitators did not 
start any group discussions. Also, the platform did not provide facilitators with any 
data about how the participants were using the program.  
In Pilot Test 2, the two facilitators entered 55 posts. However, as 4 out of 6 
participants who logged into the program were not using the interactive features, 
these posts did not result in group communication.  
Before Pilot Test 3, a one day training course was provided for the facilitators to 
assist them to use the technology supporting the program more efficiently. In Pilot 
Test 3, the two facilitators entered a total of 85 posts with the eight active 
participants in the program using the interactive features in the program. Interviews 
with the facilitators and participants showed positive outcomes. The facilitation of 
the program through group communication features and providing feedback for the 
completed activities improved group discussions. Facilitators’ feedback and their 
daily records of their experience with the online FSM resulted in a manual for 
facilitators. This manual was prepared in two sections, i.e. technology and 
facilitation, to be used in the RCT. 
3.3.1.5 PROGRAM FIDELITY 
While the program was being developed, the researcher was constantly going back to 
the Managing Fatigue manual (T. L. Packer et al., 1995), as the original resource, to 
see if the online program was following the same principles. The two facilitators of 
the online program, who were occupational therapists and experienced facilitators of 
the face-to-face FSM program, believed that the self-management goals in the face-
to-face FSM program were met in the online program (internal validity). Also, as 
explained in the previous section a manual and training course was prepared for the 
facilitators. Fidelity of the online FSM program was monitored in Pilot Tests 3, when 
the online program could mimic the face-to-face FSM program. A checklist of 
weekly tasks was prepared for the facilitators to ensure they delivered the program in 
the same way as it was planned.  





3.3.2 EFFICACY EVALUATION (OBJECTIVE 2) 
The nearly completed online FSM protocol used in Pilot Test 3 formed the 
independent variable for preliminary efficacy testing. From eleven participants who 
were recruited to participate in Pilot Test 3, only 6 consented and completed the pre-
test questionnaire. One of the six participants withdrew in the third week of the 
program. This participant reported that becoming more familiar with possible 
consequences of MS was unwanted and withdrew.  
The demographics and clinical characteristics of the five remaining participants are 
presented in Tables 3.5 and 3.6. In order to allow comparison of the results of this 
study with other published studies, both median and mean scores are presented as 
descriptive statistics. Pre-test data showed the participants’ median self-efficacy 
score range to be 14 to 33. Participants mostly reported a very high level of social 
support (Median = 35).  Missing data at the item level on the post-test measures was 
treated by carrying forward. Wilcoxon Signed Ranks test demonstrated a significant 
improvement on the Fatigue Impact Scale (p = .042) and a trend toward significance 
on the Personal Well-being index (p = .080). The results did not show a significant 
increase in participants’ activity participation (Table 3.7). 
Table  3.5 Demographics of Participants in Pilot Test 3 (Objective 2) 
Variable Frequency  Variable Frequency








With other adults 


















Language    Income per week  
English 





$600 - $999 
$1000 - $1399 










Table  3.6 Baseline Clinical Characteristics of Participants in Pilot Test 3   




Age (in years) 45 12.41 46 27 - 62 
Fatigue Severity Scale (Screening) 5.76 .67 6.0 5.00 - 6.56 
Generalised Self-efficacy Scale  26.2 7.79 30 14 - 33 
SSI: Overall 32.6 8.90 35 19 - 43 
DASS: Depression Subscale 14.6 7.38 14.6 7 - 28 
DASS: Anxiety Subscale 11.6 6.64 10.5 2 - 23 
DASS: Stress Subscale 17.9 7.33 17.5 7 - 33 
Note. SSI = Social Support Index, DASS = Depression, Anxiety and Stress Scale. 
 




Mean SD Median Range 
Pre-test 66.20 36.83 56 32 - 128 
Fatigue Impact Scale 
Post-test 55.40 38.21 43 25 - 121 
Pre-test .87 .18 .91 .59 - 1.03 
Activity Card Sort 
Post-test .97 .21 1.06 .63 - 1.18 
Pre-test 35 17.82 37 9 - 56 
Personal Wellbeing Index 
Post-test 48 13.30 41 39 - 71 
Note. SD = Standard Deviation. 
3.3.3 PREPARATION FOR THE RCT 
During the process of the three pilot tests, different aspects of recruitment and data 
collection were tested. As the same process of recruitment was carried out during the 
pilot study, the results of recruitment were analysed based on the three pilot tests. 
Almost 47% of people (32 persons out of 69 persons) who contacted the researcher 
were interested and eligible to participate in the pilot study. Also, during Pilot Test 3, 
there was an attrition rate of 12% (one out of eight participants who logged into the 
program). Confirmation of diagnosis by the participants’ physician as an inclusion 
criterion proved to be impractical. As the letter to the doctors were sent by the 
participants, the researcher could not follow-upon the letters and the average time for 
receiving the letters was 3.7 weeks (range 2.1 - 5.4 weeks). Therefore, for the RCT 





part of the study, diagnosis reported by the participants was not considered in the 
inclusion criteria and confirmation letter from the doctors was sought later. 
The calculated time to complete telephone interviews for screening participants was 
an average of 14 minutes (range 9-50 minutes) per person. This time included the 
time needed to explain the research and the process of the pilot test and its goals. The 
delivery time when mailing envelopes to WA and eastern parts of the country was 
calculated to be 5 days as an average. The Telephone Interview for Cognitive Status 
(TICS) proved to be unsuitable for the Australian culture. Three of the participants 
were offended by being asked about the Prime Minister of Australia and repeating 
‘Methodist Episcopal’ (items 8 and 9 of the test).  The feasibility of the computer test 
which had been designed by the researcher was tested and the necessary revisions 
were made. Some instructions and a ‘practice’ test were added to make it easier for 
the participants to enter the computer test and follow the instructions.   
In preparing for the evaluation of the online FSM program through an RCT, a 
specific objective of the pilot study was to conduct a sample size calculation based 
on one of the primary outcome measures, the FIS which was the main target of the 
fatigue self-management program. Analysis of the FIS change scores between pre-
test and post-test revealed that one score lay significantly outside an obvious cluster. 
In the sample size calculation this score was discarded as an outlier, giving a mean 
pre-test to post-test change score of 11.75 (SD = 13.57). Using these figures gave an 
effect size of .87 and determined that 18 participants would be required for each 
group at 80% power and 5% level of significance. This result was compared with the 
literature. A previous RCT study on the face-to-face version of the FSM program 
found significant difference between groups with an average effect size of .72 
(Mathiowetz et al., 2005) which was considerably smaller than the effect size 
calculated according to the pilot study results. Therefore, in order to guarantee a 
large enough sample in the study (to prevent Type II error), the smaller effect size 
was used and the power was re-calculated. Based on the assumption that in the RCT 
there would be no difference in the change scores of the control group over the 
course of the study, a power calculation for analysis of variance determined that 25 
participants would be required for each group at 80% power, effect size of .72 and 
5% level of significance. The attrition rate reported by the literature ranged between 





16% to 20% for self-management programs (Warsi et al., 2004) and 4% to 51% for 
online patient education programs (Nguyen, Carrieri-Kohlman, Rankin, Slaughter, & 
Stulbarg, 2004). In the present study, to estimate the number of participants needed 
for the study, a 20% attrition of participants over the 22 weeks of the study was 
considered. It was calculated that the subsequent RCT would therefore require an 
overall sample size of 95 before attrition. 
3.4 DISCUSSION 
Developing online interventions is known as ‘an arduous, sometimes tedious and 
always time-intensive process’ (Ritterband et al., 2003, p.530). Although the online 
program was designed based on an evidence-based face-to-face program, the 
formative evaluation of the program, which was facilitated by constant feedback 
from the participants and the facilitators, took longer than what was expected. 
Testing as an important stage in the development of online interventions (Eng, 1999; 
Ritterband et al., 2003) took half of the 2-year process of development and required 
intensive teamwork to ensure that the online program could mimic its face-to-face 
version. When designing the program, several difficulties were encountered; finding 
characteristics of a suitable platform to carry the self-management group program, 
designing the site to carry several components of the program and then facilitating 
access to and navigation through the program required three pilot tests. As 
recommended by the literature (Ritterband et al., 2003), the process of this study also 
required having a health professional with IT knowledge and an IT expert with some 
knowledge about rehabilitation interventions in the design team. Continuous 
feedback from the participants in Pilot Test 3 provided the possibility of testing the 
effectiveness of small technical changes concurrently with running the course hence 
saving time. Although the literature acknowledges the necessity of online programs 
and studies reporting the results of studies of efficacy of online interventions receive 
a lot of attention, the process of development of the interventions is rarely addressed. 
The format and structure of online interventions provided in the literature vary from 
online information or email coaching to highly structured programs. There are pros 
and cons for each format but the literature emphasises use of a standardised face-to-
face program as basis for the online interventions (Ritterband et al., 2003). Using the 





internet components like interactivity or graphics to help the group dynamics is also 
recommended (Ritterband et al., 2003). This online FSM program delivered 
information online on a weekly basis with graphics added for ease of understanding. 
The activities provided opportunities to practice the introduced skills in real life. The 
group discussions were the most highly valued aspect of the program with 
participants sharing their experiences, and successes and failures with the newly 
learnt strategies with each other. While the program was being developed, the 
researcher was constantly referring back to the Managing Fatigue manual (T. L. 
Packer et al., 1995), as the original resource, to see if the online program was 
following the same principles. The two facilitators of the online program, who were 
occupational therapists and experienced facilitators of the face-to-face FSM, believed 
that the self-management goals in the face-to-face FSM were met in the online 
program (internal validity). Fidelity of the online FSM was monitored in Pilot Test 3. 
A checklist of weekly tasks was prepared for the facilitators to ensure they delivered 
the program in the same way as it was planned. There is a need for further 
documentation of formative evaluation and technical view of designing online 
programs to facilitate future development studies. 
One of the limitations of this study was use of a checklist of the activities of the 
ACA- Aus tool instead of using the complete test with its pictures. The small sample 
size did not make it possible to undertake a reliability test between the two versions 
of the test.  
Despite the small sample size, this study showed the efficacy of this online fatigue 
self-management program in improving fatigue and quality of life. These results are 
in parallel with that of other studies testing the efficacy of the face-to-face version of 
the fatigue self-management program for people with MS (Mathiowetz et al., 2005; 
Mathiowetz et al., 2001; Sauter et al., 2008). Although the literature shows that the 
positive effect of the face-to-face FSM were maintained one year after the course 
(Mathiowetz et al., 2007), future studies are needed to explore whether the online 
version has the same results. Future studies should also address effect decay and the 
need for ‘booster’ session for the online version of the program.  





Self-management programs are considered complex interventions. Lenz, 
Steckelberg, Richter, & Mühlhauser (2007) concluded in a systematic review that 
when evaluating a complex intervention, the heterogeneity in their goals, methods 
and target populations should be accurately considered. Therefore, the development 
of this online FSM was based on the framework suggested for development and 
evaluation of complex interventions which includes one pre-clinical stage and four 
phases (Medical Research Council, 2000). The pre-clinical stage was completed 
before this study, when the theory for the face-to-face fatigue self-management 
program was determined. This study presents the results of the modeling and 
exploratory trial phases (Phases I & II) of the development. An RCT is required to 
evaluate the efficacy of this complex intervention (Phase III) in comparison with a 
control group.   
3.5 CONCLUSION 
While fatigue is a common problem for people with fatigue secondary to 
neurological conditions, to our knowledge, this online FSM is the first of its kind to 
be implemented. The primary purpose of the fatigue self-management program is to 
help the participants improve their everyday performance and quality of life by 
incorporating ‘energy conservation techniques’ and self-management principles into 
their own life. Through the application of a fatigue self-management program, 
occupational therapists and other health professionals expect that the participants will 
learn the self-management skills, make corresponding behaviour changes and 
experience a reduction in the effect of fatigue on their lives.  
The online FSM is now a standardised program with manuals for the participants and 
the facilitators mimicking its face-to-face version. The participants in the final pilot 
study reported that the program was easy to follow, completing the activities online 
was straightforward and interesting and that the most popular part of the program 
was the group discussions. The results show that the online fatigue self-management 
program is a viable complex intervention for people with neurological conditions. 
The participants in Pilot Test 3 improved significantly on the Fatigue Impact Scale 
and a trend toward significance was shown on the Personal Wellbeing Index. All 
outcomes showed a large effect size, however, the small sample size and non-





parametric statistics may have contributed. Further study with a larger sample size 
and more robust design is now required to compare the efficacy of this online 
program with its face-to-face version and a control group. Therefore, the exploratory 
phase of testing this complex intervention (Medical Research Council, 2000) was 
successfully completed. Different variations of the intervention components were 
tested and the feasibility of the study was evaluated. 
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4 RANDOMISED CONTROLLED TRIAL 
4.1 INTRODUCTION 
The previous chapter described the design, process and pilot testing of the online 
FSM program which is considered as Phase 2 (exploratory trial) of development and 
evaluation  of a complex intervention (Medical Research Council, 2000). This 
chapter presents the methodology, results and discussion of the randomised 
controlled trial (RCT) study to evaluate the efficacy of the online FSM program in 
comparison with an online information-only FSM program (info FSM) and a no-
intervention control group in a sample of adults with chronic neurological conditions. 
An RCT is the main and central step (Phase 3) in evaluating complex interventions 
(Medical Research Council, 2000). RCT methodology is known as the most rigorous 
way of determining whether a cause-effect relation exists between treatment and 
outcome and for assessing the efficacy of a treatment (Portney & Watkins, 2008). 
Further, the literature emphasises the importance of RCTs for testing the efficacy of 
complex and online interventions (Medical Research Council, 2000; Ritterband et al., 
2003).  
Despite the plethora of RCTs and systematic reviews examining self-management 
programs, (Barlow et al., 2002; G. Foster et al., 2007; Gibson et al., 2003; 
Monninkhof et al., 2003; Nolte et al., 2007; Steed et al., 2003; Warsi, LaValley, 
Wang, Avorn, & Solomon, 2003) and online programs (Gustafson et al., 1999; 
McKay et al., 2001; E. Murray et al., 2005; Wantland et al., 2004), there is a paucity 
of literature that focuses on efficacy of online self-management programs. The only 
available studies on online self-management programs (K. R.  Lorig et al., 2006; 
Nguyen et al., 2005; Nguyen et al., 2008)  were neither designed for people with 
neurological conditions nor were they focused on fatigue.  
4.2 METHODS 
4.2.1 STUDY DESIGN 
A three-arm randomised clinical trial was used to evaluate the online FSM program 
in comparison with the info FSM and a control (no intervention) group. This RCT 
was registered through the Australian Clinical Trials Registry (Trial registration 





number - ACTRN012607000268448). Randomisation to a face-to-face arm was not 
possible as the people for whom the online program was intended were exactly those 
people who could not attend traditional six week face-to-face programs due to 
distance, travel related fatigue, transportation difficulties etc. However, another study 
was included in this project to compare the efficacy of the face-to-face FSM group 
with that of the online FSM, info FSM and control groups (see Chapter 5). 
The recruitment method and inclusion-exclusion criteria are the same (with two 
exceptions) as the pilot study and explained in the previous chapter. The first 
exception was that the participants who had access to the face-to-face FSM program 
(located in metropolitan area of Perth, Western Australia) were excluded from this 
part of the study and included in the study on face-to-face FSM program (Chapter 5). 
The second exception was that confirmation of diagnosis by the participants’ 
physician was not considered in the inclusion criteria for the RCT. This decision was 
made based on the results of the pilot study (see section 3.3.3). 
4.2.2 OBJECTIVES 
The main objectives of this study were to evaluate the efficacy of an online FSM 
program and then to compare it with the info FSM and a control group in a sample of 
adults with chronic neurological conditions. The primary outcomes were fatigue, 
quality of life and activity participation. To meet these objectives, three null 
hypotheses were considered:  
1) There is no difference between the online FSM program and the info FSM 
program on primary and secondary outcome measures at post-test and follow-up 
among a sample of adults with chronic neurological conditions;  
2) There is no difference between the online FSM program and the control group on 
primary and secondary outcome measures at post-test and follow-up among a sample 
of adults with chronic neurological conditions; and 
3) There is no difference in fatigue, activity participation and quality of life from pre-
test to post-test and follow-up for the online FSM group or either of the control 
groups. 






An overview of the RCT process is presented in Figure 4.1. Potential participants 
contacted the researcher. Subsequently, a mutually convenient appointment was 
arranged to discuss the study further via a telephone interview. The process of 
randomisation was clearly explained to the participants following which the 
participants were matched against the inclusion-exclusion criteria. Because 
confirmation of the participants’ diagnosis was subsequently sought from 
participants’ physicians, all the participants who self-reported their diagnosis as MS, 
PD, PPS or chronic fatigue syndrome were included in the randomisation and 
allocated to group. Also, as the online FSM program was designed to provide service 
for the people who do not have access to the face-to-face program, randomisation of 
the participants to four groups (face-to-face FSM, online FSM, info FSM and control 
groups) was not feasible because restricting the inclusion criteria to participants who 
had access to both the face-to-face and online programs would have excluded the 
very people for whom the program was designed. Therefore, the participants with 
access to the face-to-face program were excluded from the RCT study. Data from 
this group of participants was used in another part of the project (Chapter 5).  
For those who met the criteria, envelopes including questionnaires and information 
sheets were sent via post.  As indicated in the information sheets, return of the 
questionnaires was taken as implied consent. The process of data collection and 
randomisation were explained in the information sheet for the participants (Appendix 
C). In order to decrease attrition, participants were informed that they may be 
contacted by the researcher to be reminded to return the completed questionnaires. 
Questionnaires were sent to the participants three weeks before the start of the 
program (Pre-test), one week after the end of the program (Post-test) and also 3 
months later (Follow-up).  
Randomisation, which is known as a crucial aspect of clinical trial design, was used 
to eliminate selection bias in the assignment of interventions. It occurred after 
collection of baseline data. Permuted block design was used to generate the 
allocation sequence. Participants of every block of 30 were randomised with 1:1:1 
ratio into the three groups; online FSM, info FSM or control group. This design was 
used to ensure that the comparison groups were approximately the same size (Altman 





et al., 2001) (Also see section 4.2.3.1). Random numbers were generated by a 
computerised program downloaded from http://mahmoodsaghaei.tripod.com/ 
softwares/randalloc.html. The computerised random number generation guaranteed 
adequate generation of an unpredictable allocation sequence (Schulz, Chalmers, 
Hayes, & Altman, 1995). The three groups of participants received interventions in 
parallel during each time block of the study. Subsequently the post-test data and 
three months follow up data were collected. 
Figure  4.1 Stages and Procedures of the RCT 





4.2.3.1 ALLOCATION CONCEALMENT 
Allocation concealment is a critical process during an RCT that prevents 
foreknowledge of treatment assignment and thus shields those who enroll 
participants from being influenced by this knowledge (Altman et al., 2001). 
Allocation concealment which seeks to prevent selection bias, protects the 
assignment sequence before and until allocation (Wood et al., 2008). In this research, 
participants were enrolled once pre-test questionnaires were returned (implied 
consent) and then allocated to a group by computerised central randomisation. This 
method of randomisation was used to decrease the likelihood of bias in group 
assignment (Altman et al., 2001). The sequence was unknown and unpredictable by 
the researcher, participants and the facilitators. Therefore, they did not know in 
advance to which treatment the next person would be allocated (allocation 
concealment). 
4.2.3.2 BLINDING  
Although blinding is important to prevent bias (e.g. performance bias and detection 
bias) at several stages of a controlled trial (Altman et al., 2001) the feasibility of it 
depends on the nature of the experimental intervention and the response variables 
(Portney & Watkins, 2008). Performance bias is ‘systematic differences in the care 
provided in the comparison groups other than the intervention under investigation’ 
(Altman et al., 2001, p.688). One of the techniques to prevent this type of bias is 
blinding of either participants or therapists. Blinding was not possible in this study as 
both the participants and the therapists were actively engaged with each other - 
which is the nature of the self-management interventions. Detection bias (also known 
as assessment bias), which happens when knowledge of a participant’s assignment 
influences the process of outcome assessment, was not possible. All the measurement 
tools used in this research were self-administered therefore blinding the assessors in 
order to preclude detection bias was not possible (Noseworthy et al., 2001). 
4.2.3.3 STRATEGIES TO PREVENT BIAS 
Despite the limitation of this study in blinding the researcher, facilitators and 
participants to the group assignment, attempts to reduce bias were implemented.  In 
order to isolate recruitment, data collection, facilitation and data entry, different 





personnel were involved at each level (Portney & Watkins, 2008). Table 4.1 shows 
strategies used to prevent bias of the research team and participants. The strategies to 
prevent bias were as followings:  
 A research assistant who was blind to the study objectives entered all the data 
into the data base. She was also blind to the allocation coding used within the ID 
codes in order to minimise data entry bias; 
 The researcher conducted all the telephone interviews and organised posting of 
the questionnaires for the pre-test, post-test and follow-up data collection. However, 
both the researcher and the facilitators were blind to returned questionnaires and all 
data were received and entered into the data base by the research assistant;  
 The researcher did not participate in any of the intervention programs and had no 
conversation with the facilitators or the participants about the progress of the groups 
or the efficacy of the program; 
 Facilitators were, as far as possible, blind to the study objectives. Different 
facilitators delivered the online FSM and the info FSM programs, thus being unable 
to bias treatment of one group over another; 
 Communication with participants other than related to actual intervention was 
undertaken by the researcher; 
 Facilitators, who ran either of the interventions, had no contact with participants 
and the facilitators of the other intervention group and had no contact with control 
participants; and 
 In order to prevent performance bias and detection bias, participants in the two 
online groups were blind to the components of the actual online intervention. 
Therefore, they did not know if they were allocated to the online FSM program or 
info FSM.  





Table  4.1 Blinding of Participants, Facilitators, Research Assistant and the 
Researcher 




Data collection - √ √ - 
Data entry √  √ √ 
Treatment 
allocation 
- √ - √ 
(online and info FSM)
Data monitoring √ - √ - 
Group facilitation √ √ - - 
Note. √ = Blind to research activities, FSM = Fatigue Self-management. 
 
4.2.4 VARIABLES 
4.2.4.1 INDEPENDENT VARIABLES 
The independent variable had three levels summarised below and in Table  4.1. No 
changes were made to the usual care that the participants were receiving from the 
community, associations or private sector. Participants were asked to continue use of 
medication as usual, but to report any changes during the data collection period. 
Participants in all groups were tested before and after the program and also three 
months later. 
ONLINE FATIGUE SELF-MANAGEMENT GROUP (ONLINE FSM)  
The online version of the fatigue self-management program was an internet based 
program, developed from the face-to-face version using a deconstruction-
reconstruction process.  Key features of the face-to-face program were captured and 
transferred to the alternative medium creating a 7-week intervention (Ghahari, 
Packer, & Passmore, in press). The process of designing the program is explained 
thoroughly in Chapter 3. The online version mimicked the face-to-face version and 
included written content, online discussion and homework assignments. The program 
included six topics: the importance of rest, communication, body mechanics, re-
arranging activity stations, setting priorities and standards and balancing schedule. 
The weekly information was based on self-management principles and blogs from 
previous participants in face-to-face FSM programs (expert panel) were also 
included in the content to facilitate transferring the message to the participants 
(vicarious learning and social persuasion). Participants shared information and 





experiences, expressed their ideas or feelings and offered advice and support to one 
another. They were provided with a ‘Guidebook and Activities’ to help them 
navigate around the program. A hard copy of all the activities was included in this 
guidebook as participants in the pilot tests found it useful to prepare a draft prior to 
working online. Further details of the features of the program are described in 
Appendix A.  
Facilitators of the online program were experienced occupational therapists with 
extensive group therapy background and also good knowledge of theory and 
facilitation of self-management programs. They received 2 days of training in use of 
the technology of the online FSM program. The manual of the original face-to-face 
program was used as a guide for intervention delivery. In addition, a second manual 
was provided for the online program. The manual included details about facilitation 
online for implementation. The facilitators actively guided the online group 
communication and commented on how the participants were completing activities 
in the program.  
The online program was supported technologically by the Information Technology 
(IT) staff in Curtin University, Centre for Research into Disability and Society 
(CRDS). Facilitators were responsible for solving minor technological problems for 
the participants, while platform related problems required problem-solving by the IT 
administrators. 
Table  4.2 Overview of Intervention Components by Group  










√ √  
Expert panel’s blogs √ √  
Facilitator √ - active √ - passive  
Group communication √   
Activities √   
Access to other 
participants 
√   
Note. √ = Components received by participants; FSM = Fatigue Self-management. 





INFORMATION-ONLY FATIGUE SELF-MANAGEMENT GROUP (INFO FSM) 
To evaluate the effectiveness of the interactive features of the self-management 
program through activities and the communication of participants with one another 
and the facilitators, a second group of participants received only weekly information 
for 7 weeks delivered through the internet. This group was designed as a placebo 
group to rule out the effect of attention. The content was identical to the written 
material used in the online FSM program (including weekly self-management based 
information and the expert panel’s blogs), but participants had no access to activities, 
the interactive components of the program and to each other. The group facilitator 
undertook a passive role in the group; she interacted individually with participants 
simply checking for any technology problems and sending standardised weekly 
reminders to the participants. Like the online FSM program, this program was 
supported by the IT staff of the Centre for Research into Disability and Society. 
CONTROL GROUP (NO INTERVENTION)  
Participants in this group continued their normal life without intervention. As per all 
groups, they received their routine care which ranged from nothing to specialist care 
and/or community care.  
4.2.4.2 DEPENDENT VARIABLES  
All primary and secondary measures described in the pilot study (Chapter 3) were 
used in the RCT study. Except for the Essential Computer Skills Test (which was 
tested via the internet for the two online groups) all variables were measured via the 
post using paper-based versions of the measures. This method of data collection was 
chosen because the participants in the other part of the study (the face-to-face fatigue 
self-management program - see Chapter 5) did not have access to the internet to 
complete the questionnaires online.  
The primary outcomes in this RCT were quality of life, fatigue and activity 
participation, all of which were collected at pre-test, post-test and follow-up. 
Sociodemographic information (Appendix D) which was used as covariates was 
collected at pre-test.  The other covariates for the RCT included depression, anxiety, 
stress, social support, self-efficacy and essential computer skills; all were collected at 
pre-test, post-test and follow-up in order to allow subsequent secondary analysis (to 





collect data for another part of this PhD project) (see Chapter 6). Table 4.3 provides a 
summary of the outcome measures. Psychometric properties of the outcome 
measures were explained in section 3.2.3.3 in the Pilot Study Chapter. 
Table  4.3 Summary of Outcome Measures 
Variable Instrument Acronym 
Primary outcome measure (dependent variables) 
Quality of Life Personal Wellbeing Index  
(Cummins et al., 2003) 
PWI 
Activity Participation Australian version of  Activity Card 
Sort  (T. L. Packer et al., 2007) 
ACS 
Fatigue Fatigue Impact Scale  
(Fisk et al., 1994) 
FIS 
Secondary outcome measures (covariates) 
Depression, Anxiety and 
Stress 
Depression Anxiety and Stress Scale  
(S. H. Lovibond & P. F. Lovibond, 
1995) 
DASS 
Social Support Duke Social Support Index  
(Koenig et al., 1993) 
SSI 
Self-efficacy Generalised Self-efficacy Scale  
(Schwarzer, 1993) 
GSE 




4.2.5 DATA MANAGEMENT AND ANALYSIS 
The primary analysis was intention-to-treat and all participants who underwent 
random allocation were analysed according to group assignment. This method was 
used to avoid bias associated with non-random loss of participants (Lachin, 2000) . 
All results were analysed using the software package SPSS 15.0 for Windows, 2007. 
Missing value analysis was conducted to test for patterns in missing data. Missing 
value analysis helps address several concerns caused by incomplete data. Checking 
for missing data is required for most statistical procedures as cases with missing 
values - which are systematically different from cases without missing values - can 
obscure the results. Also, missing data may reduce the precision of calculated 
statistics because there is less information than originally planned. Another concern 
is that the assumptions behind many statistical procedures are based on complete 
cases, and missing values can violate application of theories. The results of missing 
value analysis did not demonstrate any significant pattern of missing data.  





Following the missing value analysis, missing data were imputed at two levels; item 
level when one or more questions/items of a scale was/were not answered; and scale 
level when none of the questions were answered in a questionnaire.  
 Missing data at pre-test at the item level were substituted with the mean of the 
group, while at post-test and follow-up, missing data was treated by carrying item 
scores forward from the previous time point Table  4.4. There was no pre-test missing 
data at the scale level as return of pre-test data was considered as consent for 
participation. Missing data at scale level at post-test and follow-up were analysed as 
intent-to-treat (ITT) by replacing missing values by carrying forward total scores 
from the previous data collection points. This method, known as last observation 
carried forward (LOCF), is suggested as the preferred method for continuous data 
(Portney & Watkins, 2008). The attrition rate was 9% (n = 9) at post-test and 21% (n 
= 20) at follow-up. For participants that dropped-out, scores from the previous time 
point were carried forward for all the outcome measures. As the number of non-
compliers was small at post-test, no statistical test was used to evaluate the 
difference. The attrition rate at follow-up was not significantly different between the 
groups (p > .05).  
Table  4.4 Imputation of Missing Data 
Missing data at Pre-test Post-test Follow-up 
Item level Substituted with 
mean of the group 
Pre-test score 
carried forward 
Post-test score carried 
forward 
Scale level None Pre-test score 
carried forward 
Post-test score carried 
forward 
 
Preliminary checks were conducted to ensure that there was no violation of the 
assumptions of normality, linearity, homogeneity of variances and homogeneity of 
regression slopes. Kolmogorov-Smirnov test of normality revealed that except for the 
FIS score in the control group, all outcome measures showed a normal distribution. 
Therefore, they were analysed with parametric statistics. For non-normally 
distributed data (FIS scores), either logarithmic transformation was performed to 





correct the skewness of the distribution or non parametric tests were used in the 
analyses.  
One of the advantages of randomisation is that it allows for use of probability theory 
in the analyses to express the likelihood that any difference in outcome between 
intervention groups merely reflects chance (Greenland, 1990). Results of data 
analysis were considered statistically significant when p < .05. Initially, to ensure 
comparability of groups, the three groups were compared at baseline with respect to 
demographic and clinical characteristics, using analysis of variance (ANOVA) for 
continuous variables and chi-square test for nominal data.  
Analysis of covariance (ANCOVA) was performed to examine the impact of the type 
of intervention on the primary outcome measures (FIS, PWI and ACS) at post-test 
and follow-up (Testing hypotheses 1 and 2). The independent variable was the type 
of intervention (online FSM program, info FSM program and no intervention). The 
dependent variables consisted of the scores on the FIS, PWI and ACS scale 
administered immediately after the completion of the intervention (post-test) and 
three months later (follow-up). In order to adjust for any group differences at 
baseline, participants’ scores on the pre-intervention (pre-test) administration of the 
FIS, PWI or ACS and covariates (i.e. depression, anxiety, stress, social support and 
self-efficacy) were used as the covariates in these analyses.  
To test the change in scores at pre-test, post-test and follow-up for the online FSM, 
info FSM or the control groups (Testing hypothesis 3), repeated-measures analyses 
of variance were performed with 1 within-subject factor, time (Three levels: pre-test, 
post-test and follow-up). If significant, pairwise comparison was performed with 
Bonferroni correction for multiple comparisons. For non-normally distributed data 
(FIS for control group), changes in fatigue over time was analysed by using 
Friedman ANOVA. To do non-parametric post-hoc procedures, the difference 
between the mean ranks of the different time points was calculated. Then, the 
difference was compared to a critical difference which was based on the z-score 
(corrected for the number of the comparisons being done), total sample size (n = 95) 
and the number of conditions (k = 3).  





The inequality used for comparison of pre-test and follow-up is presented in 
Equation 4.1 is an example:  
Equation 4.1:          |  
Other comparisons (pre-test versus post-test and post-test versus follow-up) used 
analogous calculations. If the difference between the mean ranks was bigger than the 
critical difference, then that difference was considered as significant. 
The effect size was also calculated for all analyses. ‘Eta squared’ is one form of 
effect size statistics widely used in the literature. A number of criticism have been 
leveled at eta squared (Pierce, 2004). For example, some authors believe that it is 
biased (Field, 2005). In the present study, ‘partial eta squared’ was used which 
overcomes a number of concerns raised (Pallant, 2005). This is the statistics 
calculated by SPSS although it is not labeled as such in the output (Pallant, 2005).  
To interpret the strength of partial eta squared the following guidelines were used (J. 
Cohen, 1988): .01 = small effect; .06 = moderate effect ; and .14 = large effect. 
Secondary analyses included two sets of tests using ANCOVA and repeated 
measures ANOVA; firstly, comparison of a combined group (online FSM group plus 
info FSM group) with the control group and secondly, sensitivity tests using the data 
for the participants in the three groups who had complete data sets at pre-test, post-
test and follow-up and who had completed more than 5 sessions of the FSM 
program.  
4.2.6 ETHICS 
Ethics approval for the study was obtained from the Curtin University Human 
Research Ethics Committee (Approval number OT-2005-14) (see section 3.2.4). The 
process of randomisation was clearly explained in the telephone interview and also in 
the information sheet provided to the participants. The participants’ questions about 
the randomisation process were answered precisely. The participants who were 
allocated to the control groups were promised the opportunity to participate in an 
online FSM program after the end of the study. 






4.3.1 FLOW OF PARTICIPANTS 
Based on the sample size calculation presented in section 3.3.3 of the pilot study, 95 
participants were required for the RCT study before attrition to detect differences the 
groups in primary outcome measures between groups at post-test and follow-up.  
Figure 4.2 depicts the flow of participants through the study. One hundred and fifty 
two potential participants contacted the researcher. Thirty two potential participants 
(21%) were not included in the study; fourteen were not eligible because they had an 
FSS score lower than 4 or a diagnosis other than MS, PD, PPS or chronic fatigue 
syndrome; nine were not interested in the program and nine other people declined on 
the basis of time commitment or a clash of schedules.  No participant was excluded 
based on the score on the Memory Orientation Concentration Test (Katzman et al., 
1983). Thus, the pre-test questionnaires were sent to 120 potential participants. As 
return of this questionnaire was considered as implied consent, the twenty five 
individuals who did not return the completed questionnaire were excluded from the 
study, thus a total of 96 participants were allocated to groups. The study was 
conducted in four time blocks between May 2007 and March 2008. The final number 
of participants in the blocks ranged between 19 and 29 (Mean = 23.75). Participants 
in each block were randomised into three groups: online FSM, info FSM and control.  
Ninety six participants were eligible for the study.  The diagnosis confirmation letters 
from doctors were received for 77 persons (81% of the 96 participants). Self-report 
of chronic disease diagnosis is shown to agree with the medical record diagnosis 
from 73% to 83% of the time (Martin, Leff, Calonge, Garrett, & Nelson, 2000). In 
this study, in 100% of cases the diagnosis by the doctors matched with the 
participants’ self-report. As confirmed diagnosis was not required for inclusion, 
participants whose diagnosis confirmation letters were not returned, were not 
excluded from the study. 
Based on the inclusion criteria people with MS, PD, PPS and chronic fatigue 
syndrome were eligible. However, as only one participant (in the online FSM group) 
had chronic fatigue syndrome, these data were not included in any of the analyses 
and, for ease of presentation, have been excluded in all reporting of participants’ 





numbers, data, etc. Therefore, only the flow and the results for data collected for the 
ninety five participants are reported. The eligible participants were randomly 
allocated to the three groups; as a result 34 were allocated to the online FSM group, 
28 to the info FSM and 33 to the control.   





Figure  4.2 Flow of Participants through Each Stage of the RCT 
 





For the total sample, attrition was 9% (n = 9) at post-test (uncompleted post-test 
questionnaire) and 21% (n = 20) at follow-up. Eleven percent of the participants in 
the online FSM group, 4% of the info FSM group and 12% of the control group 
neither continued with the program nor completed the post-test questionnaire. 
Because of the small attrition at post-test, using a statistical test to show the 
difference between the number of drop outs between the groups was not possible. 
The attrition rate at follow-up was not significantly different between the online FSM 
group (20%), info group (14%) and control group (27%), χ2(1) =  .434, p = .510.  
An independent t-test was conducted to test the difference between the participants 
who returned the post-test questionnaires and the ones who did not return them. 
Comparison of baseline data revealed that the participants who did not return the 
post-test data were significantly more stressed [t (1,93) = 7.099, p = .009] and more 
anxious [t (1,93) = 4.428, p = .38] on the DASS scale compared to the others.  
Likewise participants who returned the post-test questionnaire but did not complete 
the follow-up questionnaire obtained significantly higher scores for depression  
[t (2.124, 84), p = .037] and anxiety [t (2.553, 84), p = .12] when compared with the 
participants who returned the follow-up data. 
The attendance rates are reported in Table  4.5. One participant in the online FSM 
program did not log into the program, however, all 28 participants in the info FSM 
commenced the program. Almost 79% of the participants in the online FSM program 
and about 82% of participants in the info FSM ‘logged on’ during the orientation 
week and during at least 3 additional weeks of the interventions. More than 64% of 
the participants in the online FSM and 75% of the participants in the info FSM 
program participated in at least 5 weeks of the programs. An independent-samples t-
test was conducted to compare the participation rate (i.e. the number of weeks that 
the participants in the experimental groups were actively involved in the program) 
between the online FSM and info FSM groups. There was no significant difference 
in the participation rate for the online-FSM group (Mean = 5.53, SD = 2.27) and that 
of the info FSM [Mean = 5.89, SD = 2.02; t (60) = -.658, p = .513].  As the results 
were not significant, there was no risk of Type I error. Further, the number of forum 
posts by the participants in the online FSM group was calculated as an indicator of 





participation rate. The number of forum posts ranged between 0 and 49 per person 
over the 7 week program (Mean = 9.32, SD = 11.90). 
Table  4.5 Completion Rates in the Fatigue Self-management Programs 













6 Weeks  22 64.7  20 71.4 
5 Weeks  24 64.7  21 75 
4 Weeks  24 73.5  23 82.1 
3 Weeks  27 79.4  23 82.1 
2 Weeks  29 85.3  23 82.1 
1 Week  30 88.2  27 96.4 
Orientation 
Week 
 33 97  28 100 
Did not 
participate 
 1 100  0 100 
Note. FSM = Fatigue Self-management. 
 
4.3.2 SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
Error! Reference source not found. gives a summary of the sociodemographic and 
clinical characteristics of participants in the online FSM, info FSM and control 
groups and the overall sample at pre-test. Randomisation resulted in equal groups 
with regards to these characteristics except for the education level which was 
significantly different between the three groups. While the number of the participants 
in the online FSM and control groups who had tertiary qualifications was equal, a 
smaller number of participants in the online FSM group had only high school or a 
lower level of education and a higher number of them had vocational qualifications. 
The majority of participants (77%) were female. This was expected as the majority 
of the participants were people with MS and 74% of all Australians with MS are 
female (Access Economics Pty Limited, 2005). Although the selection criteria 
included adults aged 20 and over, the mean age of participants was 50.25 ± 12.03 





(range 23-90 years). This was also anticipated as about 78% of the participants had 
MS. Over half of the Australians with MS are aged 40-59 (Access Economics Pty 
Limited, 2005). Onset of Parkinson’s disease also occurs in middle age or later  and 
post-polio syndrome begins 25-30 years after an acute attack of paralytic 
poliomyelitis (Umphred, 2007).  
While only 78.5% of the population in the 2006 census spoke English at home  
(Australian Bureau of Statistics, 2005), English was the first language for the entire 
group in this study. This shows that potential participants who speak languages other 
than English at home were underrepresented. According to their postal codes, sixty 
percent of the participants in the study lived in metropolitan areas of Australia and 40 
percent in rural areas. This is almost almost the same as the population distribution 
which in 2006 showed that 68% of Australians lived in major cities and the 
remainder (32%) in regional and remote areas (Australian Bureau of Statistics, 
2008).  
About 80% of the participants in this study had a vocational qualification or higher 
education compared with about half the population in Australia aged 15 years and 
over (Australian Bureau of Statistics, 2006a). Participants with school level 
education or lower may have been underrepresented.  
Only 18% of the participants were living alone. While four in five Australians 
without disability and over half of people with disability participate in the labour 
force in Australia (Australian Bureau of Statistics, 2006a),  almost two third of the 
participants (65.3%) in this study were unemployed. The employed participants were 
only working an average of 14 hours per week. The gross household income for 
almost half of the participants was between AUS$600 and $1999 per week which is 
above the median gross household income in Australia (Australian Bureau of 
Statistics, 2006b). More than two thirds of the participants made the first contact with 










(n = 95)  
Online FSM group 
(n = 34) 
Info FSM group 
(n = 28) 
Control group 
(n = 33) 
Test p - value 
Gender       
Male (%) 18 (18.9) 3 (8.8) 6 (21.4) 9 (27.3) χ2  .055 
Female (%) 77 (81.1) 31 (91.2) 22 (78.6) 24 (72.7)   
Age, years       
Mean (SD) 50.25 (12.3) 51.00  (13.6) 47.86 (12.0) 51.52 (11.0) ANOVA .47 
Range 23 - 90 23 - 74 28 - 81 31 - 90   
State       
Western Australia (%) 25 (26.4) 11 (32.4) 6 (21.4) 8 (24.2) χ2 . 856 
Queensland (%) 34  (35.8) 9 (26.4) 12 (42.8) 13 (39.4)   
New South Wales (%) 18 (18.9) 7 (20.6) 5 (17.9) 6 (18.2)   
South Australia & Victoria, 
Tasmania (%) 
18 (18.9) 7(20.6) 5 (17.9) 6 (18.2)   
Living Area       
 Metropolitan (%) 57 (60) 21 (61.8) 16 (57.1) 20 (60.6) χ2 .921 
 Country (%) 38 (40) 13 (38.2) 12 (42.9) 13 (39.4)   
Highest Education Level       
Secondary school or less (%) 29 (30.5) 7 (20.6) 9 (32.1) 13 (39.4) χ2 .037* 
Tertiary qualification (%) 40 (42.1) 13 (38.2) 14 (50.0) 13 (39.4)   
Vocational qualification (%)  26 (27.4) 14 (41.2) 5 (17.9) 7 (21.2)   











(n = 95)  
Online FSM group 
(n = 34) 
Info FSM group 
(n = 28) 
Control group 
(n = 33) 
Test p - value 
Living Situation       
Live alone (%) 18 (18.9) 7 (20.6) 4 (14.3) 7 (21.2) χ2 .953 
Live with others (%) 77 (81.1) 27 (79.4) 24 (85.7) 26 (78.8)   
Employment       
Employed (%) 33 (34.7) 10 (29.4) 13 (46.4) 10 (30.30) χ2 .929 
Unemployed (%) 62 (65.3) 24 (70.6) 15 (53.6) 23 (69.7)   
Working Hours/week       
Mean (SD) 8.06 (14.63) 6.00 (10.94) 9.75 (14.67) 8.76 (17.79) ANOVA .576 
Range 0 - 74 0 - 40 0 - 50 0 - 74   
Gross Income/week n = 81 n = 32 n = 18 n = 31   
Less than $599 (%) 34 (37.4) 12 (37.5) 9 (32.1) 13 (41.9) χ2 .811 
Between $600 and $1999 (%) 46 (50.5) 17 (53.1) 14 (50.0) 15 (48.4)   
More than $2000 (%) 11 (12.1) 3 (9.4) 5 (17.9) 3 (9.7)   
Contact       
Telephone contact (%) 18 (18.9) 8 (23.5) 7 (25) 3 (9.1) χ2 .136 
Email (%) 77 (81.1) 26 (76.5) 21 (75) 30 (90.9)   
Note. FSM = Fatigue Self-management 
* p < .05.






Table 4.7 gives a summary of the clinical characteristics of participants in the online 
FSM, info FSM and control groups and the overall sample at pre-test. Randomisation 
resulted in equal groups with regards to these characteristics. More than two third of 
the participants were diagnosed with MS. This was the result of the fact that the MS 
Societies in different states of Australia showed interest in the program and 
published flyers for this project in their magazines or sent it to their members 
through email. Participants with PD and PPS were only recruited in Western 
Australia. Most participants with MS (66.1%) had relapsing-remitting MS which is 
the most common type of MS on initial diagnosis (Umphred, 2007). Time since 
diagnosis showed a wide range of 1-71 years (Mean = 11.44 ± 13.37).  The 
participants in the three groups were not significantly different on any clinical 
characteristics. Compared to the Australian norms for the DASS, the participants’ 
depression, anxiety and stress level were within the normal range for stress and the 
mild range for anxiety and depression (P. F. Lovibond & S. H. Lovibond, 1995). 
Participants’ self-efficacy ranged between 12-40 with a mean of 29. The range of 
scores for social support was from 16 to 40 as measured by the Duke Social Support 
Index. This was comparable with the range of 12 to 33 reported for  community 
dwelling older adults with good or better self-rated health  (Goodger et al., 1999) and 
a Western Australian older adult sample with visual impairment  (Mean = 26.8, SD = 
3.3) (S. J. Girdler, 2006). However, a sample of Western Australian women with 
fatigue secondary to chronic conditions (mean age =  44.2, SD = 10.50) had a higher 
level of social support (Mean = 34.36, SD = 5.27) (Khemthong, 2006). Based on t-
test results, there was no difference between the participants in the Online-FSM and 
info FSM groups in their computer skills (p > .05). 
The participants were asked if they have changed their medication during the 
previous 3 months both at post-test and at follow-up. There was no significant 
difference between the three groups in change of their medication (p > .05 both at 






Table  4.7 Clinical Characteristics of the Participants 
Clinical Characteristics All participants Online FSM group Info FSM group Control group Test 
p - 
value 
Diagnosis       
Parkinson’s Disease or Post-polio 
syndrome a  (%) 
21 (22.1) 9 (26.5) 5 (17.9) 7 (21.2) χ2 .602 
Multiple Sclerosis (%) 74 (77.9) 25 (73.5) 23 (82.1) 26 (78.8)   
Time since Diagnosis (in years) n = 73 n = 24 n = 23 n = 26   
Mean (SD) 11.44 (13.37) 13.54 (17.74) 11.48 (11.16) 9.46 (10.33) ANOVA .963 
Range 1 - 71 1 - 71 1 - 52 1 - 52   
Type of MS       
Relapsing –remitting (%)  39 (66.1) 13 (65.0) 14 (77.8) 12 (57.1) χ2 .587 
Other types (%) 20 (33.9) 7 (35.0) 4 (22.2) 9 (42.9)   
Medication use       
Yes (%) 85 31 24 30 χ2 .967 
No (%) 10 3 4 3   
Essential Computer Skills Test (in seconds)       n = 47 n = 23 n = 24    
 Mean (SD) 105.79 (105.91) 91.70 (51.09) 119.2 (139.82) - t-test .378 
Range 34 - 620 35 - 232 34 - 620 -   
General Perceived Self-efficacy Scale      
Mean (SD) 29.02 (4.76) 29.44 (5.14) 28.71 (3.81) 28.85 (5.18) ANOVA .812 
Range 12 - 40 18 - 40 19 - 36 12 - 38   






Table 4.7 continued 
Clinical characteristics All Participants Online FSM group Info FSM group Control group Test p - value 
DASS: Depression Subscale       
Mean (SD) 10.68 (9.60) 11.00 (9.99) 10.81 (10.24) 10.79 (8.89) ANOVA .944 
Range 0 - 39 0 - 37 0 - 39 0 - 39   
DASS: Anxiety Subscale       
Mean (SD) 7.95 (7.02) 8.97 (6.69) 7.79 (7.68) 7.03 (6.87) ANOVA .528 
Range 0 - 33 0 - 24 0 - 32 0 - 33   
DASS: Stress Subscale       
Mean  (SD) 13.06 (9.42) 13.71 (8.96) 13.54 (10.54) 12.00 (9.08) ANOVA .727 
Range 0 - 42 0 - 37 0 - 42 0 - 34   
SSI: Overall       
Mean  (SD) 30.41 (4.65) 29.97 (4.05) 29.75 (4.76) 31.42 (5.09) ANOVA .299 
Range 16 - 40 22 - 37 16 - 36 19 - 40   
SSI: Social Interaction Subscale      
Mean (SD) 8.41 (1.75) 8.21 (1.77) 8.00 (1.72) 8.97 (1.65) ANOVA .066 
Range 4 - 12 4 - 12 4 - 11 4 - 11   
SSI: Satisfaction Subscale       
Mean (SD) 25.46 (4.33) 25.15 (3.90) 25.81 (4.60) 26.03 (4.58) ANOVA .652 
Range 13 - 34 16 - 32 13 - 31 16 - 34   






Table 4.7 continued 
Clinical characteristics All Participants Online FSM group Info FSM group Control group Test p - value 
FIS: Overall score       
Mean (SD) 80.53 (31.60) 79.94 (30.48) 86.14 (32.57) 76.36 (32.165) ANOVA .485 
Range 11 - 159 11 - 135 30 - 147 28 - 159   
FIS: Physical Subscale       
Mean (SD) 24.40 (7.63) 24.97 (8.02) 25.04 (7.16) 23.27 (7.72) ANOVA .581 
Range 8 - 40 8 - 39 10 - 40 10 - 40   
FIS: Cognitive Subscale       
Mean (SD) 18.96 (9.28) 19.18 (8.52) 20.43 (9.54) 17.48 (9.87) ANOVA .465 
Range 1 - 40 10 - 40 6 - 38 2 - 40   
FIS: Psychological Subscale       
Mean (SD) 37.61 (16.95) 36.29 (16.25) 41.21 (17.51) 35.91 (17.23) ANOVA .410 
Range 3 - 79 10 - 40 10 - 74 10 - 79   
Activity Card Sort       
Mean (SD) .89 (.19) .87 (.15) .88 (.22) .93 (.19) ANOVA .351 
Range .28 - 1.48 .47 - 1.04 .28 - 1.20 .30 - 1.48   
Personal Wellbeing Index       
Mean (SD) 58.48 (19.90) 57.18 (21.56) 59.74 (19.12) 58.74 (19.30) ANOVA .879 
Range 7 - 94 7 - 94 11 - 84 10 - 91   
Note.  FSM = Fatigue Self-management; DASS = Depression, Anxiety and Stress Scale; SSI = Duke Social Support Scale; FIS = Fatigue Impact Scale; Unless otherwise 
mentioned, n = 95 for all participants, n = 34 for the online FSM group, n = 28 for the info FSM group, and n = 33 the control group:* p < .05; a Groups combined because of 
small sample size. 







4.3.3 PRIMARY ANALYSES 
This section provides results for the analyses conducted to test the three hypotheses 
of the study. For ease of understanding, the results are presented in two sections; 
results for primary outcome measures (FIS, ACS and PWI) and results for secondary 
outcome measures. 
4.3.3.1 RESULTS FOR PRIMARY OUTCOME MEASURES 
Line graphs are provided for the primary outcome measures in the online FSM, info 
FSM and control groups in Figures 4.3 to 4.5 in order to help visualise the results. 
The marginal means are calculated based on the pre-test scores to simplify visual 
comparisons. It is of note that the patterns observed in the online FSM and info FSM 
are similar while those of the control group show consistently different patterns. 
Figure  4.3 Estimated Marginal Means of Fatigue Impact Scale 


































Figure  4.4 Estimated Marginal Means of Activity Card Sort  































Figure  4.5 Estimated Marginal Means of Personal Wellbeing Index 












































TEST OF HYPOTHESES 1 & 2: COMPARISON OF ONLINE FSM GROUP WITH THE 
INFO FSM AND CONTROL GROUPS ON PRIMARY OUTCOME MEASURES. 
ANCOVA tests were used to test the effect of group allocation on the primary 
outcome measures at post-test and follow-up. The pre-test scores of the primary 
outcome measure as well as depression, anxiety, stress, social support and self-
efficacy were controlled in these analyses. ANCOVA did not show any significant 
differences in the online FSM group relative to the info FSM and control groups for 
the FIS and ACS at post-test and follow-up (Tables 4.8 and 4.9). The observed power 
for these tests was low (between .11 and .64). Testing the effect of group allocation 
on PWI showed that while the groups were significantly different (p = .034) on PWI 
scores at post-test, this difference was not seen at follow up (p > .05). The effect size 
for the difference of the PWI scores at post-test was moderate to large.  Post hoc tests 
showed that the info FSM group had a significantly higher level of PWI compared 
with the control group (p =  .036) at post-test. Mean scores on the FIS, PWI and ACS 





Table  4.8 Comparison of Groups on Primary Outcomes at Post-test 
ANCOVA Results a Post-hoc test  
95% Confidence Interval 
for Difference 
 












FIS: Overall 2.209 .049 .440 .116  Online FSM ~ Info FSM -4.702 20.136 .350 
      Online FSM ~ Control -14.939 9.127 .914 
      Info FSM ~ Control -23.275 2.029 .126 
          
FIS: Physical Subscale 2.184 .048 .435 .119  Online FSM ~ Info FSM -.776 6.271 .172 
      Online FSM ~ Control -3.292 3.610 .999 
      Info FSM ~ Control -6.194 1.017 .231 
          
FIS: Cognitive Subscale 2.001 .044 .403 .141  Online FSM ~ Info FSM -1.939 5.109 .621 
      Online FSM ~ Control -4.811 2.064 .704 
      Info FSM ~ Control -6.561 .643 .139 
          
FIS: Psychosocial Subscale 1.990 .044 .401 .143  Online FSM ~ Info FSM -2.698 1.038 .416 
      Online FSM ~ Control -7.608 4.632 .912 
      Info FSM ~ Control -11.590 1.274 .154 





Table 4.8 continued 
ANCOVA Results a Post-hoc test 
95% Confidence 
Interval for Difference 
 










          
Activity Card Sort 2.292 .051 .454 .107  Online FSM ~ Info FSM -.142 .064 1.000 
      Online FSM ~ Control -.049 .155 .613 
      Info FSM ~ Control -.014 .198 .108 
          
Personal Wellbeing Index 3.519* .076 .642 .034  Online FSM ~ Info FSM -9.506 4.858 1.000 
      Online FSM ~ Control -1.648 12.361 .196 
      Info FSM ~ Control .366 14.994 .036* 
Note: FIS = Fatigue Impact Scale, n = 34 for online FSM group; n = 28 for the info FSM group and n = 33 for control group. 
a Covariates = Pre-test score for the Fatigue Impact Scale, Activity Card Sort Personal Wellbeing Index, Depression, Anxiety and Stress Scale,  Social Support Index and Self-





Table  4.9 Comparison of Groups on Primary Outcomes at Follow-up 
ANCOVA Results a  Post hoc test  
95% Confidence Interval 












FIS: Overall d 2.09 .046 .418 .131  Online FSM ~ Info FSM -.86 .138 1.00 
      Online FSM ~ Control -.174 .43 .438 
      Info FSM ~ Control -.205 .022 .160 
          
FIS: Physical Subscale 3.473* .075 .636 .035  Online FSM ~ Info FSM -1.561 6.476 .364 
      Online FSM ~ Control -5.926 1.946 .528 
      Info FSM ~ Control -8.559 -.335 .030* 
          
FIS: Cognitive Subscale 1.943 .043 .393 .149  Online FSM ~ Info FSM -3.589 4.728 .982 
      Online FSM ~ Control -6.664 1.449 .321 
      Info FSM ~ Control -7.428 1.074 .201 
          
FIS: Psychosocial Subscale 3.098 .067 .583 .050  Online FSM ~ Info FSM -5.095 10.615 .778 
      Online FSM ~ Control -12.697 2.400 .272 
      Info FSM ~ Control -15.842 .025 .051 
          






Table 4.9 continued 
ANCOVA Results a Post hoc test 
 
95% Confidence Interval 
for Difference Outcome Measure 











Activity Card Sort .599 .014 .147 .552 Online FSM ~ Info FSM -.145 .072 .795 
     
 
Online FSM ~ Control -.096 .118 .993 
      Info FSM ~ Control -.063 .159 .657 
          
Personal Wellbeing Index .363 .008 .106 .697  Online FSM ~ Info FSM -7.874 6.458 .993 
      Online FSM ~ Control -5.242 8.737 .905 
      Info FSM ~ Control -4.842 9.753 .800 
Note: FIS = Fatigue Impact Scale, n = 34 for online FSM group; n = 28 for the info FSM group and n = 33 for control group. 
a Covariates = Pre-test score for the Fatigue Impact Scale, Activity Card Sort Personal Wellbeing Index, Depression, Anxiety and Stress Scale,  Social Support Index and Self-
efficacy scores; b df  = 2, 98; c Bonferroni used for adjustment for multiple comparisons; * p  < .05. 
 





TEST OF HYPOTHESIS 3: DIFFERENCE IN PRIMARY OUTCOME MEASURES AT PRE-
TEST, POST-TEST AND FOLLOW-UP. 
One-way repeated measures ANOVA were used to examine changes in FIS, PWI 
and ACS for each group at the three assessment time points (i.e. pre-test, post-test, 
follow-up). Overall, both the online and info FSM groups but not the control group 
showed improvement on FIS and ACS scores over time. The improvement in fatigue 
levels in the online FSM group [F (2, 66) = 7.196, p = .001] and info FSM group [F 
(1.436, 38.774) = 19.48, p = .000] over time were strongly significant. The effect 
sizes for these improvements were large (partial eta squared >.014). As the FIS data 
for the control group was skewed, Friedman test was used for this part of analysis. 
The results showed that the fatigue in the control group did not improve statistically 
significantly over time [χ2(2) = 5.75, p = .062]. Paired t-tests were used to determine 
which of the time points differed significantly from one another for the FIS scores. 
This analysis revealed significant change between the pre-test and follow-up for the 
online FSM group (p = .003) and info FSM group (p < .001). Although the result for 
the Friedman test for the control group was not significant, the paired post-hoc tests 
were conducted to further explore the results. The critical difference was calculated 
equal to .59 based on Equation 4-1. Differences between mean ranks for the FIS 
scores for the control group are presented in Table 4.10.  It appeared that FIS did not 
significantly change between any of the time points as the differences between mean 
ranks were smaller than the critical difference. 
Table  4.10 Difference between Mean Ranks for Fatigue Impact Scale Data in the 
Control group 
 
R Follow-up  - R Pre-test R Post-test - R Pre-test R Follow-up  - R Post-test 
Difference .50 .41 .09 
 
The repeated measures ANOVA test replicated the same findings for the ACS. While 
the overall F for this analysis was significant for the online FSM group (F (2,23) = 
3.91, p = .025) and the info FSM group (F (2,26) = 8.63, p = .001), it was not 
statistically significant for the control group (F (1.404, 44.932) = 3.21, p = .066). 
Paired t-tests revealed significant changes from pre-test to follow-up for the online 





FSM group (p = .034) and info FSM group (p = .006) but not for the control group (p 
= .184). Although the paired t-test showed improvement of the control group in their 
ACS from post-test to follow-up, this result is not considered noteworthy as the 
overall F test for this group was not significant. The effect size calculated in the 
analyses for testing improvement of participants in the online FSM and info FSM 
groups over time was moderate to large. 
The results of the repeated measures ANOVA for PWI were different from that of 
the FIS and ACS score. Overall, the info FSM and control groups improved in PWI 
scores but the online FSM group did not. The info FSM group improved over time in 
PWI (F (2,54) = 4.11, p < .05). A paired t-test comparing the pre-test and follow-up 
mean PWI total scores revealed significant improvement for the info FSM group (p = 
.012). The control group had lower PWI scores at post-test compared to pre-test and 
then improved from post-test to follow-up (Table 4.11, Figure 4.5).  The results of 
the repeated measure ANOVA for the control group showed an overall improvement 
of PWI over time (p = .043). However, after correcting for multiple comparisons, 
only a trend toward significant improvement from pre-test to follow-up was seen for 
the control group (p = .057). The self-management program was not effective in 
increasing PWI in the online FSM group as revealed by the repeated measure 
ANOVA (F (1.6, 53.56) = 1.15, p > .05). However, as the observed power for this 





Table  4.11 Change in Scores of Primary Outcome Measures at Pre-test, Post-test and Follow-up 


















FIS: Overall         
Online FSM  7.20 (2,66)* .20 .96 .001  .206 .003 .042 
Info FSM  19.48 (1.44, 38.77)* a .39 1.00 .000   .000 .000 .306  
 
 Control   5.57(2) b - b - b .062  NS NS NS 
FIS: Physical Subscale          
  Online FSM  8.39 (2,66)* .20 .96 .001  .284 .002 .039 
  Info FSM  19.55 (41.48,39.81)* 
a .42 1.0 .000   .000 .000 .075 
  Control   7.88 (2,64)* .20 .94 .001  .025 .003 1.000 
FIS: Cognitive Subscale          
  Online FSM  4.97 (2,66)* .13 .79 .010  .474 .023 .151 
  Info FSM  8.77 (1.62, 43.71)* 
a .25 .96 .001  .002 .009 1.000 
  Control   1.26 (2,64) .04 .26 .292  1.00 .432 .951 
FIS: Psychological Subscale        
  Online FSM  8.31 (2,66)* .20 .96 .001  .151 .003 .053 
  Info FSM  16.82  (1.51,40.70)* 
a .38 1.0 .000  .000 .000 .550 
  Control   3.15 (1.64, 52.62)
 a  .09 .59 .060  .980 .210 1.000 





Table 4.11 Continued 


















Activity Card Sort         
Online FSM  3.91 (2,23)* .11 .69 .025  .053 .034 1.000 
Info FSM  8.63 (2,26)* .24 .96 .001  .012 .006 1.000  
 
 Control   3.21(1.40, 44.93) a .09 .59 .066   1.000 .184 .003 
Personal Wellbeing Index         
 Online FSM  1.15 (1.6, 53.56) 
a .03 .22 .316  1.000 .571 1.000 
 Info FSM  4.11 (2,54)* .13 .70 .022  .062 .012 1.000 
 
 Control   3.31 (2,64)* .09 .61 .043  .714 .467 .057 
Note. FIS = Fatigue Impact Scale; NS = not significant based on Friedman ANOVA therefore no p-value is available. 
 a Greenhouse-Geisser Correction as the assumption of sphericity is violated; b Friedman ANOVA was conducted, therefore observed power and effect size was not 
calculated; c Bonferroni used for adjustment for multiple comparisons; * p  < .05. 





4.3.3.2 RESULTS FOR SECONDARY OUTCOME MEASURES 
TEST OF HYPOTHESES 1 &2: COMPARISON OF ONLINE FSM, INFO FSM AND 
CONTROL GROUPS ON SECONDARY OUTCOME MEASURES 
The mean scores of the online FSM, the info FSM and control group on the 
secondary outcome measures were compared at post-test and follow-up after 
controlling for the covariates (Pre-test data for depression, anxiety, stress, self-
efficacy and social support). The three groups were not significantly different in 
depression, anxiety, stress or social support but they were significantly different [F 
(2, 86) = 3.797, p < .05] in their level of self-efficacy (Tables 4.12 and 4.13). The 
effect size for the difference between the self-efficacy scores was moderate to large 
(partial eta squared = .080). Paired t-test confirmed that both the online FSM group 
and the info group had higher levels of self-efficacy compared to the control group at 
post-test although after using Bonferroni for correction of multiple comparisons it 
showed the results to be marginal (p = .057 for the online FSM group and p = .058 
for the info FSM group). The online FSM and the info FSM groups were not 
significantly different from each other in their self-efficacy scores.  
The above results for self-efficacy were not returned at follow-up. The three groups 
were not different in self-efficacy, depression, anxiety and social support (overall 
score) levels at follow-up (p > .05). There were, however, significant difference 
between the groups in stress [F (2,86) = 3.737, p = .028] and satisfaction subscale of 
SSI [(F (2,86) = .030)]. Stress level was different among the three groups with a 
moderate to large effect size (partial eta squared = .079). Based on the paired t-test, 
the online FSM group had a lower level of stress than the control group three months 
after the intervention (p = .037). The other comparisons (online FSM group versus 
info FSM group and info FSM group versus control group) did not show the groups 
significantly different. The groups were significantly different in satisfaction at 
follow-up, F (2, 86) = 3.641, p < .05). The pairwise comparison showed that this 
difference was between the info FSM and the control group (p = .045). The info FSM 
group had significantly higher level of satisfaction at follow-up than the control 
group. The effect size for this comparison was moderate to large. The power 
observed for all the analyses in this section (both post-test and follow-up) was low, 
ranging between .104 and .677.  





TEST OF HYPOTHESIS 3: DIFFERENCE IN SECONDARY OUTCOME MEASURES AT 
PRE-TEST, POST-TEST AND FOLLOW-UP 
The effect of time on the secondary outcome measures in each of the groups was 
tested using repeated measure ANOVA (Table 4.14). There was a marginally 
significant improvement in overall SSI score [F (2,66) = 3.025, p = .055] and 
satisfaction subscale of SSI score [F (2,66) = 3.139, p = .050] only for the online 
FSM group. These changes were significant from post-test to follow-up, however, 
the results should be viewed with caution as the main ANOVA results were not 
significant. The SSI scores did not change significantly in any other group. Only the 
participants in the info FSM program improved in their self-efficacy over time, F (2, 
54) = 3.886, p = .027. The paired t-test with Bonferroni correction for multiple 
comparisons revealed a trend toward significant increase of self-efficacy scores for 
the info FSM group from pre-test to follow-up. None of the groups showed 
significant improvement in their scores for depression and anxiety or stress. The 
control group did not show significant change in any of the secondary outcome 






Table  4.12 Comparison of Groups on Secondary Outcomes at Post-test 
 ANCOVA Results a Post-hoc test  
95% Confidence Interval 
for Difference 
 










Generalised Self-efficacy Scale 3.797* .080 .677 .026 Online FSM ~ Info FSM -2.115 1.959 1.000 
     Online FSM ~ Control -.043 3.939 .057 
     Info FSM ~ Control -.050 4.102 .058 
         
DASS: Depression Subscale .691 .016 .163 .504 Online FSM ~ Info FSM -2.903 4.963 1.000 
     Online FSM ~ Control -4.744 2.945 1.000 
     Info FSM ~ Control -5.937 2.078 .729 
         
DASS: Anxiety Subscale .053 .001 .058 .948 Online FSM ~ Info FSM -2.933 2.375 1.000 
     Online FSM ~ Control -2.909 2.278 1.000 
     Info FSM ~ Control -2.741 2.668 1.000 
         
DASS: Stress Subscale .836 .019 .189 .437 Online FSM ~ Info FSM -4.552 3.045 1.000 
     Online FSM ~ Control -5.668 -1.756 .605 
     Info FSM ~ Control -3.045 4.552 1.000 





Table 4.12 continued 
ANCOVA Results a Post-hoc test 
95% Confidence Interval 
for Difference 
 













SSI: Overall  .470 .011 .125 .627 Online FSM ~ Info FSM -2.912 1.380 1.000 
     Online FSM ~ Control -2.771 1.424 1.000 
     Info FSM ~ Control -2.094 2.279 1.000 
         
SSI: Social Interaction Subscale 1.336 .030 .281 .268 Online FSM ~ Info FSM -.820 .781 1.000 
     Online FSM ~ Control -1.257 .309 .429 
     Info FSM ~ Control -1.278 .369 .543 
         
SSI: Satisfaction Subscale .471 .011 .125 .626 Online FSM ~ Info FSM -2.426 1.046 1.000 
     Online FSM ~ Control -1.989 1.383 1.000 
     Info FSM ~ Control -1.365 2.139 1.000 
Note: FSM = Fatigue Self-management Program; SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale; n = 34 for online FSM group; n = 28 for the 
info FSM group and n = 33 for control group. 
a Covariates = Pre-test Depression, Anxiety and Stress Scale, Social Support Index and Self-efficacy scores; b df  = 2, 98; c Bonferroni used for adjustment for multiple 






Table  4.13 Comparison of Groups on Secondary Outcomes at Follow-up 
ANCOVA Results a Post-hoc test  
95% Confidence Interval for 
Difference 
 





Lower bound Upper bound 
p-value c 
Generalised Self-efficacy Scale 1.096 .025 .237 .339 Online FSM ~ Info FSM -2.395 2.222 1.000 
     Online FSM ~ Control -1.090 3.423 .631 
     Info FSM ~ Control -1.099 3.605 .591 
         
DASS: Depression Subscale 2.181 .048 .435 .119 Online FSM ~ Info FSM -5.166 4.121 1.000 
     Online FSM ~ Control -8.177 .900 .161 
     Info FSM ~ Control -7.847 1.615 .335 
         
DASS: Anxiety Subscale .349 .008 .104 .706 Online FSM ~ Info FSM -2.740 3.966 1.000 
     Online FSM ~ Control -3.834 2.720 1.000 
     Info FSM ~ Control -4.857 2.247 1.000 
         
DASS: Stress Subscale 3.737* .079 .670 .028 Online FSM ~ Info FSM -4.880 3.677 1.000 
     Online FSM ~ Control -8.560 -.197 .037* 
     Info FSM ~ Control -8.136 .583 .112 





Table 4.13 Continued 
ANCOVA Results a Post-hoc test 
95% Confidence Interval for 
Difference 
 








Lower bound Upper bound 
p-value c 
SSI: Overall  2.406 .052 .474 .096 Online FSM ~ Info FSM -2.707 1.487 1.000 
     Online FSM ~ Control -.790 3.309 .412 
     Info FSM ~ Control -.267 4.006 .107 
         
SSI: Social Interaction Subscale .442 .010 .120 .644 Online FSM ~ Info FSM -1.121 .526 1.000 
     Online FSM ~ Control -1.035 .577 1.000 
     Info FSM ~ Control -.778 .916 1.000 
         
SSI: Satisfaction Subscale 3.641* .077 .658 .030 Online FSM ~ Info FSM -1.897 1.343 1.000 
     Online FSM ~ Control -.190 2.957 .104 
     Info FSM ~ Control .025 3.295 .045* 
Note: FSM = Fatigue Self-management Program; SSI = Social Support Index; n = 34 for online FSM group; n = 28 for the info FSM group and n = 33 for control group. 
a Covariates = Pre-test Depression, Anxiety and Stress Scale, Social Support Index and Self-efficacy scores; b df  = 2, 98; c Bonferroni used for adjustment for multiple 







Table  4.14 Change in Scores of Secondary Outcome Measures at Pre-test, Post-test and Follow-up 
Results of Repeated Measures ANOVA a  Post-hoc test  b Outcome 
Measure 
Group F 














Generalised Self-efficacy Scale        
Online FSM 1,613 (2,66) .047 .0329 .207  .383 .452 1.00 
Info FSM 3.886 (2,54)* .126 .678 .027  .070 .056 1.00  
Control .594 (2,64) .018 .145 .555  1.00 1.00 .817 
SSI: Overall        
Online FSM 3.025 (2,66) .084 .567 .055  .312 1.00 .037 
Info FSM 2.180 (2,54) .075 .427 .123  1.00 .210 .245  
Control 1.92 (1.69,53.90) .056 .349 .163  1.00 .337 .494 
SSI: Satisfaction Subscale        
Online FSM 3.139 (2,66) .087 .584 .050  .378 1.00 .038 
Info FSM 1.456 (2,54) .051 .298 .242  1.00 .315 .547  
Control 2.901 (2,64) .083 .548 .062  .843 .115 .469 
SSI: Social Interaction Subscale        
Online FSM 1.020 (2,66) .030 .221 .336  .700 1.00 .678 
Info FSM 1.688 (2,54) .059 .340 .194  1.00 .668 .270  
Control .010 (1.551,49.623) .000 .051 .990  1.00 1.00 1.00 






Table  4.14 continued 
Results of Repeated Measures ANOVA a  Post-hoc test b Outcome 
Measure 
Group F 














DASS: Depression Subscale        
Online FSM .6219 (2,66) .018 .150 .54  1.00 .931 1.00 
Info FSM .834 (2,54) .030 .186 .44  .626 1.00 1.00  
Control .827 (1.64,52.47) .025 .171 .422  1.00 1.00 .749 
DASS: Anxiety Subscale        
Online FSM .248 (1.693,55.584) .041 .271 .248  .204 1.00 .781 
Info FSM .285 (1.519,41.008) .010 .088 .753  1.00 1.00 1.00  
Control .264 (1.64,52.61) .008 .086 .726  1.00 1.00 1.00 
DASS: Stress Subscale        
Online FSM 1.205 (2,66) .060 .382 .130  .654 .264 1.00 
Info FSM 2.004 (1.833,49.495) .069 .396 .145  .973 .077 1.00  
Control 1.205 (2,64) .036 .254 .306  1.00 .562 .917 
Note: FSM = Fatigue Self-management Program; SSI = Social Support Index; n = 34 for online FSM group; n = 28 for the info FSM group and n = 33 for control group. 
a Covariates = Pre-test Depression, Anxiety and Stress Scale, Social Support Index and Self-efficacy scores; b Bonferroni used for adjustment for multiple comparisons;  
* p  < .05. 






4.3.4 SECONDARY ANALYSES 
4.3.4.1 COMBINATION OF THE ONLINE AND INFO FSM GROUPS 
Based on the results in the primary analyses, there were more similarities than 
differences in improvement patterns between the online FSM and info FSM groups. 
Therefore, the two groups were combined and the statistical analyses were again 
conducted. The combined group consisted of 62 participants who were compared 
with the control group on the primary and secondary outcome measures at post-test 
and follow-up (using ANCOVA tests). Also the changes in their scores over time 
were tested using repeated measures ANOVA. A summary of results are presented in 
Tables 4.15 and 4.16. Results of the sensitivity test are also presented but will be 
further reported in section 4.3.4.2. 
 
Table  4.15 Summary of Results for Comparison of Groups Using ANCOVA Test 
Intent-to-treat 
(Main study) 














Primary Outcome Measures 
FIS: Overall    ~√   
FIS: Physical Subscale  √  √  ~√ 
FIS: Cognitive Subscale    ~√   
FIS: Psychosocial Subscale    √   
Activity Card Sort   ~√    
Personal Wellbeing Index √  √  √  
Secondary Outcome Measures 
Generalised Self-efficacy Scale √  √  √  
SSI: Overall    √   
SSI: Social Interaction 
Subscale 
      
SSI: Satisfaction Subscale  √  √  ~√ 
DASS: Depression Subscale    √   
DASS: Anxiety Subscale       
DASS: Stress Subscale  √  √   
Note. √ = Groups were significantly different; ~√ = A trend towards significant difference between the 
groups; FIS = Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety and 
Stress Scale. 
 











combined group  






















Primary Outcome Measures 
FIS: Overall √ √ ~√ √ ~√ √ √  
FIS: Physical 








√ √ ~√ √ ~√ √ √  
Activity Card 




 √ √ √ √   √ 




 √  √  ~√ √  












        
DASS: Anxiety 
Subscale         
DASS: Stress 
Subscale    √    √ 
Note. √ = Groups were significantly different; ~√ = A trend towards significant difference between the 
groups; FIS = Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety and 
Stress Scale. 
 






Results of ANCOVA test comparing the combined group and control group showed 
some differences from the primary analyses (Table 4.15). At post-test, similar to the 
primary analyses, the combined and control groups were significantly different in 
PWI and self-efficacy. There was a trend toward significance for better results on the 
ACS for the combined group in comparison with the control group. These results 
were not seen for the ACS scores in the primary analyses. At follow-up, the 
participants in the combined group were significantly better on the physical and 
psychosocial subscales of FIS, overall social support score and satisfaction, 
depression and stress, than the control group. In the primary analysis only physical 
subscale of FIS, Satisfaction subscale of SSI and stress were significantly different 
between groups. Furthermore, the secondary analysis on the comparing the combined 
and control group revealed that there were trends toward significant differences 
between the two groups in their overall FIS scores and psychological subscale of 
FIS.  
The results for the repeated measures ANOVA produced considerably different 
results in comparison with the results for primary analyses (Table 4.16). All the 
improvements seen in the online and info FSM groups on the primary outcome 
measures were also shown in the analysis on the combined group. Similar to the 
online and info FSM groups, the combined group improved on the FIS and all of its 
subscales, the PWI and the ACS. In addition, the combined group showed 
improvements in self-efficacy and on the satisfaction subscale and overall score of 
SSI. There were two other differences between the results of the analyses on the 
combined group and that of the primary analyses. The data on the DASS stress 
subscale for the combined group showed significant improvement of the participants 
over time, while the results for repeated measures ANOVA on stress subscale was 
not significant for any of the three groups in the primary analyses.  The other 
difference between the results was seen on the social interaction subscale of SSI. 
While there was a trend toward significant difference for improvement in the online 
FSM group on satisfaction in the primary analyses, the combined group did not show 
this change over time.  
F-ratios, effect size, observed power, p-value and the results for post-hoc tests for the 
ANCOVA tests and repeated measures ANOVA for the combined group are 






presented in Appendix F. The analyses for the combined group compared to the 
control group had a greater power in comparison with the observed power for the 
primary analyses. 
4.3.4.2 SENSITIVITY TESTS 
Sensitivity tests were performed using the data for the participants in the three groups 
(online, info FSM and control groups) who had complete data sets at pre-test, post-
test and follow-up data and completed more than 5 sessions of the FSM program 
(both  for the online and the info FSM groups). There was not a considerable 
difference between the intent-to-treat and sensitivity tests results (Tables 4.15 and 
4.16).   
The same results for the ANCOVA tests (comparison of the three groups in primary 
and secondary outcome measures at post-test and follow-up) were produced as in the 
intent-to-treat analysis. On the secondary outcomes, the only exceptions were 
between the groups on satisfaction subscale of the SSI at follow-up and self-efficacy 
at post-test. In contrast to the results of intent-to-treat, the results for the sensitivity 
test showed no difference between the groups in satisfaction subscale of the SSI. The 
p-value dropped from .030 in the intent-to-treat test to .053 in the sensitivity test 
which showed only a trend toward significant difference between the info FSM 
group and the control group at follow-up (Appendix G). The other difference 
between intent-to-treat analysis and the sensitivity test was seen between the groups 
on self-efficacy scores at post-test. There was only a trend toward significance for 
difference between the online FSM and info FSM, and the control group in the 
intent-to-treat test. But this difference was highly significant in the sensitivity test [F 
(2, 86) = 7.69, p =.001]. Both the online FSM group (p = .004) and the info FSM 
group (p = .005) had significantly higher self-efficacy scores than the control group 
at post-test. The effect size of the test was large (partial eta squared = .215). Similar 
to the primary analyses, the self-efficacy scores were not significantly different 
between groups at follow-up in sensitivity analysis. 
There were almost no differences between the results of the primary analyses and the 
sensitivity test when comparing the pre-test, post-test and follow-up in each group. 
The only exception was improvement of the control group over time in their ACS 






score which showed only a trend toward significance in the primary analysis but a 
statistically significant improvement was seen for the control group on the ACS in 
the sensitivity test. F ratio, effect size, observed power, p-value and the results for 
post-hoc tests for the ANCOVA tests and repeated measures ANOVA for the 
combined group are presented in Appendix F. 
4.3.4.3 ANALYSIS ON PEOPLE WITH MS 
Analyses were performed using the data for the participants with MS only in the 
three groups (online, info FSM and control groups). Other than a slight trend toward 
significant difference between groups (using ANCOVA tests) in the depression scale, 
no differences between the results for people with MS and the results of the main 
analyses (MS, PD and PPD) were seen (Table 4.17).  
Results of the main study and the study on people with MS when using repeated 
measures ANOVA showed only slight differences for the online and info FSM 
groups while the control group had very different results (Table 4.18). For the online 
FSM most of the results for the people with MS were the same as results of the main 
study. However, statistically significant improvement was seen in the people with 
MS on their anxiety and stress. This result was not seen in the main study. The other 
difference was significant improvement on the ACS in the main study while this 
result dropped to a trend towards significance in the analysis for the people with MS. 
The results of the two studies produced almost the same results for the info FSM 
group. The only difference was that the participants with MS showed only a trend 
toward significant improvement on the PWI while this improvement was significant 
when data for all participants were entered to the analysis.  
 
The results for the two control groups (MS only and total group) had considerable 
differences. A trend toward significant improvement on the overall FIS and 
psychological subscale of the FIS was seen in the main study while this result 
changed to significant improvement on the overall FIS and no significant 
improvement on the psychological subscale of the FIS in the MS only control group. 
The control group of participants with MS improved over time on the SSI and 






satisfaction subscale of SSI while these results were not seen in the control group in 
the main study. 
Table  4.17 Summary of Results for Comparison of Groups Using ANCOVA Test 
(Only Participants with MS) 
All participants 
(Main study) 




Post-test Follow-up Post-test Follow-up 
Primary Outcome Measures 
FIS: Overall     
FIS: Physical Subscale  √  √ 
FIS: Cognitive Subscale     
FIS: Psychosocial Subscale     
Activity Card Sort     
Personal Wellbeing Index √  √  
Secondary Outcome Measures 
Generalised Self-efficacy Scale √  √  
SSI: Overall     
SSI: Social Interaction Subscale     
SSI: Satisfaction Subscale  √  √ 
DASS: Depression Subscale    ~√ 
DASS: Anxiety Subscale     
DASS: Stress Subscale  √  √ 
Note. √ = The groups were significantly different; ~√ = A trend towards significant difference between 
the groups; FIS = Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety 
and Stress Scale. 
 






Table  4.18 Summary of Results for Change of Scores Over Time Using Repeated 
Measures ANOVA (Only Participants with MS) 
All participants 
(Main study) 




















Primary Outcome Measures 
FIS: Overall √ √ ~√ √ √ √ 
FIS: Physical 
Subscale √ √ √ √ √ √ 
FIS: Cognitive 
Subscale √ √  √ √  
FIS: Psychosocial 
Subscale √ √ ~√ √ √  
Activity Card Sort √ √ ~√ ~√ √ ~√ 
Personal Wellbeing 
Index  √ √  ~√ √ 
Secondary Outcome Measures 
Generalised Self-
efficacy Scale  √   √  




      
SSI: Satisfaction 
Subscale ~√   ~√  √ 
DASS: Depression 
Subscale       
DASS: Anxiety 
Subscale    √   
DASS: Stress Subscale    √   
Note. √ = The groups were significantly different; ~√ = A trend towards significant difference between 
the groups; FIS = Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety 
and Stress Scale. 
4.4 DISCUSSION 
The aim of this study was to evaluate the efficacy of an online fatigue self-
management program for people with chronic neurological conditions. Although the 
participants in both the online FSM and info FSM groups improved over time on the 
FIS and ACS, they were not significantly different from the control group or from 
each other. Therefore, the first null hypothesis (no difference between the online 
FSM group and the info FSM group) and second null hypothesis of the study (no 
difference between the online FSM group and the control group) could not be 
rejected. The thirds null hypothesis (no improvement in the online FSM group) was 






rejected. The participants in the online and info FSM groups improved on the FIS 
and ACS. These may attributable to several reasons. Firstly, the info FSM group 
acted more similar to an experimental group than an ‘attention’ group. Secondly, the 
participants in the control group showed a trend towards significant improvement on 
the FIS and ACS. Thirdly, there is a possibility of Type II error in this study as the 
power of the ANCOVA analyses to test the hypotheses of difference between the 
online FSM group and the two control groups was low. Each of these three theories 
for non significant results of the differences between the online FSM group and the 
control groups are further discussed below. It is important to note that as a 
comprehensive discussion and comparison of the online FSM program with the face-
to-face FSM program is presented in the next chapter, discussion in this chapter is 
focused on comparison of the online FSM program with the two control groups and 
the literature on online interventions.  
Non significant differences between the online FSM group and the info FSM group 
were surprising as, when designing the present study, the info FSM group was 
planned as a control group to counter the possibility that effects may occur due to 
attention. However, the info FSM group seemed to offer more than attention to the 
participants. The info FSM program included ‘self-management type’ information 
such as the blogs from the expert panel (Appendix A) which showed others with 
chronic conditions successfully using the self-management skills introduced and 
practiced in the program. The information and the expert panel blogs provided for 
the participants in the info FSM group were identical to that presented to the online 
FSM group. Participants in the info FSM program received the information 
individually and without a facilitator and did not meet each other in the ‘group’. 
Therefore, contrary to the online FSM group, the participants in the info FSM 
program did not have access to group communication component of the program. 
Given that the literature emphasises (Nguyen et al., 2004) that ‘pure’ information is 
not sufficient for behaviour change, it appears likely that the info FSM program 
offered more than simply ‘attention’ to the participants, in effect an ‘individual self-
management information’ program.  
Interestingly, while the online FSM and info FSM group were not significantly 
different from each other in any of the outcome measures at any of the time points, 






there were similarities and differences in areas/patterns of improvement between the 
online and info FSM groups. Although both the online and info FSM groups 
improved on the FIS, their pattern of improvement over time was different. The info 
FSM group improved during the program (between pre-test and post-test) and not 
after completion of the program (between post-test and follow-up) and the opposite 
pattern was seen for the online FSM group (no improvement between pre-test and 
post-test and improvement between post-test and follow-up). This is consistent with 
the results of a systematic review on online interventions (Nguyen et al., 2004). The 
author found that information control groups which offered access to study websites 
with minimal or no feedback from the facilitators appeared to also show some 
benefit. A longer follow-up study was needed for the present study to test whether 
the benefits of online FSM and info FSM continue over time. 
Another similarity between the online and info FSM groups was seen in the self-
efficacy results. The ANCOVA tests showed that the three groups were significantly 
different in self-efficacy levels at post-test. Although after adjusting for multiple 
comparison there was only a trend toward significantly higher self-efficacy scores for 
the online and info FSM groups when compared to the control group, the less 
conservative sensitivity analysis (Appendix G), where the participants with complete 
data sets were analysed, reached statistical significance in this measure (p < .05). 
This finding parallels that of previous research (S. Girdler, 2004; K. R. Lorig et al., 
1999; Mathiowetz et al., 2005)  which has suggested that one of the positive 
outcomes of self-management interventions for adults with chronic conditions is an 
increase in self-efficacy. However, the difference on the self-efficacy at post-test was 
not apparent at 12-week follow-up. This is inconsistent with other studies which have 
found improvement in self-efficacy after online programs for chronic conditions (K. 
R. Lorig, Ritter et al., 2001; K. R. Lorig et al., 2004). This may be the result of using 
a general self-efficacy scale in the present study while other studies used either 
disease specific scales (K. R. Lorig, Ritter et al., 2001; K. R. Lorig et al., 2004) or a 
self-efficacy scale designed specifically to cover the intervention topics (Mathiowetz 
et al., 2005) . Because this study included participants with different neurological 
conditions, applying a disease specific measurement tool was not possible. A disease 






specific self-efficacy scale may be more sensitive to change and difference between 
the groups.  
The online and info FSM groups had other different areas of improvement over time. 
The participants in the info FSM group improved in their PWI over time while this 
improvement was not seen in the online FSM group. However, the improvement in 
the social support in the online FSM group was not seen in the info FSM group. The 
non significant improvement of PWI in the online FSM group is inconsistent with the 
results of the Mathiowetz, Finlayson, Matuska, Chen, & Luo’s study (Mathiowetz et 
al., 2005). Both the present study and the study by Mathiowetz and colleagues were 
based on the same fatigue self-management program, and were specifically run by 
occupational therapists. Response shift may be an explanation for this result which 
has also been found in some people who take part in self-management programs (R. 
H. Osborne, Hawkins, & Sprangers, 2006). Response shift has been defined as a 
change in the meaning of one’s self-evaluation of a target construct like quality of 
life as a result of (a) recalibration (change in a person’s internal standards of 
measurement) (b) re-prioritisation (change in a person’s values) or (c) re-
conceptualisation (a change in the way a person defines a target construct; e.g. 
quality of life). The group-based intervention may stimulate social comparisons, 
improve knowledge of issues around self-care and understanding of symptoms. The 
response shift was more possible to happen in the online FSM group than the other 
two groups (info FSM and control group) as only the participants in this group had 
access to group communication.  The second explanation for lack of improvement on 
the PWI scores for the participants in the online FSM groups may be performance 
bias (causing Type II error). As explained previously, the participants were not 
blinded to their allocation therefore the participants in the control group may have 
tried new strategies to help them with their fatigue.  
The similarities and differences between the online and info FSM groups show the 
importance of determining which components of a self-management program are 
responsible for what outcomes. Authors of several systematic reviews have called for 
further research in this area (Nolte et al., 2007; S. Taylor, 2005; Warsi et al., 2004). 
Nguyen (2004) who reported on a systematic review on online patient education 
interventions also put emphasis on the importance of determining which participants 






will most benefit from structured interventions that involve extensive professional 
guidance versus those programs with minimal contact between the participants and 
the facilitator as there is much available online information. The ‘group 
communication’ component of the FSM program is a good example. The group 
communication proved to be a popular component of the online FSM program. There 
was a high level of contribution by the participants (mean of 9.23 forum posts per 
person over the 7 week program) in comparison with other studies (K. R. Lorig et al., 
2002) (mean of 8.0 posts per person during 1 year of the study with email discussion 
group). This shows the enthusiasm of participants for the interactive component of 
the program. This is also consistent with the results of the deconstruction-
reconstruction stage of designing the online program (Ghahari et al., in press) which 
emphasised the interactive component as the most important part of this self-
management program (Ghahari et al., in press). On the other hand, anecdotal 
feedback from the participants in the online group suggested that although 
participating in the group discussions and contributions was enjoyable, it was time 
consuming and required a great deal of energy which may have resulted in the lack 
of change from pre-test to post-test for this group of participants. This may explain 
why the participants in the online FSM group did not start improving in their fatigue 
and activity participants until after the end of the program while the info FSM group 
improvement was seen during the program but not after it. This result supports the 
literature which suggests that people are more likely to feel empowered by being able 
to digest the information at their own pace and to better use it to enhance treatment 
efficacy (Ritterband et al., 2003).  
Improvement of the control group may be another reason for not finding significant 
difference between the three groups on the outcome measures.  In this study, 
participants in the online FSM and the info FSM programs showed significant 
improvement over time (using repeated measures ANOVA analyses) in their overall 
FIS score and ACS levels. Therefore, null hypothesis number 3 of the study was 
rejected. But although the improvement in the control group in fatigue was not 
statistically significant, there was a slight trend towards significance. This may 
explain why there was no significant difference between groups (using ANCOVA 
analyses) in the overall FIS scores and the ACS at post-test and follow-up between 






the groups i.e. the null hypotheses 1 and 2 were not rejected. In fact, the info FSM 
group had a sharp decrease in the physical and psychological fatigue from pre-test to 
post-test and then from the post-test to follow-up. As a result, the results of post-hoc 
tests showed significant difference between the info FSM and control groups on the 
physical subscale of the FIS and a marginally significant difference for the 
psychological subscales of the FIS at follow-up. The effect sizes for these differences 
were medium to large (.06 < partial eta squared < .14). These differences for the FIS 
subscales were not significant between the online FSM group and the other two 
groups. The change in scores in the control group may be a result of performance 
bias (causing Type II error) as the participants were not blind to their allocation. 
Alternatively, their failure in accessing the fatigue self-management program may 
have been a motivation to seek additional therapeutic interventions.  
In general participants in this study did not show any improvement in depression, 
anxiety or stress. It is possible that people had already maximised their potential for 
adaptation to extreme fatigue at least in terms of mood, since analyses at baseline 
showed that DASS scores for participants in the present study were within the 
normal stress levels with only mild anxiety and depression levels compared to the 
Australian population. However, this may be attributable to the persons’ diagnoses as 
the results of the secondary analysis showed that people with MS improved 
significantly in their anxiety and stress. The other possible reason for lack of 
significant improvement in the DASS scores for all participants may be attrition. The 
participants who dropped out had significantly worse anxiety and stress levels than 
the participants who completed the three data sets. It is possible that the most anxious 
participants withdrew. However, the three groups had different stress levels at 
follow-up with the online FSM group having a significantly lower level than the 
control group. The online FSM and the info FSM groups were not statistically 
different from each other at follow-up. The improvement on the stress subscale of 
DASS for the online FSM group may be attributable to the group communication 
component of this program. This result is consisted with the literature suggesting 
improvement in social support as a benefit of group self-management programs 
(Gallant, 2003). However, the groups may have behaved differently on the variables 
which were not measured in this study. For example, the control participants may 






have accessed health-related websites at the same rate as the intervention 
participants. We do not know whether participants continued their routine care in the 
same manner as before they were randomised or if they sought other interventions 
for their fatigue. It is possible that people who volunteered for the program, also 
actively sought other information/programs to help them deal with their fatigue. It is 
also important to highlight that the online and info FSM programs were provided in 
addition to routine care. Although the medication used by the participants was 
monitored, it was not possible to control the type of other services they were 
receiving during the study.  
Another possible explanation for the non significant difference between groups may 
be the low power of the analyses. The observed power for all ANCOVA tests (to test 
hypotheses 1 and 2) on all primary outcome measures at post-test and follow-up were 
low, ranging from 11% to 64% with most scores falling below 46%. Compared to a 
desired level of 80%, this is still low. The standard deviation for most of the scores 
was large. For example, the mean scores for overall FIS for whole the sample in the 
RCT study was 80.53±31.60 (observed power of 42%).  This extremely low power 
and also visual analyses of the results (Figure 4.3 to 4.5) suggests that a larger 
sample size was needed to detect the difference between groups on the primary 
outcome measures at post-test and follow-up. The results for comparison of the 
combined group (online and info FSM groups) with the control group strongly 
confirms this theory. In comparison with the control group, the participants in the 
combined group showed significant improvement on the physical and psychological 
subscales of FIS at follow-up. Trend towards significance was also seen in the 
participants on the overall FIS and the cognitive subscale of FIS at follow-up.  In 
addition, the combined group had a significantly higher PWI score and trend towards 
significant improvement on the ACS at post-test in comparison with the control 
group. The results for the repeated measure ANOVA for the combined group also 
confirmed the above findings. Similar tests for the secondary outcome measures also 
show similar results for the efficacy of the program for the combined group. The 
combined group was significantly better than the control group in self-efficacy (at 
post-test) and overall SSI, satisfaction subscale of SSI, depression and stress (at 
follow-up). Therefore, it seems that because of the small sample size (Portney & 






Watkins, 2008) the analyses of sample data were unable to statistically document the 
difference between the three groups (online FSM, info FSM and control groups) 
(Type II error). 
Several issues must be considered when interpreting the findings. These have been 
enumerated below. 
(1) Some caution must be exercised in generalising these findings to the overall 
population of adults with chronic neurological conditions. This study was limited to 
people who had MS, PD or PPS, who had at most mild cognitive problems, and were 
older than 20 years of age. It is unknown if these findings would apply to all people 
with neurological conditions. Further, online interventions are limited to those people 
who are computer literate and who have access to the internet. This group of adults 
may have had particular characteristics which influenced the outcomes of the study 
such as access to other information online. Further, although clinically the online 
FSM program would be intended for such a group, participants recruited to the 
present study had higher levels of education compared to their peers in the same age 
range in the general population and are more likely to seek information as a strategy 
to manage their conditions. People with higher education are also more likely to need 
and/or have access to information technology. The use of computer also allows for 
participation by people who cannot or will not attend a face-to-face fatigue self-
management program because of barriers like transportation, job commitments or 
geography. Given the nature of neurological conditions, some participants missed 
sessions of this randomised control trial because of exacerbations, hospitalisation, or 
other challenges. Seven people in the online FSM arm and 4 persons in the Info FSM 
arm were lost to follow-up. The elimination of these participants from a single 
outcome analyses (sensitivity analysis) would have threatened the internal validity of 
the study and possibly led to some misleading interpretations (Altman et al., 2001; 
Portney & Watkins, 2008). As such, the conservative intention-to-treat approach to 
analysis was adopted, with participant outcomes being analysed in line with study 
assignment, rather than according to the intervention actually received (Portney & 
Watkins, 2008). The self-selection of the participants may also raise the issue of how 
generalisable the findings are. However, self-selection takes place in all efficacy 
studies with respect to ethical right of the participants. Further, self-selection to 






participate is likely to involve those with sufficient time, interest and motivation 
which is in line with the client-centred and readiness to change approaches (Dijkstra 
et al., 2001; Law, 1998; Prochaska & Norcoss, 2001).  
(2) Although the external validity of the study may have been affected by the method 
of recruitment (self-selection through advertisement), the randomisation ensured the 
internal validity of the trial (Altman & Bland, 1999). In addition, because recruitment 
to the study was through self-selection, it was not possible to describe reasons for 
refusal or calculate participation rates; selection bias may have occurred. Based on 
the literature at least half of individuals with MS, PPS and PD suffer from extreme 
fatigue (Berlly et al., 1991; Fisk et al., 1994; Friedman & Friedman, 1993).  The 
flyers for this program were not received by all those with extreme fatigue as the 
flyers were circulated by the related associations and not all the people with these 
diagnoses are members of the associations. Also, statistics shows that only half of 
people with disabilities have access to the internet (Australian Bureau of Statistics, 
2002-2003). Therefore, this program did not reach all the people who could 
potentially benefit. 
(3) A systemic bias in the evaluation may have occurred as the result of the desire to 
appease or reward the group facilitator. This effect may be linked to social 
desirability. Through the group process and sharing of personal information, strong 
positive relationships between participants and facilitators may develop during the 
course. Furthermore, participants may be conscious that they are evaluating the 
course and participation may have required considerable personal effort. The 
combined effects of these experiences may have led to an ‘artificially’ higher score 
on items resulting in an overestimate of the outcomes for individuals. This bias is 
difficult to control and has been found to be more common in women and older 
people (Visser, Breemhaar, & Kleijnen, 1989). 
(4) The participants in this study were not tested for their level of disability and 
exacerbation of their condition. While the majority of the participants were people 
with MS it is possible that a relapse in symptoms prevented people using the skills 
they had newly learnt during the program. The level of disability at baseline and/or a 
change in the level of disability during the study could have impacted on the 






outcomes of the fatigue self-management program. Although randomisation should 
have accounted for differences, this could not be confirmed. Also, it is unknown if 
the participants with different diagnoses (MS, PD and PPS) benefited from the 
program differently; establishing the results based on statistical tests was not possible 
because of the small sample size for participants with PPS and PD (Table 4.7). 
(5) An important point to take into consideration in RCT studies is missing data. 
Missing data at post-test and follow-up, which is a common observation in RCTs, 
may have resulted in systematic bias in this study. The attrition rate in this study (9% 
at post-test and 21% at follow-up) was in the same range as other studies on self-
management programs in chronic disease. In one systematic review of 71 trials there 
was an average dropout rate of 17% across all diseases, ranging from 16% to 20% 
(Warsi et al., 2004). Also, the attrition rate in the present study was not high when 
compared with other studies on online patient education and support interventions 
which report the attrition anywhere from 4% to 51% (Nguyen et al., 2004). The 
Nguyen review showed that studies with online recruitment which did not have face-
to-face contact appeared to have higher attrition rates. Unlike other studies on online 
interventions that report higher attrition in the participants in the experimental groups 
comparing to the control groups (Nguyen et al., 2004), there was no significant 
difference in attrition rate among the three groups in the present fatigue self-
management study. However, some differences were found in clinical characteristics 
between those who did and did not provide complete data. The higher anxiety and 
stress level of the participants who did not return the post-test questionnaires 
compared to the other participants suggests that the participants’ mood can affect 
their participation in the programs. The participants with better psychological 
outlook may have greater capacity to benefit from online self-management programs.  
Despite these cautions, the present study has important strengths. The methodology 
addresses many of the limitations noted in previous research designs, in particular 
randomised allocation to the intervention groups. Pre-test analysis revealed that this 
randomisation resulted in comparable groups with regards to sociodemographic and 
clinical characteristic indicating that the study was internally valid (Altman & Bland, 
1999). 






Findings in this study highlighted the need for further studies in the area of self-
management. The cost effectiveness of this method of delivery compared to the 
traditional face-to-face delivery could be a subject for more exploration. Although 
there are obvious financial and structural barriers to design and development of such 
programs, they may be cost effective as they reduce the cost of travel (for the 
participants and/or the facilitators) to zero. As currently the face-to-face programs 
are known as ‘gold standards’, more rigorous studies are required to compare the 
online fatigue self-management program with the face-to-face fatigue self-
management program. Also, a study with a larger sample size is needed to explore 
the effect of the program on the fatigue, activity level and quality of life in 
comparison with a control group. An RCT with different facilitators is also needed to 
compare the effect of characteristics of the facilitators on the efficacy of the program.  
4.5 CONCLUSION 
The primary purpose of a fatigue self-management program is to help the 
participants improve their everyday performance and quality of life by incorporating 
‘energy conservation techniques’ and self-management skills into their lives. 
Through the application of a fatigue self-management program, occupational 
therapists and other health professionals expect that the participants will learn the 
self-management skills, make corresponding behaviour changes and experience a 
reduction in the effect of fatigue on their lives. This involves introduction, practice 
and personal selection of specific strategies for managing fatigue and making 
behavioural and environmental changes. Specific strategies included in the FSM 
program are balancing activity and rest, modifying life standards, adjusting priorities 
and changing body position for certain activities. While some people may need to 
decrease the number of the activities they do to control their fatigue, the ultimate 
goal for a fatigue self-management program is decreasing fatigue level at the same 
time as improving activity choice and level and consequently improving quality of 
life.  
In compliance with the framework for development and evaluation of complex 
interventions, this component of the project was an RCT to test efficacy of the online 
fatigue self-management program (Phase 3) (Medical Research Council, 2000). To 






our knowledge, this online FSM program is the first of its kind implemented for 
people with neurological conditions. Although the RCT did not show significant 
differences between the online FSM program and the control groups, the participants 
in the online and info FSM programs definitely improved over time. The low power 
in all analyses when comparing the groups revealed that a bigger sample size is 
required to detect possible differences between the online FSM and control groups. 
Results of the secondary analysis on the combined group showed that the online 
FSM and info FSM group complemented each other. The combined group showed 
significant differences when compared to the control group. This further suggests 
that the need for a larger sample size. It also suggests that the online program needs 
to be edited. While the improvement in social support shows that the interactive 
component and the activities of the online program are needed, it needs to be less 
time consuming for the participants. The facilitators can rely more on the group 
dynamics and the self-management focus inherent in the program. Online 
interventions like the online FSM program represent an important strategy for 
bridging the gap in the service for those who can not participate in face-to-face 
programs. New knowledge gained from this study can further support the idea of 
providing other self-management programs online.  The results of this study also add 
to the growing body of the evidence emerging regarding how information technology 
may assist with improving health outcomes related to chronic conditions. The 
findings provide some evidence of the potential benefits of online fatigue self-
management program for people with chronic neurological conditions. 
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5 COMPARISON TO FACE-TO-FACE PROGRAM 
5.1 INTRODUCTION 
The previous chapter presented the RCT study to evaluate the efficacy of the online 
FSM in comparison with the info FSM and control groups in a sample of adults with 
chronic neurological conditions. The literature suggests incorporating face-to-face 
treatment interventions as one of the experimental conditions when testing the 
efficacy of an online program (Ritterband et al., 2003). Therefore, a face-to-face 
group was also included in this study. As the online FSM program was designed to 
provide service for the people who do not have access to the face-to-face program, 
randomisation of the participants to four groups (face-to-face FSM, online FSM, info 
FSM and control groups) was not feasible because restricting the inclusion criteria to 
participants who had access to both the face-to-face and online programs would have 
excluded the very people for whom the program was designed. Subsequently, this 
part of the PhD project was designed to apply a nonequivalent pre-test post-test 
control study to compare participants in the face-to-face FSM group with participants 
in the online and control groups. Because the results of the study showed 
improvement in both the online FSM and the info FSM groups over time in primary 
and secondary outcomes, the info FSM group was also included in the nonequivalent 
pre-test post-test control study. As a result, this chapter presents the methodology, 
results and discussion of the nonequivalent pre-test post-test control study of the 
face-to-face fatigue self-management program. The participants’ characteristics of 
the four groups are first compared at baseline. As per the RCT, the progress of the 
participants in the face-to-face group over time is explored and these results are 
compared with the online FSM, info FSM and control groups.  
5.2 METHODS 
5.2.1 STUDY DESIGN AND PROCEDURE 
A nonequivalent pre-test post-test control group design was used to compare the 
efficacy of a face-to-face FSM group with the online FSM, info FSM and the control 
groups. The recruitment method, inclusion-exclusion criteria, blinding and 
procedures were identical to those explained in Chapter 4 (Efficacy of the Online 





Fatigue Self-management Program). The only exception was that if the participants 
had access to the face-to-face program they were excluded from the RCT and 
allocated to the face-to-face group rather than being randomised to one of the other 
three groups (online FSM, info FSM or control group) (Figure 5.1).  
5.2.2 OBJECTIVES 
The main objective of this study was to evaluate the efficacy of the face-to-face FSM 
program and compare it with an online FSM, info FSM and control groups in a 
sample of adults with chronic neurological conditions. To meet this objective, two 
null hypotheses were considered:  
1) There is no difference between the face-to-face FSM program and each of the  
online FSM, info FSM and control groups on the on primary and secondary outcome 
measures at post-test and follow-up among a sample of adults with chronic 
neurological conditions; and 
2) There is no improvement in fatigue, quality of life or activity participation at pre-
test, post-test and follow-up for the face-to-face FSM group among a sample of 
adults with chronic neurological conditions. 
5.2.3 VARIABLES 
5.2.3.1 INDEPENDENT VARIABLES 
The independent variable had four levels. The intervention groups, which are 
summarised in Table 5.1, included the online FSM, info FSM and control groups 
(explained in detail in Chapter 4) and a face-to-face FSM group. The face-to-face 
FSM was the 6-week intervention following the published protocol outlined in 
Managing Fatigue (T. L. Packer et al., 1995). The conceptual frameworks used in 
this protocol (self-efficacy theory, self-management approach and group model of 
service delivery) are explained thoroughly in Appendix A. Each session of this 
program was highly structured and included an education session, practice activities, 
discussions and homework assignment. All teaching content, worksheets, handouts 
and homework assignments were standardised and provided. Based on self-efficacy 
theory (Bandura, 1997b) each session incorporated strategies known to increase 
confidence in the ability to engage in specific behaviours.  





The facilitators of the face-to-face group were occupational therapists at the MS 
Society of WA who completed a 2-day training course. They were trained using the 
material and content of the original intervention with step-by-step training in how to 
deliver the program. During the training, an explanation of fidelity and its 
importance were provided to the facilitators, and common challenges to fidelity, as 
well as strategies to enhance and monitor fidelity were discussed. Each face-to-face 
program was taught at a community setting easily accessible to group participants. 
Treatment delivery fidelity was measured with the use of weekly checklists 
completed by facilitators, documenting compliance with the protocol. Also the 
participants were asked to complete a checklist for testing the treatment enactment 
fidelity.  













√ √ √  
Expert panel’s 
blogs 
 √ √  
Facilitator √ - active √ - active √ - passive  
Group 
communication 
√ √   
Activities √ √   
Access to other 
participants 
√ √   
Note. √ = Components received by participants; FSM = Fatigue Self-management. 
 
5.2.3.2 DEPENDENT VARIABLES  
All measures described in the pilot study (Chapter 3) and the RCT (Chapter 4) were 
used in this study. All variables were tested via the post by using paper-based 
versions of the measures. Data collection procedure was identical to the procedure 
for the pilot and the RCT studies (sections 3.2.3.3 and 4.2.3). 
5.2.4 DATA ANALYSIS 
The primary analysis was intention-to-treat and the missing data were treated as 
explained in the RCT study. All results were analysed using the software package 





SPSS 15.0 for Windows, 2007. Data analysis was performed using the same 
statistical tests as the ones used for the RCT study. Hence only a summary of data 
analysis is provided here. Missing value analysis was conducted to test for patterns in 
missing data. Preliminary checks were conducted to ensure that there was no 
violation of the assumptions of normality, linearity, homogeneity of variances, 
homogeneity of regression slopes, and reliable measurement of the outcome 
measures and covariates. T-test and chi-square test were used to compare the groups 
at baseline on their sociodemographic and clinical characteristics.  
ANCOVA was performed to examine the impact of the type of intervention on the 
primary outcome measures (FIS, PWI and ACS) and secondary outcome measures 
(GSE, SSI, and DASS) at post-test and follow-up (Testing hypotheses 1 and 2). If 
significant, pairwise comparison was performed with Bonferroni correction for 
multiple comparisons. All analyses was adjusted for multiple comparisons of the four 
groups, hence p < (.05/3) = .017 (Bonferroni adjustment) was considered as 
significant. To test the change in scores from pre-test to post-test and follow-up for 
face-to-face FSM group (Testing hypothesis 2), repeated measures ANOVA were 
performed with time (pre-test, post-test and follow-up) as the within-subject factor. 
Results of repeated measures ANOVA were considered statistically significant when 
p < .05. 
5.2.5 ETHICS 
Ethics approval for the study was obtained from the Curtin University Human 
Research Ethics Committee (Approval number OT-2005-14). See details in sections 
3.2.4 and 4.2.6. 
5.3 RESULTS 
5.3.1 PARTICIPANT FLOW 
Figure 5.1 depicts the flow of participants through the study. The study was 
conducted between April 2007 and August 2008. Description of the flow of the 
participants for the online FSM, info FSM and control groups is thoroughly 
explained in Chapter 4. Hence in the present chapter only the flow of the participants 
in the face-to-face group is presented.  





Twenty nine participants were eligible for the study. Six people declined on the basis 
of time commitment or a clash of schedules. Three participants did not return the 
completed time 1 questionnaire therefore they were not included in the analyses as 
the return of the first questionnaire was considered as consent. The twenty 
participants, who completed the first questionnaire and gave consent, participated in 
the groups. The number of participants in each face-to-face group ranged between 3 
and 8 (Mean = 5 ± 2.6). The diagnosis confirmation letters from the doctors were 
received for 16 persons (80% of the 20 participants) and in 100% of cases the 
diagnosis by the doctors matched with the participants’ self-reported diagnosis.   
Attendance rates are reported in Table 5.2 which includes the data for the online 
FSM, info FSM and face-to-face groups for comparison. One participant in the face-
to-face FSM did not attend any sessions in the program. Almost 90% of the 
participants in the face-to-face FSM attended at least 4 weeks of the intervention but 
55% missed at least one session of the program. An independent-samples t-test was 
conducted to compare the participation rate (i.e. the number of weeks that the 
participants in the experimental groups were actively involved in the program) 
between the online FSM, info FSM and face-to-face FSM groups. There was no 
significant difference in the participation rate for the face-to-face FSM group (Mean 
= 4.95, SD = 1.64) and that of the online FSM (Mean = 5.53, SD = 2.27; t (2) = -
.996, p = .324) and the info FSM group (Mean = 5.89, SD = 2.02; t (46) = -1.718, p = 
.093). 
  





Figure  5.1  Flow of Participants  






Table  5.2 Participation Rates in the Fatigue Self-management Groups 















6 Weeks 22 64.7 20 71.4 9 45 
5 Weeks 24 64.7 21 75 17  85 
4 Weeks 24 73.5 23 82.1 18 90 
3 Weeks 27 79.4 23 82.1 18 90 
2 Weeks 29 85.3 23 82.1 18 90 
1 Week 30 88.2 27 96.4 19 95 
Orientation 
Week 
33 97 28 100 - 100 
Did not  
participate 
1  - 0 - 1 - 
Note. FSM = Fatigue Self-management. 
 
5.3.2 SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
Table 5.3 gives a summary of the sociodemographic and clinical characteristics of 
participants in the four groups at pre-test. As expected by the sampling strategy, the 
groups differed by geographic area, both in terms of the state and country versus 
metropolitan area. The participants in the face-to-face group were all from one 
metropolitan area i.e. Perth, Western Australia. Unexpected difference also existed 
between groups. The participants in the face-to-face group had higher gross income 
than the other groups although this difference did not reach statistical significance. 
While the groups were not significantly different in time since diagnosis, the face-to-
face group had a range of 1-17 years compared to 1-71 years for the online FSM 
group and 1-52 for the info FSM and the control group.   
The scores on the FIS and FSS reflect the different constructs that the two 
measurement tools measure (Dittner et al., 2004). Although a score of 4 or higher on 





the FSS was considered as an inclusion criterion, at least one of the participants in 
the face-to-face group had a score of zero on the FIS. 
The face-to-face FSM group was not significantly different from the other groups in 
their mood (depression, anxiety and stress) and social support at baseline. But their 
self-efficacy level was higher than the info FSM group (p < .017), with the face-to-
face group demonstrating higher self-efficacy. The ACS scores were considerably 
higher for the face-to-face FSM participants when compared to participants in the 
online FSM group (p = .007). This difference was not significant when the face-to-


































Gender         
Male  5 (25) 3 (8.8) .113 6 (21.4) .519 9 (27.3) 1.00 
Female  15 (75) 31 (91.2)  22 (78.6)  24 (72.7)  
Age, years         
Mean (SD)  52.05 (11.76) 51.00 (13.6) .388 47.86 (12.0) .236 51.52 (11.06) .868 
Range  27-74 23-74  28-81  31-90  
State          
Western Australia  20 (100) 11 (32.4) .000* 6 (21.4) .000* 8 (24.2) .000* 
Queensland  0 (0) 9 (26.4)  12 (42.8)  13 (39.4)  
New South Wales  0 (0) 7 (20.6)  5 (17.9)  6 (18.2)  
South Australia, Victoria, 
and Tasmania 
 0 (0) 7(20.6)  5 (17.9)  6 (18.2)  


































Living Area         
Metropolitan  20 (100) 21 (61.8) .001* 16 (57.1) .000* 20 (60.6) .001* 
Country  0 (0) 13 (38.2)  12 (42.9)  13 (39.4)  
Highest Education Level        n = 18 n = 22  n = 19  n = 29  
Secondary School or Less  10 (55.6) 7 (20.6) .001* 9 (32.1) .042* 13 (39.4) .068 
Tertiary Qualification  7 (38.9) 13 (38.2)  14 (50.0)  13 (39.4)  
Vocational Qualification 
 1 (5.6) 14 (41.2)  5 (17.9)  7 (21.2)  



































Living Situation         
Live alone  3 (15) 21 (61.8) .728 4 (14.3) .628 7 (21.2) .725 
Live with others  17 (85) 13 (38.2)  24 (85.7)  26 (78.8)  
Employment         
Employed  7 (35.0) 10 (29.4) .447 13 (46.4) .311 10 (30.30) .476 
Unemployed  13 (65.0) 24 (70.6)  15 (53.6)  23 (69.7)  
Working Hours/Week      
Mean (SD)  6.75 (11.77) 6.00 (10.94) .670 9.75 (14.67) .453 8.76 (17.79) .656 
Range  0-40 0-40  0-50  0-74  
Gross Income/week  n = 18 n = 32  n = 18  n = 31  
Less than $599   3 (15) 12 (37.5) .0395 9 (32.1) .334 13 (41.9) .056 
Between $600 and $1999   11 (55) 17 (53.1)  14 (50.0)  15 (48.4)  
More than $2000  4 (20) 3 (9.4)  5 (17.9)  3 (9.7)  
Note. FSM = Fatigue Self-management;; Unless otherwise mentioned n=20 for face-to-face FSM group, n=34 for online FSM group, n=28 for info FSM group and n=33 for 


































Diagnosis        
Parkinson’s Disease or Post-polio 
syndrome  
7 (35.0) 9 (26.5) .549 5 (17.9) .198 7 (21.2) .341 
Multiple Sclerosis       13 (65.0) 25 (73.5)  23 (82.1)  26 (78.8)  
Time since Diagnosis (in years)  n = 14 n = 24  n = 23  n = 26  
Mean (SD)  6.48 (5.88) 13.54 (17.74) .155 11.48 (11.16) .127 9.46 (10.33) .314 
Range  1-17 1-71  1-52  1-52  
Type of MS         
  Relapsing–remitting           6 (60%) 13 (65.0) .548 14 (77.8) .284 12 (57.1) 1.00 
Other types (%)  4 (40%) 7 (35.0)  4. (22.2)  9   (42.9)  
Contact         
Telephone   18 (90%) 8 (23.5) .000* 7 (25) .000* 3 (9.1) .000* 
Email   2 (10%) 26 (76.5)  21 (75)  30 (90.9)  




































General Perceived Self-efficacy        
Mean (SD) 31.60 (4.10) 29.44 (5.14) .058 28.71 (3.81) .016* 28.85 (5.18) .049 
Range 25-40 18-40  19-36  12-38  
DASS: Depression Subscale       
Mean (SD) 9.25 (10.05) 11.00 (9.99) .269 10.81 (10.24) .756 10.79 (8.89) .564 
Range 0-33 0-37  .39  0-39  
DASS: Anxiety Subscale        
Mean (SD) 7.40 (7.70) 8.97 (6.69) .217 7.79 (7.68) .865 7.03 (6.87) .857 
Range 0-34 0-24  0-32    
DASS: Stress Subscale        
Mean (SD) 10.95 (8.36) 13.71 (8.96) .135 13.54 (10.54) .367 12.00 (9.08) .676 
Range 0-34 0-37  0-42  0-34  


































SSI: Overall score       
Mean (SD) 34.70 (4.08) 29.97 (4.05) .149 29.75 (4.76) .296 31.42 (5.09) .840 
Range 24-41 22-37  16-36  19-40  
SSI: Social Interaction Subscale        
Mean (SD) 8.15 (1.79) 8.21 (1.77) .456 8.00 (1.72) .771 8.97 (1.65) .095 
Range 3-10 4-12  4-11  4-11  
SSI: Satisfaction Subtest       
Mean (SD) 26.55 (4.19) 25.15 (3.90) .110 25.81(4.60) .291 26.03 (4.58) .681 
Range 17-34 16-32  13-31  16-34  




























difference  with 
the face-to-face 
FSM group 
FIS: Overall         
Mean (SD)  64.80 (31.68) 79.94 (30.48) .044 86.14 (32.57) .014* 76.36 (32.165) .208 
Range  0-107 11-135  30-147  28-159  
FIS: Physical Subscale         
Mean (SD)  20.40 (8.92) 24.97 (8.02) .029 25.04 (7.16) .026 23.27 (7.719) .221 
Range  0-31 8-39  10-40  10-40  
FIS: Cognitive Subscale       
Mean (SD)  14.30 (7.81) 19.18 (8.52) .021 20.43 (9.54) .011* 17.48 (9.871) .225 
Range  0-27 10-40  6-38  2-40  
FIS: Psychological Subscale       
Mean (SD)  30.35 (16.61) 36.29 (16.25) .102 41.21 (17.51) .018 35.91 (17.23) .254 
Range  0-54 10-40  10-74  10-79  




























difference  with 
the face-to-face 
FSM group 
Activity Card Sort         
Mean (SD)  1.02 (.30) .87 (.15) .007* .88 (.22) .035 .93 (.19) .09 
Range  .80-1.93 .47-1.04  .28-1.20  .30-1.48  
Personal Wellbeing Index       
Mean (SD)  66.00 (19.03) 57.18 (21.56) .68 59.74 (19.12) .14 58.74 (19.30) .09 
Range  16-100 7-94  11-84  10-91  
Note. FSM = Fatigue Self-management;; Unless otherwise mentioned n=20 for face-to-face FSM group, n=34 for online FSM group, n=28 for info FSM group and n=33 for 
control group; * p < .017. 
 






5.3.3 TEST OF HYPOTHESIS 1: COMPARISON OF THE FACE-TO-FACE 
FSM GROUP TO EACH OF THE ONLINE FSM, INFO FSM AND 
CONTROL GROUPS ON THE PRIMARY AND SECONDARY 
OUTCOME 
Results of ANCOVA tests (after controlling for time 1 scores of the primary outcome 
measure and all the covariates) showed that while the face-to-face, online and info 
FSM groups were not different at any time point on any outcome measures, there 
were significant differences between the face-to-face FSM and the control group. 
After controlling for pre-test scores, the face-to-face FSM group had significantly 
better scores than the control group at post-test on the overall FIS and also the 
cognitive and psychosocial subscales (p < .017). The effect size for the three tests 
was large (eta square > .14). The face-to-face and control groups were not different 
on the physical subscale of the FIS. However, the observed power for the test was 
only 31%. The two groups were not different on any outcome at follow-up (Tables 
5.5 and 5.6). The groups were not significantly different on the ACS and PWI at 
post-test or follow-up. Further, as the results in Tables 5.7 and 5.8 show, the face-to-
face group was not significantly different from other groups in any of the secondary 
outcome measures (self-efficacy, social support, depression, anxiety and stress) at 
post test and follow-up.  
5.3.4 TEST OF HYPOTHESIS 2: DIFFERENCE ON PRIMARY AND 
SECONDARY OUTCOME MEASURES AT PRE-TEST, POST-TEST 
AND FOLLOW-UP IN THE FACE-TO-FACE GROUP 
One-way repeated measures ANOVA was used to examine changes in the primary 
and secondary outcome measures  for the participants in the face-to-face FSM group 
at the three assessment time points (pre-test, post-test and follow-up). The results of 
the tests are presented in Tables 5.9 and 5.10. The participants showed significant 
improvement in overall FIS scores and all subscales (physical, cognitive and 
psychological). Scores on the ACS and PWI nor any secondary outcome measures 





Table  5.5 Comparison of Face-face FSM to each of Online FSM, Info FSM and Control Groups on Primary Outcomes at Post-test  
95% confidence interval 
for difference 





Lower bound Upper bound Effect size Observed power p-value 
Online FSM 3.109 -22.212 1.469 .063 .408 .085 
Info FSM .307 -15.498 8.826 .008 .084 .582 FIS: Overall 
Control 8.015* -24.651 -4.156 .151 .791 .007 
Online FSM 1.727 -5.856 1.230 .036 .251 .195 
Info FSM .516 -2.715 4.035 .004 .067 .695 FIS: Physical Subscale 
Control 2.196 -5.167 .787 .047 .305 .145 
Online FSM 2.671 -6.222 .646 .055 .361 .109 
Info FSM .46 -4.490 2.234 .011 .102 .502 FIS: Cognitive Subscale 
Control 12.180* -7.5559 -2.027 .213 .927 .001 
Online FSM 2.515 -10.139 1.203 .952 .342 .121 
Info FSM .614 -8.030 4.806 .006 .079 .614 FIS: Psychosocial Subscale 
Control 6.797* -12.330 -1.582 .141 .723 .012 





Table  5.5 continued  
95% confidence interval 
for difference 













Online FSM .834 -.042 .112 .018 .145 .366 
Info FSM .011 -.111 .100 .000 .051 .919 Activity Card Sort 
Control 1.583 -.044 .189 .034 .234 .215 
Online FSM .001 -7.548 7.342 .000 .050 .978 
Info FSM 4.228 -10.688 -.092 .096 .519 .046 Personal Wellbeing Index 
Control .405 -4.424 8.512 .009 .096 .528 
Note. FSM = Fatigue Self-management Program; FIS =  Fatigue Impact Scale. 







Table  5.6 Comparison of Face-face FSM to each of Online FSM, Info FSM and Control Groups on Primary Outcomes at Follow-up 
95% confidence interval  
for difference 
ANCOVA Results b 
Outcome Measure Comparison group F a 
Lower bound Upper bound  Effect size Observed power p-value 
Online FSM .834 -.042 .112 .018 .145 .366 
Info FSM .154 -12.494 18.510 .008 .084 .582 FIS: Overall 
Control 2.658 -.164 .017 .056 .358 .110 
Online FSM .215 -4.784 2.992 .005 .074 .645 
Info FSM .780 -2.493 6.362 .019 .319 .382 FIS: Physical Subscale 
Control 1.578 -5.479 1.270 .034 .233 .215 
Online FSM .161 -4.957 2.176 .013 .120 .437 
Info FSM .254 -5.629 3.383 .006 .678 .617 FIS: Cognitive Subscale 
Control 4.546 -6.601 -.188 .092 .550 .038 
Online FSM .005 -6.177 5.739 .000 .051 .941 
Info FSM .518 -4.929 10.379 .013 .108 .476 FIS: Psychosocial 
Subscale 
Control 2.203 -12.048 1.825 .047 .306 .145 






Table 5.6 continued 
95% confidence interval  
for difference 





Lower bound Upper bound  Effect size Observed power p-value 
Online FSM .005 -.113 .122 .000 .051 .941 
Info FSM .360 -.103 .191 .009 .090 .552 Activity Card Sort 
Control .500 -.094 .196 .011 .106 .483 
Online FSM .820 -11.243 4.265 .018 .144 .370 
Info FSM 5.251 -10.448 -.655 .116 .609 .027 Personal Wellbeing Index 
Control 1.845 -10.561 2.054 .039 .265 .181 
Note. FSM = Fatigue Self-management Program; FIS = Fatigue Impact Scale. 






Table  5.7 Comparison of Face-face FSM to each of Online FSM, Info FSM and Control Groups on Secondary Outcomes at Post-test 
95% confidence interval for 
difference 




F a  
Lower bound Upper bound  Effect size Observed power p-value 
Online FSM 1.830 -3.000 .588 .037 .263 .183 
Info FSM 3.790 -3.409 .062 .085 .477 .058 Generalised Self-efficacy Scale 
Control .589 -1.33 2.96 .013 .117 .4447 
Online FSM 2.805 -3.785 .346 .056 .375 .101 
Info FSM .175 -1.603 2.440 .004 .069 .678 SSI: Overall 
Control .000 -1.61 1.62 .000 .05 .993 
Online FSM 1.345 -.302 1.123 .028 .206 .252 
Info FSM .528 -.540 1.146 .013 .109 .472 SSI: Social Interaction Subscale 
Control 1.46 -1.27 .32 .031 .22 .234 
Online FSM 2.190 -.456 2.994 .045 .305 .146 
Info FSM .032 -1.547 1.850 .001 .054 .858 SSI: Satisfaction Subscale 
Control .068 -1.12 1.46 .001 .057 .796 






Table 5.7 continued 
95% confidence interval for 
difference 





Lower bound Upper bound  Effect size Observed power p-value 
Online FSM .1018 -3.464 3.957 .000 .052 .894 
Info FSM 1.773 -1.373 6.685 .041 .255 .190 DASS: Depression Subscale  
Control .029 -2.87 3.40 .001 .054 .867 
Online FSM .001 -1.119 1.868 .000 .050 .982 
Info FSM .035 -2.562 3.088 .001 .054 .852 DASS: Anxiety Subscale 
Control .923 -2.66 .940 .020 .156 .342 
Online FSM 1.666 -4.756 1.038 .034 .244 .203 
Info FSM 1.795* -5.717 1.157 .042 .258 .188 DASS: Stress Subscale 
Control 6.472 -6.78 -.7 .123 .702 .14 
Note. FSM = Fatigue Self-management Program; SSI =Duke Social Support Index; DASS = Depression, Anxiety and Stress Scale. 






Table  5.8 Comparison of Face-face FSM to each of Online FSM, Info FSM and Control Groups on Secondary Outcomes at Follow-up 
95% confidence interval  
for difference 





Lower bound Upper bound  Effect size Observed power p-value 
Online FSM .633 -3.107 1.346 .013 .122 .430 
Info FSM .961 -2.845 .986 .023 .160 .333 Generalised Self-efficacy Scale 
Control .239 -1.80 2.96 .005 .077 .627 
Online FSM .189 -2.329 1.501 .004 .071 .66 
Info FSM 2.641 -3.481 .377 .061 .355 .112 SSI: Overall 
Control .004 -2.03 1.91 .000 .050 .951 
Online FSM 1.228 -.289 .998 .028 .192 .274 
Info FSM .496 -1.129 .545 .012 .016 .485 SSI: Social Interaction Subscale 
Control .001 -.899 .871 .000 .050 .974 
Online FSM .940 -2.290 .800 .020 .158 .337 
Info FSM 2.813 -2.812 .260 .064 .374 .101 SSI: Satisfaction Subscale 
Control .002 -1.51 1.45 .000 .050 .962 





Table 5.8 continued 
95% confidence interval  
for difference 




F a  
Lower bound Upper bound  Effect size Observed power p-value 
Online FSM .558 -2.542 5.544 .012 .113 .459 
Info FSM .742 -2.671 6.644 .018 .138 .394 DASS: Depression Subscale  
Control .172 -5.72 3.76 .004 .069 .680 
Online FSM .000 -2.908 2.903 .000 .050 .999 
Info FSM .453 -2.236 4.474 .11 .101 .504 DASS: Anxiety Subscale 
Control .204 -4.27 2.71 .004 .073 .654 
Online FSM .119 -2.814 3.976 .003 .063 .732 
Info FSM .586 -2.029 4.506 .014 .116 .448 DASS: Stress Subscale 
Control 1.79 -7.65 1.54 .037 .258 .184 
Note. FSM = Fatigue Self-management Program; SSI= Duke Social Support Index; DASS= Depression, Anxiety and Stress Scale. 






Table  5.9 Change in Scores of Primary Outcome Measures at Pre-test, Post-test and Follow-up in Face-to-face Group 
 Results of Repeated Measures ANOVA   Post-hoc test p-value a 
Outcome Measure  
 
F 
(df k-1, df n-2) 






FIS: Overall score  8.82 (2,38)* .392 .960 .001   .010 .014 1.00 
FIS: Physical Subscale 7.67(1.54,29.34)* .288 .931 .004   .040 .061 .655 
FIS: Cognitive Subscale 5.85(2,38)* .235 .846 .006   .016 .051 1.00 
FIS: Psychological Subscale 8.54(2,38)* .310 .954 .012   .012 .019 1.00 
           
Activity Card Sort  2.49(1.27, 24.20) .116 .470 .121   .108 .257 1.00 
           
Personal Wellbeing Index 788(2,38) .598 .040 .174   1.00 .813 1.00 
Note. FIS = Fatigue Impact Scale.  






Table  5.10 Change in Scores of Secondary Outcome Measures at Pre-test, Post-test and Follow-up in Face-to-face Group 
 Results of Repeated Measures ANOVA   Post-hoc test p-value a 
Outcome Measure  
 
F 











Generalised Self-efficacy Scale .738 (2,38) .037 .166 .485   .683 1.00 1.00 
SSI: Overall  .986(2,38) .049 .209 .383   1.00 1.00 .453 
SSI : Social Interaction Subscale .385 (2,38) .020 .107 .683   1.00 1.00 1.00 
SSI: Satisfaction Subscale 
1.397 
(1.99,37.87) 
.068 .281 .260   1.00 .678 .414 
DASS: Depression Subscale .056 (2,38) .003 .058 .945   1.00 1.00 1.00 
DASS: Anxiety Subscale .587 (1.33,25.09) .030 .122 .497   .208 1.00 1.00 
DASS: Stress Subscale 
2.046 
(1.409,26.77) 
.097 .326 .159   .022 1.00 .649 
Note. SSI = Duke Social Support Index; DASS = Depression, Anxiety and Stress Scale. 
a Bonferroni used for adjustment for multiple comparisons; * p  < .05. 






The aim of this study was to evaluate the efficacy of the face-to-face FSM program 
in comparison with the three groups tested in the RCT part of this project (online 
FSM, info FSM and control groups). This study showed that, similar to other studies 
(Mathiowetz et al., 2001; Vanage et al., 2003) and similar to the results for the online 
and info FSM groups, persons with chronic neurological conditions who participated 
in the 6-week face-to-face FSM program significantly improved in all FIS scores 
(physical, cognitive and psychological) over time. They were also significantly 
different from the control group at post-test on the cognitive subscale, psychological 
subscale and overall FIS scores.  
While the result for the overall FIS score and psychosocial subscale of FIS for the 
face-to-face FSM group is parallel to that of other studies on the same program 
(Mathiowetz et al., 2005; Mathiowetz et al., 2001; Vanage et al., 2003), the results 
for other FIS subscales were different between the studies. In the present study, the 
scores for cognitive FIS subscales were significantly lower than the control group 
while the scores for the physical subscale were not different. This is inconsistent with 
other studies that have found lower scores for the physical subscales after 
participating in the face-to-face FSM program but not for the cognitive subscale. 
This difference in results between studies may be because the participants in the 
present study had three different diagnoses (MS, PD and PPS) while the sample for 
the other three studies included only people with MS (Mathiowetz et al., 2005; 
Mathiowetz et al., 2001; Vanage et al., 2003). Further studies are needed to explain 
why the two versions of the program have different effects on the various aspects of 
fatigue. 
Unlike participants in the online and info FSM groups who showed improvement in 
quality of life, activity participation, self-efficacy and social support, the participants 
in the face-to-face group in this study did not improve over time in any of these 
outcome measures other than the FIS. This result is also inconsistent with the 
findings in other studies which report increases in self-efficacy and quality of life 
scores after participating in the face-to-face fatigue self-management program 
(Finlayson, 2005; Mathiowetz et al., 2005) or other self-management programs (For 





example S. J. Girdler, 2006; K. R. Lorig, 2001). This may be the result of using a 
general self-efficacy scale in the present study while the other studies used disease 
specific scales. This may be as a result of the fact that the participants in the face-to-
face group were different from the participants in the RCT part of the study with 
respect to some demographic and clinical characteristics at base-line. The 
participants in the face-to-face group had higher levels of income and lower levels of 
education in comparison to the other groups. While the participants in the RCT part 
of the study had ACS score ranging from .87 to .93 at baseline (which suggests that 
they had lost some of their activities because of fatigue (Appendix E), the 
participants in the face-to-face FSM group had a mean score of 1.02 before starting 
the program (no change in their activity level because of fatigue). The high baseline 
scores indicated that, on average, the participants in the face-to face group had not 
experienced any loss in their activity. Hence, it is not surprising that scores did not 
improve post-intervention. Also, this group of participants had higher mean self-
efficacy scores at pre-test when compared with the other groups. This difference 
reached statistical significance when compared with the info FSM group. Therefore, 
the likelihood of improvement in self-efficacy for participants in the face-to-face 
group was low. Further, the potential to improve for this group of participants on any 
of the subscales of DASS (depression, anxiety and stress) was also low as their 
DASS scores at baseline were within the normal range or marginal for mild 
difficulties (S. H. Lovibond & P. F. Lovibond, 1995). Although the scores for PWI in 
the face-to-face group were not significantly different from the other groups, the 
mean for the group (Mean = 66.00, SD = 19.03) was nearer the normal range in 
Australia (Mean = 74.92, SD = 12.36) (International Wellbeing Group, 2006); 
therefore the likelihood of improvement in PWI was lower for the participants in the 
face-to-face group. All these differences suggest that the participants who had access 
to the face-to-face program were different from the participants who only had access 
to the internet to participate in the program. This suggests that these two versions of 
the program can provide service for two different groups of people with fatigue. 
The small sample size is an important limitation of this study which should be taken 
into consideration when generalising the results. The program was delivered in only 
two suburbs in the metropolitan area of Perth, Western Australia (WA). Therefore, a 





limited number of Australians could access this version of the program during the 
study. Also, the MS Society WA Inc. had been providing this service for people with 
MS for three years before the start of this project. Consequently, a large number of 
the members of the MS Society had previously participated in the program and 
therefore were not eligible for this study. Another limitation of this research, which 
may have affected external validity of the results, was the quasi- experimental design 
of the study. Randomisation of the participants to the four groups was not feasible as 
the face-to-face program was only being delivered in WA during the data collection 
period of this project and the people for whom the online program was designed (e.g. 
people in rural or remote areas or people who were employed) had no access to the 
face-to-face program. Therefore, a non-equivalent pre-test post-test design was 
chosen for this part of the study and the sample recruitment happened in parallel with 
the RCT part of the program.  
The results of this study suggest the need for further exploration of the efficacy of the 
fatigue self-management program in online and face-to-face versions with a larger 
sample size and also using an RCT design by providing the face-to-face version of 
the program in several metropolitan and country areas in Australia. It also suggests 
the need to examine equality of access to services. Those in the RCT and without 
access to effective interventions appear to have greater fatigue and poorer overall 
health. 
5.5 CONCLUSION 
The results of this study on the face-to-face FSM program in comparison with online 
FSM program suggest that the online and info FSM program was successfully 
mimicking its face-to-face version. Further, the differences in some outcome 
measures, and some clinical and demographic characteristics show that the potential 
participants that these two versions of the program can target, are different. The 
participants who volunteered for participation in the online FSM program had lower 
activity levels and higher fatigue levels than the participants who have access to the 
face-to-face program. This suggests that the online program reaches people with 
poorer baseline scores. Therefore, providing the two versions of the program for the 
community may bridge one of the service gaps identified by the literature. Future 





research is needed to determine whether similar results can be achieved if the face-
to-face program was provided widely in Australia and a randomised controlled trial 
could be conducted. 
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6 PREDICTORS OF IMPROVEMENT 
6.1 INTRODUCTION  
The previous two chapters described the evaluation of the online and face-to-face 
versions of the FSM program. However, recent systematic reviews have emphasised 
the scarcity of literature studying which components of self-management 
interventions are essential to help people to improve in their quality of life and/or 
other intervention-specific outcomes (Lenz et al., 2007; S. Taylor, 2005; Warsi et al., 
2004). This study tried to answer three of these clinical questions. The first question 
was ‘who benefits most from self-management programs?’. For clinicians, it is 
important to know which group of people with what kind of clinical characteristics 
(such as level of self-efficacy, depression, anxiety and/or stress) should be selected 
for self-management programs. Some literature reviews report that there is evidence 
for more improvement in younger female participants (Nolte et al., 2007) and 
individuals with more severe symptoms (Guevara, 2003; R. Taylor, Lovibond, 
Nicholas, Cayley, & Wilson, 2005) as a result of self-management programs. 
However, they call for further study to determine which demographic or baseline 
clinical characteristics predict better outcomes. The second clinical question 
examined was related to the underlying mechanisms for self-management programs. 
This knowledge is required to decide how to design programs and to train the 
facilitators of the self-management programs and how to increase the likelihood of 
improvement of the participants. For example, while the literature shows strong 
relationships between fatigue and mood (specifically depression), it is unknown 
whether mood changes as a result of participation in a fatigue self-management 
program. Alternatively, it may be necessary to treat depression prior to enrolment. 
The third question to answer was whether activity level at baseline is a predictor for 
improvement in fatigue after participating in fatigue self-management programs. The 
evidence related to activity is contradictory. Some studies have found fatigue and 
activity level are negatively correlated and some have not found any significant 
relationship between them. As the emphasis of the fatigue self-management program 
(T. L. Packer et al., 1995) is how to balance activity and fatigue, it is important to 




know how more active and less active people respond to the program and what helps 
them to improve their fatigue.  
Therefore, in this part of the project a secondary analysis approach was employed to 
re-evaluate the data collected to answer these three questions, not yet answered in the 
literature.  As Portney (2008) mentions “the major advantages of this approach are 
the minimal expense involved, the ability to study large samples, and the elimination 
of the most time-consuming part of the research process-data gathering” (p.353). 
This chapter presents the methodology, results and discussion of the secondary 
analysis of data collected from participants in all four study arms (face-to-face FSM, 
online FSM, info FSM and control). Only participants with complete data sets (pre-
test, post-test and follow-up) were analysed.   
6.2 METHODS 
6.2.1 OBJECTIVES 
The aim of this study was to answer the following clinical questions: 
 What clinical and demographic characteristics predict the likelihood of 
improvement in FIS, PWI and ACS for people with fatigue? 
 By what mechanisms do people improve? (i.e. Changes in which variables are 
predictors of positive health outcome?)  
 What are the predictors of improvement in fatigue for people with different 
baseline activity levels?  
6.2.2 STUDY DESIGN AND SAMPLE 
A secondary analysis was conducted on all complete data sets in order to evaluate all 
data collected from the fatigue self-management programs (RCT and face-to-face 
studies). This included participants in the online, info and face-to-face FSM groups. 
The control group was also included as the participants in this group showed 
significant (or trends toward significant) improvements in some outcome measure in 
the RCT. All outcome measures (primary and secondary) were collected at pre-test, 
post-test and follow-up in the RCT study and face-to-face study in order to be used in 
this part of the research. Regression analysis which is a powerful statistical approach 




for explaining and predicting quantifiable clinical outcomes (Portney & Watkins, 
2008), was used to be able to predict outcomes and characteristics which are crucial 
to effective fatigue self-management programs.  
6.2.3 VARIABLES 
In order to address objectives 1 and 2 of the secondary analyses, three dependant 
binary variables were defined to categorise individuals into those who improved in 
the outcome of PWI, FIS, ACS and those who did not (Figure 6.1). The definitions 
used were based on the minimal clinically important difference (MCID). MCID is 
defined as ‘the smallest difference in score in the domain of interest that can be 
defined which patients perceive as beneficial and which would mandate, in the 
absence of troublesome side-effects and excessive cost, a change in the patient’s 
management’ (Jaeschke, Singer, & Guyatt, 1989p. 408). It can be used as a cut-off 
score when there is not enough evidence to make decisions on clinically important 
changes in scores (Make, 2007). The literature reports that 7-20 point change in the 
modified version of the FIS (Gillson, Richard, Smith, & Wright, 2002; Kos et al., 
2007; Kos et al., 2003; Oken et al., 2004; Rammohan et al., 2002) is clinically 
significant; however, there is no evidence available for the original FIS which was 
used in this study. Similarly, there is no evidence available to indicate clinically 
significant change for the ACS or PWI. Hence an MCID was  required. A variety of 
approaches has been proposed for estimating the MCID (Sloan, 2005): the 
distribution (statistical) approach, the anchor (external measure) approach and the 
opinion approach. In this study, MCID was decided based on a statistical approach. 
Half the standard deviation of scores at baseline, which is the most common 
statistical method for deciding on MCID (Norman, Sloan, & Wyrwich, 2003) was 
used as the cut-off score for categorising the participants after considering its clinical 
usefulness. The participants were categorised into improved and not improved 
groups.  The unimproved group was coded as ‘zero’ and the improved group was 
coded as ‘one’. 
One additional binary categorical variable ‘Combined Outcome Index (COI)’ was 
also defined. The scores on the three variables ‘clinically improved in PWI’, 
‘clinically improved in FIS’ and ‘clinically improved in ACS’ were summed. The 
COI was coded based on ‘Zero’ as participants who improved in one or none of the 




outcomes (PWI, FIS and ACS) and ‘one’ for the participants with improvement in 2 
or all three measures (Figure 6.1). 






Had positive outcomes in PWI=
Had positive outcomes in FIS=
Had positive outcomes in
 Combined Outcome Index =  
Had positive outcomes in ACS=
0, No
1, Yes
0, No (0 or 1 of the above)
1, Yes (2 or 3 of the above)
 
 
These categorical variables were used instead of the continuous variables of PWI, 
FIS and ACS as the goal of this study was to find predictors of the clinically 
significant improvement in the outcomes rather than predictors for change. The 
independent variables were demographic variables, clinical characteristics of the 
participants at baseline and the change in the clinical characteristics from pre-test to 
follow-up (22 weeks difference).  
As objective 3 was focused on improvement in fatigue and  activity level of  the 
participants, the dependent variables used in this part of the study were the binary 
categorical variable of clinical improvement in FIS (which was calculated for 
objectives 1 and 2), and a second variable named as ‘activity level’. A binary 
categorical variable with two levels (less active group and more active group) was 
created for this dependent variable.  The mean current activity level calculated via 
the ACS (refer to section 3-5) was used as the cut-off score for defining the binary 
activity level variable. Independent variables were the same as those used for 
objectives 1 and 2.  




6.2.4 DATA ANALYSIS 
OBJECTIVES 1 AND 2 
The participants in each group (with or without positive outcomes in FIS, PWI, ACS 
and COI) were compared on baseline demographic and clinical characteristics as 
well as their change in outcome measures from pre-test to follow-up. Differences 
between groups were examined using chi-square for categorical variables and 
independent t-tests for continuous variables. The variables which showed significant 
differences between groups were then entered into a logistic regression model to 
assess how well the set of predictor variables explained the dependent categorical 
variable (improved or not improved in FIS, PWI, ACS and COI).  While the chi-
square and t-tests can assess any association between two variables (one of which is 
the binary outcome variable), logistic regression may be used as a multivariate 
method to assess which of a set of associated variables independently predict the 
binary outcome variable (after adjustment for other variables in the regression 
model).  Based on the literature, logistic regression is useful for situations in which 
the researcher needs to predict the presence or absence of a characteristic or outcome 
based on values of a set of predictor variables (Field, 2005). Similarly to multiple 
linear regression, a logistic regression model may be developed in a stepwise 
manner, either adding on deleting variables one at a time. Stepwise regression is a 
useful tool in the exploratory phase of research (Menard 1995). Exploratory testing 
makes no a-priori assumptions regarding the relationships between the variables, thus 
the goal is to discover relationships. Backward stepwise regression appears to be the 
preferred method of exploratory analyses, where the analysis begins with a full or 
saturated model and variables are eliminated from the model in an iterative process 
(Portney & Watkins, 2008). The fit of the model is tested after the elimination of 
each variable to ensure that the model still adequately fits the data. When no more 
variables can be eliminated from the model (based on the significance if variables 
remaining in the model), the analysis has been completed. In backward elimination 
(Likelihood Ratio) removal testing is based on the  likelihood-ratio statistic based on 
the maximum partial likelihood estimates. For ease of presentation, logistic 
regression with backward stepwise selection elimination (Likelihood ratio) is 
referred to as ‘logistic regression’ in this thesis. 





The aim of Objective 3 was to examine if the baseline activity level (less active/ 
more active) may have a bearing on FIS outcome. This could be analysed using the 
logistic regression model as described. However, the model may need to include 
interaction terms between activity level and each other independent variable in case 
the relationship between each independent variable and FIS outcome differed for 
each activity level. It was decided that a simpler approach was to divide the 
participants into activity level groups first, and then develop a logistic regression 
model for each of these two groups. This would allow a (possibly) different set of 
variables to be associated with FIS outcome for each baseline activity level group. 
Therefore, the participants were categorised into four groups according to activity 
level (less active/more active) at baseline and FIS outcome (improved/not improved) 
and (Figure 6.2). Independent t-test and chi-square tests and then logistic regression 
were used in the same way as objectives 1 and 2. Chi-square and independent t-tests 
were used to find the differences between the groups and the logistic regression was 
applied to find the predictors for membership to the groups.  
 
Figure  6.2 Groups Based on Improvement in Fatigue and Activity Level 
Fatigue Impact scale score
Less active at baseline 
n=45
More active at baseline
n=47
Without positive outcomes in FIS
n=22
With positive outcomes in FIS
n=23
Without positive outcomes in FIS
n=26















The sample included 92 participants (80% of the participants in the whole study) 
who had completed all measures at pre-test, post-test and follow-up. The participants 
were categorised using half the standard deviation for each outcome measure score at 
baseline (minimal clinical important change). The means and standard deviation, 
minimally important change and the resulting number of participants in each group is 
presented in Table 6.1. MCID for the FIS and ACS (15.95 and .11) were near or 
equal to the mean change scores (-17.6 and .11 respectively) but the MCID for PWI 
was 9.33 which was considerably higher than the mean change score of 2.8 for this 
outcome measure. 
 
Table  6.1 Minimally Important Change, Mean and Standard Deviation for Baseline 
































MCID = Minimal Clinically Important Difference 
 
6.3.2 RESULTS FOR OBJECTIVE 1: BASELINE CHARACTERISTICS THAT 
PREDICT POSITIVE OUTCOME 
A summary of results for chi-square and independent-sample t-tests exploring the 
relationship between demographic and baseline clinical characteristics and the 
positive outcomes in PWI, FIS and ACS are presented in Table 6.2 (For more 




detailed results refer to Appendix H). None of the demographic characteristics were 
significantly different between the groups of participants with and without positive 
outcomes in PWI, FIS, ACS and COI with the exception of age which was 
significantly lower in the people with positive outcomes in PWI in comparison with 
people without positive outcomes in this outcome measure. This age difference was 
not seen for the participants with positive outcomes in the FIS, ACS or COI 
compared to those in the other group. 





Table  6.2 Comparison of Participants ‘With Positive Outcomes’ and Those ‘Without 
Positive Outcomes’ Relative to Baseline Demographic and Clinical Characteristics 
Difference between groups 
with/without positive outcome 
Independent variable 
PWI FIS ACS COI 
Group allocation 
(Face-to-face FSM/ Online FSM/ Info 
FSM/ Control) 
× × × × 
Diagnosis (MS/ PPS/ PD) × × × × 
Education (High school/ Tertiary 
education/ Vocational training) 
× × × × 
Gender (Male/ Female) × × × × 
Income (Less than $599/ Between $600 
and $1999/ More than $2000) 
× × × × 













Age (year) √ × × × 
FIS: Overall × - √ √ 
FIS: Physical Subscale × - √ √ 
FIS: Cognitive Subscale × - √ √ 
FIS: Psychosocial Subscale × - √ √ 
Activity Card Sort × √ - × 
Personal Wellbeing Index - × √ √ 
Generalised Self-efficacy Scale × × √ √ 
SSI : Overall × × × √ 
SSI: Social Interaction Subscale × × × × 
SSI: Satisfaction Subscale × × √ × 
DASS: Depression Subscale × √ √ √ 
















DASS: Stress Subscale × √ √ √ 
Note. FIS = Fatigue Impact Scale; ACS = Activity Card Sort; PWI = Personal Wellbeing Index; COI 
= Combined outcome Index; SSI = Social Support Index; PPS = Post-polio Syndrome; PD = 
Parkinson’s Disease; DASS = Depression Anxiety and Stress Scale; × = no difference between 
groups; √ = significant difference between groups at p < .05; -= Not included in the analysis. 
 
Baseline clinical characteristics were similarly compared for the people with and 
without positive outcomes in PWI. Based on the results of independent t-tests, no 
significant difference was seen in clinical characteristics of the people who had 
positive outcomes and those who did not have positive outcome in PWI. This was 




not the case on the FIS and ACS. The participants with positive outcomes on the FIS 
had significantly lower baseline ACS scores and higher depression and stress scores 
than the participants without positive outcomes on the FIS. People with positive 
outcome on the ACS showed lower baseline PWI, self-efficacy and subjective social 
support in SSI and higher scores on the FIS (overall score and all three subscales) 
and depression, anxiety and stress in comparison with people without positive 
outcome. This indicates that the people with positive outcome in either FIS or ACS, 
tended to be significantly worse at baseline than those who did not have positive 
outcome. 
As only age was significantly different between the groups, no further analysis was 
performed for the demographic characteristics. Also, there was no significant 
relationship between having a positive outcome in the PWI and clinical characteristic 
of the participants at baseline. Therefore, logistic regression was only used to explore 





Table  6.3 Baseline Characteristics that Predict Improvements in Outcomes 
R square 95% Confidence interval 
Outcome variable 





Odds ratio Lower bound Upper bound 
p-value 
FIS .076 .102 ACS -3.180 .042 .003 .614 .021 




.045 1.047 1.016 1.077 .002 
COI .154 .212 
FIS physical 
subscale 
.082 1.085 1.008 1.168 .030 
Note. ACS = Activity Card Sort; FIS = Fatigue Impact Scale; ACS = Activity Card Sort; COI = Combined Outcome Index. 
 




Based on the results of chi-square and t-tests the participants who had a positive 
outcome on the FIS had significantly lower baseline scores on the ACS and better 
scores on depression and stress. Therefore, these baseline scores were entered into 
logistic regression model as independent variables to find which baseline scores 
predicted positive outcome on the FIS after adjustment for the other variables.  The 
only significant independent predictor for positive outcome in FIS was baseline ACS 
score The results showed that a higher level of retained activity at baseline is a 
predictor of lower possibility of having a positive outcome in fatigue (p = .02) but 
this set of variables only accommodated for between 8 and 10 percent of the 
variability. This result reveals that there are other important predictors for positive 
outcome in FIS.  
A logistic regression model was also used to predict positive outcome in activity 
level. The independent variables to be entered to the logistic regression model were 
baseline PWI, self-efficacy, subjective social support, the three FIS subscales, and 
depression, anxiety and stress which were significantly different between the groups 
with and without positive outcome (Table 6.3). The only significant predictor of 
positive outcome on the ACS was the psychological subscale of FIS (p = .002) but 
again the model accommodated for only between 11.0 and 15.0 percent of the 
variability. The results showed that selecting participants with a higher level of 
psychological fatigue at baseline increases the likelihood of having a positive 
outcome in ACS in a self-management program (OR = 1.047, CI = 1.016 and 1.077). 
The same analysis was conducted to find predictors of positive outcome on the COI. 
Baseline scores for PWI, self-efficacy, the overall SSI score, all three subscales of 
the FIS and all three subscales of the DASS were significantly different between the 
participants in the positive outcome in COI  group and the other participants. 
Therefore, these variables were entered into the model as independent variables. The 
results showed that a higher level of physical FIS at baseline increased the likelihood 
of positive outcome in two or more outcomes p = .030 (OR = 1.085, CI = 1.008 and 
1.168). This means that people with higher physical FIS are better candidates for 
fatigue self-management programs. 




6.3.3 RESULTS FOR OBJECTIVE 2: CHANGE IN CLINICAL 
CHARACTERISTICS THAT PREDICT POSITIVE OUTCOMES 
Another set of analyses was performed to explore what changes in clinical 
characteristics predicts better outcomes following a fatigue self-management 
program. Tables 6.4 and 6.5 show results of group comparisons and logistic 
regressions. A greater positive change in self-efficacy, social interaction, SSI overall 
score and  CAL, and a greater decrease in depression, stress, overall FIS, cognitive 
and psychosocial subscales of SSI were seen for the participants who had positive 
outcome in PWI in comparison with the participants without positive outcome on the 
PWI. Therefore, change scores of self-efficacy, social interaction, fatigue impact 
subscales, depression and stress were entered to the logistic regression model to find 
the best predictors of positive outcome in PWI. Improvement in depression (p = 
.022) and social interaction (p < .000) were the only two significant predictors of 
positive outcomes on the PWI, explaining between 25.2 and 36.2 percent of the 
variability. A decrease in depression and an increase in social interaction enhanced 
the likelihood of improvement in PWI scores. For every one unit increase in 
depression, the odds ratio of improvement (versus not improvement in PWI) 
decreased by 10% (OR = .90, CI = .81 to .98) while for every one unit increase on 
social interaction scores the odds ratio increased by 53% (OR = 1.53, CI = 1.21 to 
1.92).  




Table  6.4 Comparison of Change Score for Participants ‘With Positive outcomes’ 
and Those ‘Without Positive Outcomes’ on the Predictor Variables (t-test and chi-
square) 
Difference between groups  
with/without positive outcome Change in independent variable 
from baseline to follow-up PWI FIS ACS COI 
FIS: Overall √ - √ - 
FIS: Physical Subscale × - √ - 
FIS: Cognitive Subscale √ - √ - 
FIS: Psychosocial Subscale √ - √ - 
Activity Card Sort × √ - - 
Personal Wellbeing Index  - √ √ - 
Generalised Self-efficacy Scale √ √ √ √ 
SSI: Overall √ √ × × 
SSI: Social Interaction Subscale √ √ × √ 
SSI: Satisfaction Subscale × × × × 
DASS: Depression Subscale √ √ × √ 
DASS: Anxiety Subscale × √ × √ 
DASS: Stress Subscale √ √ × √ 
Note. FIS = Fatigue Impact Scale; ACS = Activity Card Sort; PWI = Personal Wellbeing Index; COI 
= Combined outcome Index; SSI = Social Support Index; DASS = Depression Anxiety and Stress 
Scale; × = no difference between groups; √ = significant difference between groups; - = not included 
in the analysis. 
 
The next part of analysis was focused on finding the answer to the question of what 
changes in clinical characteristics predict positive outcomes on the FIS.  The results 
showed that improvements in self-efficacy and anxiety were predictors of positive 
outcome in FIS. Independent t-test was used to compare the participants who 
improved on the FIS with those who did not improve. The results revealed that the 
participants who had positive outcomes on the FIS from pre-test to follow-up had 
significantly different change scores on self-efficacy, SSI overall score, the social 
interaction subscale of SSI, level of activity, PWI, and all subscales of the DASS 
(depression, anxiety and stress). These variables were entered to a logistic regression 
model. Improvement in self-efficacy (p = .012) and reduction in anxiety (p = .025) 
were the only two significant predictors of improvement in FIS. For every one unit 
increase in self-efficacy, the odds ratio of positive outcomes in FIS increased by 24% 
(OR = 1.24, CI = 1.048 to 1.467). Further, for every one unit increase in anxiety 
score the odds ratio of positive outcomes in FIS decreased by 13% (OR = .872, CI = 




.773 to .983). These two variables explained between 30 to 40 percent of the 
variability. The other variables (SSI overall score, social interaction subscale of SSI, 
ACS, PWI, and depression and stress subscales of DASS) were not independently 
significant predictors in the model. Therefore, based on these results, improvement in 






Table  6.5 Predictors for Improvement in Outcome Measures (Changes in Clinical Characteristics) 
R square 95% Confidence Interval 
Outcome variable
Cox and Snell Nagelkerke 




Lower bound  Upper bound 
p-value 
Change in Depression -.111 .895 .814 .984 .022 
PWI .252 .362 Change in SSI: Social 
Interaction subscale 
.423 1.526 1.213 1.920 .000 
Change in GSE .215 1.240 1.048 1.476 .012 
FIS .300 .400 
Change in Anxiety -.137 .872 .773 .983 .025 
ACS .094 .127 Change in FIS psych -.053 .949 .914 .985 .006 
Change in GSE .282 1.326 1.106 1.591 .002 
COI .311 .429 
Change in FIS cog -1.624 .871 .796 .953 .003 
Note. FIS = Fatigue Impact Scale; ACS = Activity Card Sort; PWI = Personal Wellbeing Index; COI = Combined outcome Index; SSI = Social Support Index; DASS = 
Depression Anxiety and Stress Scale. 
 





The same tests were performed in order to find predictors of positive outcomes on 
the ACS. Results of the independent t-test were significant for change in self-
efficacy, the overall FIS score and all subscales of FIS. Logistic regression showed 
that the only significant predictor for improvement in ACS was psychological fatigue 
(p = .006) but it explained only 9 to 13% of the variability. For every one unit 
increase in psychological fatigue, the odds ratio of improvement in ACS decreased 
by 5% (OR = .949, CI = .914 to .985). The results showed that variables other than 
those under exploration in this study need to be considered to understand a positive 
outcome in ACS   
The participants who had positive outcome on the COI had a higher positive change 
in self-efficacy, social interaction subscale for SSI than the participants without 
positive outcomes. Also, their scores decreased significantly in all the three subscales 
of the FIS and the three subscales of the DASS in comparison with the group without 
positive outcome in COI. After entering the significant variables into a logistic 
regression model, change in GSE and change in the cognitive subscale of FIS were 
significantly correlated with improvement in 2 or more outcomes (p = .002 and p = 
.003 respectively). The R2 for this model was large (between .311 and .429). For 
every one unit increase for GSE the likelihood to improve in 2 or more outcomes was 
increased 33%. Also, for one unit increase in depression level, the odds ratio of 
improvement was 13% lower. Therefore, change in self-efficacy is not only a 
predictor for positive outcome in FIS but also it is a strong predictor of positive 
outcome in COI, i.e. 2 or more outcomes (FIS, ACS and PWI).  
6.3.4 RESULTS FOR OBJECTIVE 3: RELATIONSHIP BETWEEN 
IMPROVEMENT IN FATIGUE AND ACTIVITY LEVEL 
The third objective of this study was to find the predictors of improvement in fatigue 
for people with different baseline activity level. Results of chi-square tests showed 
that there was no relationship between activity level at baseline and positive outcome 
in FIS (p = .677) and the participants were almost equally distributed between the 
four groups. For ease of presentation the four groups were numbered from 1 to 4 
(Figure 6.2).   





To explore the difference in demographic and clinical characteristics of the less 
active participants with positive outcome in their FIS (group 1) with the ones without 
a positive outcome in FIS (group 2), independent t-test and chi-square tests were 
performed. The only significant result was their baseline self-efficacy scores which 
were significantly lower for group 2 who did have a positive outcome (Table 6.6 and 
Appendix H).  
The independent t-test examining change of scores in clinical characteristics from 
pre-test to follow-up, are presented in Table 6.7.  The participants who were not 
active at baseline but had positive outcomes (group 2) on their FIS scores were 
significantly different in their change scores in self-efficacy, overall SSI, social 
interaction subscale of SSI, anxiety and stress as compared to the participants in 
group 1 who did not have a positive outcome. 
The variables with significant difference were entered to a logistic regression model 
to explore predictors for the improvement in FIS for less active people. Change in 
self-efficacy and stress were shown to be the significant predictors of positive 
outcome in FIS in less active people (p = .009 and p = .038 respectively). The model 
explained between 32.7 and 43.7 percent of the variability (Table 6.8).  
The same analyses were used to find the predictors of positive outcome in FIS for 
people who were more active at baseline. Independent t-tests were used to compare 
the demographic and clinical characteristics of the two groups (group 3 and group 4) 
and found that participants who had positive outcomes on their FIS had marginally 
significantly (p = .049) higher scores in depression (Mean = 8.33, SD = 6.83) at 
baseline than the group who did not have a positive outcome (Mean = 4.73, SD = 
5.4). When the mean change scores were tested, there was a significant difference 
between the groups in self-efficacy, depression and stress. The variables were 
entered into the regression model. Change in self-efficacy (p = .021) and change in 
stress level were again the significant predictors for improvement in FIS. For every 
one unit increase in self-efficacy, the odds ratio of improvement in FIS increased by 
37% (OR = 1.369, CI = 1.049 to 1.786). Further, for every one unit increase in stress 
level the odds ratio of improvement in FIS decreased by 25% (OR = .746, CI = .558 
to .997). These two variables explained between 22 to 30 percent of the variability. 





Therefore, regardless of the level of activity at baseline, an increase in self-efficacy 
and a reduction of stress are the predictors of improvement in FIS in people with 
fatigue.





Table  6.6 Summary of Results for Demographic and Baseline Clinical 
Characteristics of the Participants who Improved in FIS with Those Who did not 
Improve in FIS 
Activity Level 
Less active  More active  














(Face-to-face FSM/ Online FSM/ Info FSM/ 
Control) 
× × 
Diagnosis (MS/ PPS/ PD) × × 
Education (High school/ Tertiary education/ 
Vocational training) 
× × 
Gender (Male/ Female) × × 
Income (Less than $599/ Between $600 and 
$1999/ More than $2000) 
× × 













Age (year) × × 
Activity Card Sort × × 
Personal Wellbeing Index × × 
Generalised Self-efficacy Scale √ × 
SSI: Overall × × 
SSI: Social Interaction Subscale × × 
SSI: Subjective Support Subscale × × 
DASS: Depression Subscale × √ 













DASS: Stress Subscale × × 
Note. FIS = Fatigue Impact Scale; MS =Multiple Sclerosis; PPS = Post-polio Syndrome; PD = 
Parkinson’s Disease; SSI = Social Support Index; DASS = Depression Anxiety and Stress Scale; × = 
no difference between groups; √ = significant difference between groups. 





Table  6.7 Comparison of Participants ‘With Positive Outcomes’ and Those ‘Without 
Positive Outcomes’ in FIS on Each Outcome Measure Based on Change Scores 
Activity Level 
Less active group More active group 
Change in Measure Comparison of groups 
with/without positive 
outcome in FIS 
Comparison of groups 
with/without positive 
outcome in FIS 
Activity Card Sort × × 
Personal Well Being Index × × 
Generalised Self-efficacy Scale √ √ 
SSI : Overall √ × 
SSI: Social Interaction Subscale √ × 
SSI: Subjective Support Subscale × × 
DASS: Depression Subscale × √ 
DASS: Anxiety Subscale √ × 
DASS: Stress Subscale √ √ 
Note. FIS = Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression Anxiety and 
Stress Scale; × = no difference between groups; √ = significant difference between groups. 
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6.4 DISCUSSION  
In order to understand how self-management programs work, it is important to ask 
what influences which outcome measures and for whom. However, 35 systematic 
reviews available testing the efficacy of self-management programs for adults have 
shed only limited light on the predictors of improvement after participation in these 
programs (T. L. Packer, 2008). This shortage of evidence exits for both general and 
disease specific self-management programs including the fatigue self-management 
program. The authors of the systematic reviews pinpoint that subgroup analyses are 
under reported, hampering attempts at aggregating data or conduction meta-analysis. 
Therefore, the aims for this secondary analysis study were to find the answers to 
three questions: What clinical and demographic characteristics predict the likelihood 
of improvement in FIS, PWI and ACS for people with fatigue? What changes in 
clinical characteristics predict the likelihood of improvement in FIS, PWI and ACS 
for people with fatigue? What are the predictors of improvement in fatigue for people 
with different baseline activity levels?  
Based on the results of this study, it appears that there is no need for the clinicians to 
select the participants for self-management programs based on any demographic 
characteristic except age. The participants with lower age were more possible to 
improve in PWI. Also, the more the person’s activity participation is restricted 
compared to the previous five years (as measured by the retained activity score on 
the ACS), and the worse their fatigue at baseline, the higher the possibility that they 
will improve. These results are consistent with those emerging in some systematic 
reviews that suggest no demographic characteristic other than age contributes to 
better outcomes after participation in self-management programs (Nolte et al., 2007) 
and that people with more severe baseline scores benefit more than the others 
(Guevara, 2003; Nolte et al., 2007; S. Taylor, 2005).  
From a clinical point of view, it is important to know how/why people improve in 
their fatigue. For the participants with fatigue in the present study, improvement in 
FIS was related to changes in all other variables (ACS, PWI, GSE, all three DASS 
subscale, and social interaction) except for subjective social support. However, when 
using these results, it should be considered that there were some overlaps between 





the FIS and ACS items. The significant predictors for a better outcome in fatigue 
were changes in self-efficacy and anxiety. Anxiety is reported to be significantly 
correlated with fatigue (Shulman et al., 2001). However, the relationship between 
changes in fatigue and anxiety has not been reported in the literature. The finding 
that improvement in self-efficacy predicts better fatigue outcomes is consistent with 
previous research by Mathiowetz et al.(Mathiowetz et al., 2005). In their study, 
Mathiowetz et al. demonstrated an improvement in both fatigue and self-efficacy 
following participation in the fatigue self-management program but they did not 
report on the correlation of the changes.  
An outcome that may be theoretically expected following the fatigue self-
management program is improvement in activity participation. However, the 
literature does not show a clear relationship between fatigue and activity 
participation. Some authors have found negative correlations (Freal et al., 1984; T. L. 
Packer et al., 1994) while no significant relationship has been reported by others 
(Parmenter et al., 2003).  A newly developed framework for self-management by 
Packer (2008) proposes that participation, as defined by the WHO, should be the 
outcome of interest in self-management interventions. The pARTicipation framework 
is underpinned by the ART of managing Activities, Relationships, and Treatment. In 
this framework, self-management is the clients’ ability to manage their activities, 
roles and treatment to enable them to engage in the activities they need to and want 
to do. The RCT part of the present study supports this framework; participants in 
both online and info FSM groups improved over time in their activity level. 
However, the results of the study on predictors of improvement did not yield clear 
insight into how to help people with fatigue improve their level of activity. Although 
the results showed psychological fatigue of the participants as one of the significant 
predictors of improvement in activity level, it seems that there are other important 
contributing factors for improvement in activity as the change in psychological 
fatigue explained only about 10% of the logistic regression model. It is possible that 
the changes required for improving activity participation are quite complex and 
further exploration is therefore required. For example, disease specific scales may 
detect changes and correlations better ad the influence of other variables needs to be 
examined. 





The mechanisms for improvement in quality of life, as an outcome of interest in most 
studies on self-management programs, are not identified yet. Diminished depression 
and increased social interactions were predictors of improvement in PWI for the 
participants in the present study. This result supports the studies on Australian 
populations which show that depression is the strongest correlate with PWI scores 
(Davern, Cummins, & Stokes, 2007). The result is also in parallel with the definition 
of self-management by Barlow et al who emphasise that a self-management program 
should include ‘the ability to monitor ones condition and to affect the cognitive, 
behavioural and emotional responses necessary to maintain a satisfactory quality of 
life’ (Barlow et al., 2002). Therefore, fatigue self-management programs, and 
perhaps other self-management programs as well, with an emphasis on social support 
and improving mood appear more likely to succeed in assisting people to improve 
their quality of life. This is also consistent with the results of studies on people with 
cancer which have did not find any factors associated with the changes following 
fatigue management (Barsevick et al., 2004; Yates et al., 2005). However, both of 
these studies used raw change scores rather than clinically meaningful change. 
Although there are studies on fatigue secondary to many acute/chronic conditions, no 
studies were found, that looked at predictors of improvement for people with 
neurological conditions.  
It may be unrealistic to expect a clinically significant change in all outcomes of 
interest following one program, but to be cost effective, clinicians may target more 
than one outcome in a particular program. In this study, significant improvement in 
the FIS, PWI and/ or ACS were sought. The results showed that improvement in self-
efficacy and cognitive fatigue are the predictors for better outcomes in at least two 
outcome measures (PWI, ACS or FIS). This emphasises the importance of self-
efficacy suggested by the self-management literature (Burckhardt, 2005; Newman, 
Mulligan, & Steed, 2001). Based on the self-efficacy theory, self-efficacy beliefs 
provide the foundation for human motivation, well-being, and personal 
accomplishment. This is because unless people believe that their actions can produce 
the outcomes they desire, they have little incentive to act or to persevere in the face 
of difficulties. How people behave can often be better predicted by the beliefs they 
hold about their capabilities than by what they are actually capable of accomplishing 





(Bandura, 1997b). The result that improvement in cognitive fatigue is congruent with 
other literature on effectiveness of self-management programs (Kathleen Farrell, 
2002; S. J. Girdler, 2006; K. R. Lorig et al., 1999). While cognitive fatigue is shown 
to be the hardest component of fatigue to improve (Mathiowetz et al., 2005; Schwid 
et al., 2003), fatigue self-management programs need to have a strong focus on 
cognitive fatigue to help people improve in different aspects of their lives.   
There is a clinical myth that less active people and more active people have different 
needs in regards to their fatigue. This study did not support this belief. Surprisingly, 
regardless of activity level of the participants at baseline, improvement in self-
efficacy and stress were still the predictors of better fatigue outcomes. Change in 
some other aspects of the persons’ life like changing the level of activity 
participation or social support were not shown to be important factors in increasing 
the possibility of reduced fatigue. This suggests that ‘self-management’ of fatigue is 
more internal than external to the person. 
As discussed in the previous chapter, one of the difficulties in explaining how self-
management programs work is that their ‘active ingredients’ are not known yet. One 
of the difficulties for the researchers is the complex nature of self-management 
programs (Duncan et al., 2007). Further studies similar to the present study are 
required to provide more information on how and for whom the self-management 
programs work. 
6.5 CONCLUSION 
The need to understand precisely what is occurring in an intervention to achieve an 
observed change is an important area of inquiry that has profound implications for 
education, research and practice. The aims of this study were to answer three 
important clinical questions: who and how people improve in their fatigue, activity 
and quality of life, and what should be done for people with different levels of 
activity to help them improve in their fatigue. Younger people and people with 
severe symptoms appear to be candidates who benefit most from for self-
management programs. Self-efficacy should be considered one of the most important 
aspects of a self-management program when designing and providing the service. 





Also, the facilitators of the programs should pay special attention to improving the 
participants’ mood in order to guarantee better results. The other clinical outcome of 
this study is that improvement in self-efficacy and stress helps both people with low 
levels and high levels of activity to reduce their fatigue. Therefore, these two groups 
of participants can both benefit from the same kind of fatigue self-management 
program. 
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7.1 OVERVIEW  
The present thesis was organised to report the methodology, results, discussion and 
conclusion of each study in a separate chapter. Hereby, an overview of the study is 
presented to summarise the project followed by implications of the results for 
practice and policy, and recommendations for future research. 
Fatigue is one of the most common symptoms experienced by people with 
neurological conditions. Although the literature suggests different approaches to 
treatment of this pervasive symptom, there is not a comprehensive well-supported 
guideline to manage fatigue. There is strong evidence that the face-to-face fatigue 
self-management program designed by Packer et al (1995) is effective in improving 
fatigue in people with MS. However, in Australia and many other developed and 
developing countries this program is not available to people who have difficulty 
accessing services due to geographical location, transportation problems, work 
commitments or who lack confidence to participate in face-to-face programs. This is 
the issue not only for this particular program but also for any self-management 
program in Australia. Evidence highlights the need for self-management programs to 
be delivered in different formats to ensure equity of access. One of the suggested 
ways is delivering the programs online. There is sufficient evidence that people with 
disability have access to the internet. Thus, providing and evaluating an online 
fatigue self-management program seemed to be both necessary and feasible. 
This project was designed firstly to refine and further develop a pre-designed online 
fatigue self-management program and secondly to evaluate it in a sample of adults 
with chronic neurological condition through a randomised controlled trial. Further, 
the study intended to explore who and how people with fatigue improve in their 
health outcomes.  
The aims of the project were met through four studies (a pilot study, an RCT, a study 
on face-to-face fatigue self-management group and a study on predictors of 
improvement). The pilot study included a formative evaluation (to further develop 
and standardise the online fatigue self-management prototype) and a preliminary 




efficacy evaluation (in preparation for the subsequent RCT study). The pilot study 
which included three pilot tests took 12 months. The process of refining the online 
program was labour intensive and required a design team with different expertise. 
The information and feedback collected from the participants, facilitators and the 
electronic data were used to further develop the program after each pilot test. The 
final product of this part of the study was a standardised online fatigue self-
management program which was user friendly for the population with basic 
computer skills. The fidelity of the program was also tested in different ways during 
the program to ensure that it was mimicking the face-to-face program and following 
self-management principles. Further, the information gathered during the final pilot 
test showed that, after minor refinements, the data collection and participant 
recruitment process planned for the RCT were feasible. A sample size calculation 
was also conducted based on the data obtained from the preliminary efficacy study.  
The pilot study was followed with an RCT study that included 95 participants who 
were randomised to one of these three groups: online FSM, info FSM and control. 
The groups were compared in three time points (pre-test, post-test and follow-up) on 
primary outcome measures (FIS, ACS and PWI) and secondary outcome measures 
(self-efficacy, SSI and DASS). The results showed that although both the online and 
info FSM groups improved over time on the FIS and ACS, they were not 
significantly different from the control group or from each other. This may be 
attributable to the low observed power for the analyses and a larger sample size may 
detect significant differences. The findings of this study also showed that the online 
and info FSM groups acted similarly. Therefore, the two groups were combined to 
make a larger sample. In comparison with the control group, the participants in the 
combined group showed significant improvement on the physical and psychological 
subscales of FIS. Trend towards significance was also seen in the participants on the 
overall FIS, the cognitive subscale of FIS and the ACS.  In addition, the combined 
group had a significantly higher PWI score at post-test than the control group. The 
results for the repeated measure ANOVA for the combined group also confirmed the 
above findings. Therefore, it is possible that a Type II error hindered the project with 
no significant differences between the online FSM and control group detected. Also, 
the findings suggested that the info FSM program was more than an attention group. 




Further comparison of the online FSM group and the info FSM group revealed 
interesting differences between the areas/patterns of improvements in each group. 
While the interactive component of the online program seemed to be attractive for 
the participants in this group, it seems that the ‘silence’ in the info FSM group gave 
them time to start practicing their newly learnt skills sooner than the online FSM 
group. It may be the reason why the participants in the online FSM group started 
improving after the program while those in the info FSM group improved during but 
not after completion of the program. There were other similarities and differences 
between the two groups. The participants in both groups improved in their self-
efficacy. This is consistent with the self-management principles which are based on 
the self-efficacy theory. But the stress level for the online FSM group was lower than 
the control group. This finding was not seen for the info FSM group. The difference 
between the groups on stress may be attributable to the group function of the online 
FSM group. Thus, although the results of the RCT did not show the efficacy of the 
program in comparison with no intervention, the findings are promising as the 
participants in this program improved over time in different aspect of their health. A 
larger study with a longer follow-up is required to further explore the efficacy of the 
online fatigue self-management program. 
The literature recommends incorporating a well-supported face-to-face group as one 
of the experimental conditions when evaluating effectiveness on an online program. 
Thus, the third study was designed to compare a group of participants in the face-to-
face FSM program with each of the three other groups (online FSM, info FSM and 
control groups) using a nonequivalent pre-test post-test study. The twenty 
participants in the face-to-face FSM group had better health status at baseline 
compared to the other groups. The findings showed that after controlling for the 
baseline data these participants had better scores on the FIS than the control group at 
post-test while these results were not seen in comparison to the online and info FSM 
groups. Therefore, further study is needed to explore the efficacy of the online FSM 
for people with fatigue secondary to chronic condition. The study also provided some 
evidence that the people with limited access to the face-to-face services have poorer 
baseline scores which may be a reflection of service availability for rural areas. 




 The fourth study was designed to explore who and how people improve in their 
health outcomes and how people with different activity level improve in their fatigue. 
Regression analyses were performed to find whether baseline demographic, clinical 
characteristics and/or change in clinical characteristics from pre-test to follow-up 
were predictors for positive health outcomes. In this study, 92 participants with 
complete data set (pre-test, post-test and follow-up) were included. In parallel to the 
results emerging in systematic reviews, younger people with more severe baseline 
scores appear to be more likely to significantly improve in their health outcomes. 
Improvement in mood and self-efficacy of people with fatigue were found to be 
predictors of better results for fatigue. Another interesting finding of this study was 
that improvement in self-efficacy and stress helps people with neurological 
conditions to improve in their fatigue regardless of their activity level at baseline.  
7.2 IMPLICATIONS FOR POLICY AND PRACTICE 
The results of this study demonstrated that the online fatigue self-management 
program can significantly improve fatigue and activity participation for adults with 
chronic neurological conditions over time. This conclusion was reached using a 
rigorous methodology and a conservative approach to data analysis. To our 
knowledge, this is the first online self-management program to address fatigue for 
people with chronic conditions. The ability to improve health outcomes of vulnerable 
or at risk populations who traditionally are excluded from such programs has broad 
implications for health policy and funding. Providing this effective program online 
and integrating it to the health care system ensures equitable access to self-
management programs by Australians in rural and remote areas, those who cannot 
travel to face-to-face programs and those who are isolated at home due to chronic 
conditions.   
As evidenced in this research, online programs can significantly improve health 
outcomes for adults with chronic neurological conditions. This result is promising for 
those clinicians and researchers who wish to provide service for people with chronic 
conditions who have no access to the face-to-face services for any reason. Given that 
the results of repeated measure ANOVA showed that the online program is effective, 
it can be replicated for other conditions, symptoms or disease groups. However, the 




results are more generalisable to people with one of the three diagnoses in this study 
(MS, PPS and PD)  but it could be speculated that is would be beneficial to people 
with other neurological conditions. 
An understanding of predictors of improvement in health outcomes may guide 
clinicians how to choose participants for the self-management programs. Clinicians 
are always worried about who to refer to their programs. The findings of the study 
showed that recruiting younger participants with more severe baseline scores 
increases the likelihood of improvement for the participants in self-management 
programs. Further, the facilitators of self-management programs need to be equipped 
with the knowledge and skills to improve self-efficacy and stress in the participants 
regardless of their activity level.  
7.3 SUGGESTIONS FOR FURTHER RESEARCH 
Although the present study demonstrated that people with chronic neurological 
conditions benefit from participating in an online fatigue self-management program, 
it seems that possible differences between the experimental and control group was 
not detected as a result of low power due to small sample size. Therefore, another 
clinical trial with a larger sample size is required to confirm or refute the efficacy of 
the online FSM program in comparison with a control group. Also, adding a third 
arm to the study for the face-to-face group would allow for a comparison of the 
efficacy of different formats of the program using a more rigorous methodology. 
Future research should also examine if the changes fade/continue in long-term and 
the need for ‘booster’ sessions in sustaining the effects of program over time. Further 
study is required to develop and evaluate other online programs for other common 
symptoms in chronic neurological conditions like depression and cognitive problems. 
Using disease specific measurement tools may also result in different findings. A 
clinical trial may also provide the FSM program in different populations with fatigue 
(e.g. chronic fatigue syndrome, head injury, spinal cord injury, cancer). In addition, 
there is limited understanding of the role of some important variables like disability 
level, comorbidities, and/or exacerbation of symptoms on the effect of the FSM 
program. 




With the growing population of people with chronic conditions it is necessary to find 
different options for treatment (Bodenheimer, Lorig et al., 2002; Jordan & Osborne, 
2007). By examining the differential impact of different formats of self-management 
programs like online, telephone coaching, peer support, teleconference and video-
taped programs, innovative programs may result. This is particularly important as 
Australians with chronic conditions have different levels of access to the health care 
service which is mostly provided in the metropolitan areas.  
Although previous studies have found self-management programs to be cost effective 
for different diagnoses (Daniëlle et al., 2006; Gallefoss & Bakke, 1999; Groessl & 
Cronan, 2000; K. R. Lorig et al., 2002; Wheeler et al., 2003), the economic effects of 
the fatigue self-management program both from the view of DALY; and the cost to 
the health care system is, as yet, unknown. Objectifying the impact of self-
management interventions like the FSM program on avoiding or delaying 
unemployment (which is strongly correlated with fatigue) would have important 
economic and social implications. 
Research is required to explore if the program should be modified to meet the need 
for Australian people from different cultures (like indigenes population) and with 
first languages other than English. There is a possibility that the therapist’s skills and 
competency may contribute to the results of the program. Research on this issue 
would clarify if the therapists need to be trained or have special expertise to promote 
better outcomes from self-management programs.  
7.4 CONCLUSION 
While fatigue is a common problem for people with fatigue secondary to 
neurological conditions, this online FSM program is the first of its kind to be 
implemented. The primary purpose of the fatigue self-management program is to 
help the participants improve their everyday performance and quality of life by 
incorporating ‘energy conservation techniques’ and self-management principles into 
their own life. Through the application of the fatigue self-management program, 
occupational therapists and other health professionals expect that the participants will 
learn the self-management skills, make corresponding behaviour changes and 
experience a reduction in the effect of fatigue on their lives. New knowledge gained 




from this study can further support the idea of providing other self-management 
programs online.  The results of this study also add to the growing body of evidence 
emerging regarding how information technology may assist with improving health 
outcomes related to chronic conditions. Further, some predictors of improvement in 
health outcomes in this group of people were determined. The findings provide some 
evidence of the potential benefits of online fatigue self-management program for 
people with chronic neurological conditions. Online interventions like the online 
FSM program represent an important strategy for bridging the gap in service for 
those who can not participate in face-to-face programs. 
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 FATIGUE SELF-MANAGEMENT PROGRAM 
 
A.1 AIM 
Packer et al. (1995) developed the six-week, community based Face-to-face Fatigue 
Self-management Program (face-to-face FSM program) for adults experiencing 
fatigue secondary to chronic conditions. The authors mention the following as the 
aim of the program: ‘It does not aim to correct the underlying mechanisms that cause 
fatigue, nor does it accept that the solution is to decrease activity levels or reduce the 
breadth and extent of activities. Rather it promotes a positive attitude aimed at active 
decision-making and optimum use of available energy to fit the unique needs of each 
individual (p.2)’. 
A.2 CONCEPTUAL FRAMEWORK 
The face-to-face FSM program was written using three theoretical models. The 
PRECEDE model (Green et al. 1979), which is an educational development model, 
was employed to determine content. An understanding of psychoeducational groups 
was used to guide the order of material presented and the structure of individual 
sessions, and to maximize participation of all group members. The program was also 
based on the definition of “Handicap” by WHO (1980), defined at the time as “the 
inability to participate in normal roles” (WHO 1980). The term ‘handicap’ was 
usually attributed to a problem at the level of society. Therefore the program was 
primarily aimed at reducing disability by increasing an individual’s ability to 
participate in those self-care, productive, and leisure activities that are self-identified 
as important, meaningful, or necessary.  
A.3 STRUCTURE OF THE FACE-TO-FACE FSM PROGEAM 
The face-to-face FSM program is a community program which is conducted in six 
sessions. Each session begins with a warm-up exercise and a review of homework. 
This is followed by presentation and discussion f new material and introduction of 
homework activities. A brief review concludes each session. The topics of the six 






Session 1 The Importance of Rest 
Session 2 Communication and Body Mechanics 
Session 3 Activity Stations 
Session 4 Priorities and Standards 
Session 5 Balancing Your Schedule 
Session 6 Course Review and Future Plans 
 
All the necessary elements for a professional and effective intervention are included 
in the manual of the face-to-face FSM program. The highly structured manual of the 
face-to-face FSM program contains 10 sections as below: 
 Introduction. Explains the purpose and rationale behind the program, the 
organization of the manual and instructions for its use. 
 Planning and Preparation. Instructions to initiate and run the program. 
 Pre-group Session. Information for the individualized pre-group screening 
session including assessments, interview questions, and selection criteria. 
 Sessions 1-6. These sessions are all structured in the same way, with the 
convenience of the therapist in mind. Included in each session are the 
following: 
 Purpose of the session 
 List of all required overheads, handouts, and supplies 
 Outline of the session 
 Teaching notes for therapist 
 Master copies of all overheads 
 Master copies of all handouts 
 Therapist worksheets  
 Bibliography. Additional reading for interested therapists. 
Two facilitators run the program. The facilitators can be occupational therapists or 
any other health professional who is equipped with the necessary group skills. 
Facilitators have the freedom to adjust the material in the interest of time and to meet 
the specific needs of group members; however, the authors emphasise that keeping 
the established format is necessary. 
The sequence of teaching, activity, and homework assignments allows for carryover 
into the home setting, making the information more relevant to each group member’s 
particular situation. Table A11 shows the phases of psychoeducational group in the 















Outline of session 
Orientation Creating a safe working 
atmosphere.  
 
Establishing focus of session 
Homework review Dissatisfaction/Resolution Reviewing negative and 
positive aspects of each 
members experience 
Teaching session, 
practice activity, and 
homework 
assignment 
Working/Production Presenting new information 
through didactic lecture, 
discussions, and activities.  
 
Encouraging insight and 
feedback through discussion 
Conclusion Termination/Graduation Reviewing new content.  
 
Clarifying homework.  
 
Emphasizing application of 





A.4 DECONSTRUCTION AND RECONSTRUCTION  
The goal in designing the Online Fatigue Self-management Program (online FSM) 
was to mimic the face-to-face FSM program and to follow the same aims (Refer to 
section  A.1). Therefore, the fundamental principles and requirements of the self-
management program were analysed through a deconstruction process. Participants 
in previous Face-to-face programs were invited to attend a focus group. They 
confirmed that sharing stories with other members of the group was the strongest and 
the most important part of this program (Figure A1). This is congruent with self-
efficacy theory that highlights the potency of vicarious learning (Bandura, 1997).  





Figure A2 shows the main components of the fatigue self-management program as 
described by the group. The weekly information provide new ideas and strategies to 
the participants. Group communication around the application of the strategies 
highlights the importance of making changes and gives some ideas of how to 
customize them to each person’s situation. Individuals practice using the new 
strategies in their lives while completing the activities. They learn the process of 
problem solving based on personal choice and a review of their life routines. The 
outcomes and consequences of the changes and new habits are reviewed in the group 
where the experiences are shared with other participants. The advantages and 
disadvantages of the new strategies for each person are discussed while other 
participants and the facilitators give feedback. This process in congruent with self-
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efficacy theory; it facilitates learning self-management skills through modeling, 
social persuasion and skills mastery.  
Figure A2: The Three Important Components of the Fatigue Self-management Program 
 
The online 7-week program was designed to follow the same principles and 
procedures as the face-to-face FSM program. Participants receive information 
weekly; they share their stories via group discussions and try the newly presented 
skills by completing the activities, posting feedbacks to gain comments from 
facilitators and other participants. Therefore, the three main components of the 
program include information, activities and group communication which were 
integrated into the online FSM program (Figure A3). 
 
238 









Information (Figures A3 and A4) is written in simple English based on the face-to-
face FSM. It consists of the information text and expert panel comments and is 
posted to the website weekly. Expert panel consists of a group of participants in the 
previous face-to-face FSM. They talk about their experiences with fatigue and the 
impact of changes they have made in their life styles to manage fatigue. Their 
comments are added to the information text to facilitate the process of modeling for 
improving self-efficacy (Bandura, 1997). 




A.4.2 GROUP COMMUNICATION 
Group communication is facilitated using ‘forums’ (an in-built feature of Moodle). 
The forums are designed to be easily accessible from the front page of the program, 
and all forum discussions are posted to all participants’ email addresses. Participants 
can read and reply to the forums directly from their emails. Group discussion is 
encouraged from the first week of the program when the participants start 
introducing themselves to each other and talk about their expectations from the 
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group. Questions about the weekly topics are discussed in ‘Weekly discussions’ 
(Figure A3). Participants are also encouraged to talk in ‘Open Discussion’ about the 
issues they face as a result of fatigue. They also add the address for useful email or 
webpage addresses which found or may find useful to ‘New Web Pages to Visit’. 
‘Messages from Facilitator’ is used for sending important general messages to all 
participants.  
A.4.3 ACTIVITIES 
Activities, which are the same as those in the face-to-face FSM, are presented online 
in the format of multiple choice questions, drop down menus and journals. 
Completing these activities requires only limited computer knowledge. The activities 
are easy to complete and the instructions are clearly understandable. The activities 
are introduced weekly to participants according to the topic being discussed. The 
participants complete the activities online and seek and give feedback to the group. 
They share their experiences about the effects of changes on their fatigue based on 
the activities. The facilitators give individual and group feedback about the 
completed activities. 
A.4.4 ONLINE ACCESSIBILITY 
Moodle, Version 1.7 (http://moodle.org; accessed 2006) is the platform used for 
carrying the online FSM program. The “Living effectively” website 
(http://livingeffectively.net.au/) was created in the central website of Curtin 
University and is administered by IT staff of the School of Occupational Therapy.  
The first week of the program is designed to facilitate navigation and group 
formation online. It covers a basic overview of each of the components of the 
program. Participants are encouraged to introduce themselves to each other and talk 
about their expectations from the group. The information and activities in this week 
are designed to become familiar with the program and to learn about different 
components of the program. The following six weeks of the program include all the 3 
components of information, group communication and activities. With the progress 
of the group toward the end, the amount of information decreases and the number of 
activities and discussion  increases.  
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The online FSM is designed to be easily accessible and user-friendly for participants 
with limited computer knowledge. The minimum computer literacy necessary for the 
participants is the ability to use the Internet for simple searching and sending of 
email. Full participation in the program requires 2-3 hours weekly. As the program is 
open 24 hours and 7 days a week for the 7 weeks of the program, the participants can 
logon at their convenience. The number of participants in the program can vary 
between 4 and 12.  
A “Guidebook and Activities” was prepared to further assist the participants to start 
the program. It is posted to participants prior to commencement of the program. It 
includes simple instructions and illustrations on how to enter the website, navigate 
through out the program and use different components of the program. Also, a hard 
copy of the activities is included in the guidebook to help the participants who prefer 
to prepare a draft before completing the activities online.  
A.4.5 FACILITATION 
The facilitators of the program are health professionals specifically trained to deliver 
the face-to-face FSM. They receive a one-day training program to use technical 
aspects of the Moodle platform and also to learn online facilitation techniques. The 
login data and electronic records which are easily accessible for the facilitators 
provide the facility for them to observe the participants’ behaviour online. The 
facilitators of the program are responsible for answering questions and helping 
participants to solve problems encountered in the program. If they are not able to 
overcome technical problems, the IT administration staff provide support (IT person 
in school of Occupational Therapy, Curtin University of Technology) to assist the 
participants. Group communication is always encouraged and guided by the 
facilitators of the online FSM. The facilitators also provide feedback for activities 












ESSENTIAL COMPUTER SKILLS TEST 
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ESSENTIAL COMPUTER SKILLS TEST 
The main purpose of this test was to test physical ability of navigating on the 
computer screen. The participants were asked to complete the test twice: once as a 
practice and once as a test. The time for completing the test was recorded 
electronically by the platform from the time they started the first question to the time 
they clicked on the ‘submit all and finish’ icon. The test (as per the whole online 
FSM program) is written with Verdana font size 10 to make it easier for the 




Table B1: Essential Computer Skills Test 
Essential Computer Skills Test is to find out how fast you can 
complete computer tasks. The results of this simple, short test 
will be used for research purposes, so please try your best to 














You can run this practice only once.  
This is a timed test so please try your best to answer the 
questions as fast as possible.  
 
 
This is to test how fast you are at “clicking”.  
 
 
Below are four pictures of appliances.  
 
 
Using the mouse, take the pointer and click on the number that 
represents vacuum cleaner: 
Choose one answer.  
 a. Picture 1  
 b. Picture 2  
 c. Picture 3  
 d. Picture 4  
 










This is to test how fast and accurate you are at “typing”.  
Please read the following sentence and type it in the box:  
I like to go to the beach.  
Answer:  
          
 
 
This is to test how fast you are at “scrolling”.  
To begin, click on the word “start”, using your mouse, scroll 
down the page until you see the word “stop” and click on it. 
Choose one answer. 
 
 a. Start  











ө (Note. The length of this part was about half a page on the 
screen). 
 
Click on "stop"  
Choose one answer.  
 a. Start  
 b. Stop  
 
 




Table B1 continued 
This is to test how fast you are at “clicking”.  
Using the mouse, take the pointer and choose “Apple” in the 
box below, then click on the "submit all and finish" then go 
back to the front page of program and complete the computer 
test. 
Choose one answer.  
 a. Orange  
 b. Apple   
 c. Banana  
 d. Cherry  
 





















Figure C1: Advertisement 
 
 
Are you over 20 years old? 
 
Are you a person with Multiple Sclerosis, Parkinson’s disease,  
Chronic Fatigue Syndrome or  
Post-polio Syndrome? 
 
Would you like to join us  
in a research project to evaluate  
the Fatigue Self-management Program? 
 
For more information regarding the project, 
please contact: 
 
Setareh Ghahari  
Tel. (08) 9266 1790  
E-mail: ghahari.setareh@postgrad.curtin.edu.au 
Or  
Leave a message with Linda Whitby 
Centre for Research into Disability and Society 






 For more information visit: http://livingeffectively.net.au/ 
Fatigue Self-management Program
Continued on next page 
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Facts about fatigue 
The symptom of fatigue is common in neurological conditions. It is a troublesome symptom 
that is frequently misunderstood by family and friends because it is not obvious. For some 
people it limits social ad work activities and can impact on lifestyles on a daily basis. 
What can be done? 
Changing life style and behavior is one way to help. We call this fatigue self-management. 
Some face-to-face programs already exist. 
Tell me more about the research study 
This is a research study, which means that it is being run for a limited time to test 
effectiveness of a new online fatigue self-management program.    
If you have access to transportation you can participate in the face-to-face version of the 
program and if not, you will be randomized to one of the following groups: 
-  Online fatigue-management Group 
-  Online Support Group 
-  Control Group 
Do I need to be a computer expert to join the online program? 
Not at all! You will need only very basic computer skills, such as using a mouse and typing 
small amounts of text. You must have regular access to the Internet - this could be at home, 
a local community centre or library.  
How much does it cost me? 
Self-management program is free except for your telephone costs and any charges from any 
Internet service provider that you use to access the Internet. 
What should I do?  
Contact Setareh Ghahari Tel. (08) 9266 1790. 
E-mail: ghahari.setareh@postgrad.curtin.edu.au. 
Fatigue Self-management Program FAQ 
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Figure C2: Consent Form (Pilot Test) 
 
 
I consent to participate in this research project. The nature of the research has been 
explained to me to my satisfaction and all of my questions answered. I understand that I am 
free to withdraw from the study at any time without any consequences. 
I understand that the discussion session/telephone interview will be tape-recorded but 
information obtained as part of the discussions will be treated as confidential. I understand 
that I will be asked to complete a questionnaire and to return the completed questionnaires 
to the researcher within one week. If required, I may be contacted with in a two week period 
to confirm return of the completed questionnaire booklet. I further understand that there are 
no known risks to participating in this study.  
I know that results of this study may be published but if so my identity will be protected and 
my personal results will not be disclosed.  
Name:  _______________    Date: __________________ 
Signature: ____________________________        
Principal Investigator: Setareh Ghahari, PhD Student, School of Occupational Therapy, Tel: 
(08) 9266 1790. 
Supervisor: Professor Tanya Packer, School of Occupational Therapy,  
Tel: (08) 9266 3621.                                 
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Figure C3: Consent Form (Diagnosis Confirmation)  
 
Dear Dr.__________________ 
I, _______________________, am participating in a research study to examine the 
effectiveness of online self- management program for adults with chronic neurological 
conditions. 
Self-management  involves (the person with the chronic disease) engaging in activities that 
protect and promote health, monitoring and managing the symptoms and signs of illness, 
managing the impact on illness on functioning, emotions and interpersonal relationships and 
adhering to treatment regimes (Centre for the Advancement of Health, 1996).  
The aims of the study are to: 
 1) To trial and standardize two online self-management group interventions for adults 
with chronic conditions. 
 2) To evaluate the effectiveness of online self-management group interventions.  
      3) To examine possible interactions among self-efficacy, social support and depression 
and how they influence change in quality of life and activity participation as a result of the 
intervention. 
Setareh Ghahari (PhD Student), Professor Packer and I would like your help to ensure that 
we have the most accurate medical information about me. 
Participant’s Signature: _________________________ 
P.S. You are welcome to contact the principal investigator of the research project, Ms. 
Setareh Ghahari on  9266 1790 or  
Email: Ghahari.setareh@postgrad.curtin.edu.au.  
Her supervisor Professor Tanya Packer can be contacted on (08) 9266 3621. 
This study has been approved by the Curtin University Human Research Ethics Committee. 
If needed, verification can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, C/- Office of Research and Development, Curtin University of 
Technology, GPO Box U1987, Perth 6845 or by telephoning 9266 2784.
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Figure C4: Diagnosis Confirmation Information 
 
Participant’s ID:  
Which one of the following medical conditions am I diagnosed with?     
1 Post-polio Syndrome         
2 Chronic Fatigue Syndrome   
3 Parkinson’s Disease            
4 Multiple Sclerosis              




1  Relapsing/Remitting 
2  Primary Progressive 
3  Secondary Progressive 
4  Progressive/Relapsing 
5  Unknown 
5 None of above                    
In what month and year was the diagnosis made? 
Month____________  Year___________ 
Are you aware of any other factor/s that may interfere with participating in daily activities? 
         1 Yes            2  No 
If yes, please describe:  
Thank you for taking the time to complete this form.  
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Figure C5: Participant Information Sheet 
 
What is the research about? 
We are conducting a research to evaluate fatigue self-management group program for adults 
with chronic neurological conditions to evaluate its effectiveness for increasing individuals’ 
quality of life and activity participation.  
What will I be asked to do? 
You will be asked to participate in  
 a face-to-face program 
or will be assigned randomly to 
 an online self-management program 
 an online support group or 
 another group which will receive the program at a later stage. 
The group consists of about 10 people and will take about 2-3 hours per week for a length of 
6-7 weeks. You may also be asked to have a telephone interview to discuss the effect of the 
program on your life. In addition, facilitators of programs may need to make contact with 
you to follow up possible problems. You are not obliged to participate in the study and you 
may withdraw your participation from the study at any time. 
What information will I be asked to provide? 
You have received this envelope as a result of agreeing to participate in the program. You 
will receive a questionnaire to complete before and after the intervention and three months 
later. The questionnaires include questions about you (gender, age, education, marital status, 
language, living arrangement and socio-economic status), quality of life, activity 
participation, depression, social support, fatigue impact and self-efficacy. This will take 
approximately 45 minutes.  
Completing the questionnaires and sending them back to researcher means that you have 
given your permission for your data to be used in the research 
The researcher may call you to remind you.  
Also, there is a letter to forward to your physician confirming your diagnosis. 
Please complete and sign the letter and send it to your doctor (your GP or specialist) in the 
stamped envelope which is provided 
Continued on next page 
 
254 
Figure C5 continued 
 
In addition, your first name, the city where you live and your picture or the symbol that you 
have chosen previously in telephone interview will be visible to other participants. The 
online program is designed in a way that will send all the posts to your email automatically. 
What will happen to the private information and information from the groups? 
Complete confidentiality will be ensured in any publications or presentations that arise from 
this research and no personal details will be published. No names will be included on the 
questionnaires that you will be asked to complete. Instead you will be given a unique 
identity number and only the researchers will have access to the code. Your statements in 
the online program which will be analysed as data will be treated as confidential and your 
name will not be published in any way. All information will be kept in a secure cabinet.  
Who do I contact if I have any question or want further information? 
You are welcome to contact the principal investigator of this research project, 
Ms. Setareh Ghahari on (08) 9266 1790 or email: Ghahari.setareh@postgrad.curtin.edu.au.  
Her supervisor Professor Tanya Packer can be contacted on (08) 9266 3621. 
This study has been approved by the Curtin University Human Research Ethics Committee. 
If needed, verification can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, C/- Office of Research and Development, Curtin University of 
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Participant ID number:  
 
Questionnaire Booklet (1) 
 
Evaluation of an 
Online Fatigue Self-management Group Intervention for 
Adults with Chronic Neurological Conditions 
 
 
Thank you for taking the time to participate in this survey. 
 
The purpose of this study is to test an online fatigue self-management group intervention for 
adults with chronic neurological conditions. 
 
You will be asked questions about your quality of life, activity participation, depression, 
social support, fatigue and self-efficacy. This will take approximately 45 minutes.  
 
The questionnaire will be treated with the strictest confidence.  
 
Once you finish with the questionnaire, please place your completed questionnaire in the 
stamped envelope provided and post it back to the Principal Investigator within 7 days after 
receiving it. 
 
Completing this questionnaire and sending it back to researcher means that you have given 
















Below are some questions regarding your personal background. Please put a cross (X) in the box which best 
describes you. 
Gender 
Male (1)  
Female (2)  
 
How old are you? 
20-29 (1)  
30-39 (2)  
40-49 (3)  
50-59 (4)  
60-69 (5)  
70-79 (6)  
80 and Above (7)  
 
What is the language spoken most commonly in your home? 
 
English (1)  
Italian (2)  
Greek (3)  
Chinese (4)  
Arabic (5)  
Vietnamese (6)  
Other (7)  
(Please specify)  _____  
 
4. What is your highest education level? 
 
Highest year completed at school 
(Please specify)  
______ 
  
University undergraduate degree (1)  
Post-graduate degree (2)  
TAFE (3)  
Apprenticeship (4)  





5.      What is your current living situation? 
 
Alone (1)  
 With others:  
 (Please specify) 
Number of adults:     ____ 
(2) 
 













6.      Are you currently in paid employment? 
 Yes (1) 
 
How many hours a week do you work in paid employment?  
                                                        ______ Hours per week 
 
No (2)    
 
7.      Which income range best represents the total weekly gross income of your household? 
 
Nil income (1)  
$1 - 299 per week ($1 - $15,548 per year) (2)  
$300 – 599 per week ($15,600 – 31,148 per year) (3)  
$600 – 999 per week ($31,200 – 51,948 per year) (4)  
$1000 - 1,399 per week ($52,000 – 72,748 per year) (5)  
$1,400 – 1,999 per week ($72,800 – 103,948 per year)   (6)  
$2000 – 2,499 per week ($104,000 – 129,948 per year) (7)  
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Table E: Mean and Standard Deviation of Primary Outcome Measures 
Time 






Face-to-face FSM 64.80 (31.67) 50.45 (32.03) 50.95 (32.01) 
Online FSM 79.94 (30.48) 72.41 (33.21) 64.29 (34.25) 
Info FSM 86.14 (32.57) 66.82 (32.30) 69.79 (32.35) 
FIS: Overall a 
Control 76.36 (32.16) 69.79 (32.35) 67.64 (36.69) 
Face-to-face FSM 20.40 (8.92) 17.05 (9.17) 16.01 (9.09) 
Online FSM 24.97 (8.02) 23.00 (9.45) 20.35 (9.52) 
Info FSM 25.04 (7.16) 19.75 (8.09) 17.71 (9.69) 
FIS: Physical Subscale a 
Control 23.27 (7.72) 20.85 (8.47) 20.12 (8.59) 
Face-to-face FSM 14.30 (7.81) 10.95 (8.54) 11.09 (7.78) 
Online FSM 19.18 (8.52) 17.41 (9.10) 15.56 (9.02) 
Info FSM 20.43 (9.54) 16.25 (8.94) 15.25 (9.68) 
FIS: Cognitive Subscale a 
Control 17.48 (9.87) 16.97 (8.83) 16.03 (10.03) 




Table E1 continued 
Time 






Face-to-face FSM 30.35 (16.61) 23.10 (16.03) 24.05 (16.64) 
Online FSM 36.29 (16.25) 32.50 (16.49) 29.03 (17.33) 
Info FSM 41.21 (17.51) 31.11 (17.47) 28.93 (19.95) 
FIS: Psychological Subscale a 
Control 35.91 (17.23) 32.06 (17.38) 31.73 (19.39) 
Face-to-face FSM 1.02 (.30) 1.10 (.40) 1.17 (.62) 
Online FSM .87 (.15) .92 (.17) .93 (.20) 
Info FSM .88 (.04) .98 (.051) 1.00 (.05) 
Activity Card Sort b 
Control .93 (1.00) .93 (.05) 1.00 (.049) 
Face-to-face FSM 66.00 (19.03) 65.07 (18.88) 63.50 (18.16) 
Online FSM 57.18 (21.56) 59.20 (18.91) 60.92 (20.91) 
Info FSM 59.74 (19.11) 63.62 (18.00) 64.13 (20.63) 
Personal Wellbeing Index b 
Control 58.74 (19.30) 56.25 (21.69) 61.36 (20.07) 
Note. FIS= Fatigue Impact Scale; FSM = Fatigue Self-management program. 
a Decreasing scores= Improvement;  b Increasing scores= Improvement. 
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Table E2: Mean and Standard Deviation of Secondary Outcome Measures 
Time 






Face-to-face FSM 31.60 (4.10) 30.75 (4.59) 31.15 (3.86) 
Online FSM 29.44 (5.14) 30.32 (4.98) 30.44 (5.71) 
Info FSM 28.71 (3.81) 29.79 (4.60) 30.04 (4.35) 
Generalised Self-efficacy Scale b 
Control 28.85 (5.18) 28.39 (5.92) 29.18 (5.45) 
Face-to-face FSM 34.70 (4.08) 35.15 (5.33) 34.30 (4.43) 
Online FSM 33.04 (4.78) 32.29 (5.70) 33.65 (5.90) 
Info FSM 33.18 (5.42) 33.00 (7.40) 34.25 (6.76) 
SSI: Overall b 
Control 35.00 (5.79) 34.61 (6.28) 34.00 (6.49) 
Face-to-face FSM 26.55 (4.19) 26.75 (4.80) 25.90 (4.20) 
Online FSM 25.51 (3.90) 24.32 (4.74) 25.50 (4.79) 
Info FSM 25.18 (4.60) 25.11 (6.18) 25.93 (5.42) 
SSI: Social Interaction Subscale b 
Control 26.03 (4.58) 25.61 (5.33) 25.03 (5.29) 
Face-to-face FSM 8.15 (1.79) 8.40 (1.54) 8.40 (2.19) 
Online FSM 8.21 (1.77) 7.97 (1.87) 8.15 (1.89) 
Info FSM 8.00 (1.72) 7.89 (2.10) 8.32 (2.00) 
SSI: Satisfaction Subscale b 
Control 8.97 (1.65) 9.00 (1.50) 8.97 (1.76) 
Continued on next page 
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Table E2 continued 
Time 






Face-to-face FSM 9.25 (10.05) 9.15 (11.60) 9.65 (11.92) 
Online FSM 11.00 (10.00) 10.41 (10.20) 9.65 (9.70) 
Info FSM 10.18 (10.24) 8.43 (10.33) 9.14 (11.95) 
DASS: Depression Subscale a 
Control 10.79 (8.89) 10.42 (9.92) 11.94 (11.43) 
Face-to-face FSM 7.40 (7.70) 6.35 (7.51) 6.95 (8.41) 
Online FSM 8.97 (6.69) 7.71 (6.32) 8.47 (7.59) 
Info FSM 7.79 (7.69) 7.21 (9.67) 7.11 (9.72) 
DASS: Anxiety  Subscale a 
Control 7.03 (6.87) 6.85 (5.89) 7.48 (7.62) 
Face-to-face FSM 10.95 (8.36) 8.60 (8.76) 10.10 (8.64) 
Online FSM 13.71 (8.96) 12.21 (7.75) 11.35 (8.98) 
Info FSM 13.54 (10.54) 12.32 (11.32) 11.36 (11.21) 
DASS: Stress Subscale a 
Control 12.00 (9.08) 12.52 (10.13) 13.85 (10.84) 
Note. SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale; FSM = Fatigue Self-management program. 













COMPARISON OF THE COMBINED GROUP WITH THE 
CONTROL GROUP AND IMPROVEMENT OF THE 
COMBINED GROUP OVER TIEM 
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Table F1: Comparison of Combined and Control Groups on Primary Outcomes at Post-test  
95% confidence interval 
for difference 
ANCOVA Results  
Outcome Measure 
F a 
Lower bound Upper bound Effect size Observed power p-value 
FIS: Overall 2.097 -15.142 2.377 .017 .226 .226 
FIS: Physical Subscale .739 -3.624 1.435 .008 .136 .392 
FIS: Cognitive Subscale 2.795 -4.579 .395 .031 .280 .098 
FIS: Psychosocial Subscale 1.989 -7.579 1.268 .022 .286 .162 
Activity Card Sort 3.752 -.002 .145 .041 .482 .056 
Personal Wellbeing Index 6.442* 1.392 11.445 .069 .709 .013 
Note. FIS= Fatigue Impact Scale. 





Table F2: Comparison of Combined and Control Groups on Primary Outcomes at Follow-up 
95% confidence interval  
for difference 
ANCOVA Results  
Outcome Measure  
F a 
Lower bound Upper bound Effect size Observed power p-value 
FIS: Overall 3.873 -.155 .001 .043 .495 .052 
FIS: Physical Subscale 4.664* -5.973 -.248 .051 .570 .034 
FIS: Cognitive Subscale 3.814 -5.782 .051 .042 .489 .054 
FIS: Psychosocial Subscale 5.480* -11.825 -.966 .059 .639 .022 
Activity Card Sort .514 -.049 .105 .006 .109 .475 
Personal Wellbeing Index .674 -2.941 7.083 .008 .128 .414 
Note. FIS= Fatigue Impact Scale. 





Table F3: Comparison of Combined and Control Groups on Secondary Outcomes at Post-test 
95% confidence interval for 
difference 
 ANCOVA Results  
Outcome Measure 
F a 
Lower bound Upper bound  Effect size Observed power p-value 
Generalized Self-efficacy Scale 7.672** .560 3.407  .080 .782 .007 
SSI: Overall .181 -1.828 1.183  .002 .071 .671 
SSI: Social Interaction Subscale 2.698 -1.028 .098  .030 .369 .104 
SSI: Satisfaction Subscale .001 -1.190 1.223  .000 .050 .978 
DASS: Depression Subscale  .098 -4.126 1.383  .011 .165 .325 
DASS: Anxiety Subscale .040 -2.042 1.667  .000 .055 .841 
DASS: Stress Subscale 1.451 -4.268 1.407  .016 .222 .232 
Note. SSI = Duke Social Support Index; DASS = Depression, Anxiety and Stress Scale. 




Table F4: Comparison of Combined and Control Groups on Secondary Outcomes at Follow-up 
95% confidence interval  
for difference 
ANCOVA Results  
Outcome Measure 
F a 
Lower bound Upper bound Effect size Observed power p-value 
Generalized Self-efficacy Scale 2.209 -.407 2.819 .024 .312 .141 
SSI: Overall 4.332* .070 3.008 .047 .539 .040 
SSI: Social Interaction Subscale .105 -.677 .487 .001 .062 .747 
SSI: Satisfaction Subscale 7.175** .390 2.632 .075 .755 .009 
DASS: Depression Subscale  4.331** -6.664 -.153 .047 .539 .004 
DASS: Anxiety Subscale .504 -3.184 1.507 .006 .504 .479 
DASS: Stress Subscale 7.430** -7.094 -1.112 .078 .769 .008 
Note. SSI = Duke Social Support Index; DASS = Depression, Anxiety and Stress Scale. 




Table F5: Change in Scores of Primary Outcome Measures at Pre-test, Post-test and Follow-up in the Combined Group 
 Results of Repeated Measures ANOVA  Post-hoc test p-value  
Outcome Measure  
 
F 














FIS : overall score  
23.257 
(1.626,99.165)*** 
.276 1.000 .000  .000*** .000*** .009** 
FIS: Physical Subscale a  
24.749 
(1.728,105.400) *** 
.289 1.000 .000  .000*** .000*** .002** 
FIS: Cognitive Subscale a 
12.940 
(1.759,107.929)*** 
.175 .000 .000  .004** .000*** .143 
FIS: Psychological Subscale a 
23.254 
(1.601,97.635)*** 
.276 1.000 .000  .000*** .000*** .023* 
Activity Card Sort    12.02 (2,122)*** .165 .993 .000  .001** .000*** 1.00 
Personal Wellbeing Index 3.614 (2, 122)* .056 .659 .030  .259 .052 1.00 
Note. FIS= Fatigue Impact Scale. 
a Greenhouse-Geisser Correction as the assumption of sphericity is violated. 





Table F6: Change in Scores of Secondary Outcome Measures at Pre-test, Post-test and Follow-up in the Combined Group 
 Results of Repeated Measures ANOVA  Post-hoc test p-value a 
Outcome Measure  
 
F 














Generalized Self-efficacy Scale 4.72 (2,122)* .072 .781 .011  .031* .003** 1.00 
SSI: Overall 4.61 (2,122)* .070 .771 .012  .473 .363 .008** 
SSI : Social Interaction Subscale 2.059(2,122) .033 .417 .132  .691 1.000 .106 
SSI: Satisfaction Subscale 4.071(2.122)* .063 .714 .019  .615 .325 .020* 
DASS: Depression Subscale 1.11 (2,122) .018 .241 .333  .652 .626 1.000 
DASS: Anxiety Subscale 1.289 (2,122) .021 .275 .280  .406 1.000 1.00 
DASS: Stress Subscale 4.11 (2,122)* .063 .719 .019  .331 .026* .612 
Note. SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale. 











RANDOMISED CONRTOLLED TRIAL 
 (SENSITIVITY TEST) 
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Table G1: Comparison of Online FSM, Info FSM and Control Groups on Primary Outcomes at Post-test (Sensitivity Test) 
ANCOVA Results Post-hoc Test 
 
Outcome Measure 




p-value Comparisons Confidence interval p-value 
FIS: Overall 1.494 .052 .305 .233 Online FSM ~ Info FSM -11.375 20.932 .851 
     Online FSM ~ Control -21.709 9.209 .691 
     Info FSM ~ Control -26.869 4.812 .252 
FIS: Physical Subscale .629 .022 .150 .537 Online FSM ~ Info FSM -3.287 6.010 .854 
     Online FSM ~ Control -5.212 3.819 .974 
     Info FSM ~ Control -6.629 2.514 .615 
FIS: Cognitive Subscale 2.346 .079 .455 .105 Online FSM ~ Info FSM -3.675 4.869 .981 
     Online FSM ~ Control -6.934 1.292 .263 
     Info FSM ~ Control -7.637 .801 .145 
FIS: Psychosocial Subscale 1.609 .055 .326 .209 Online FSM ~ Info FSM -4.889 11.910 .668 
     Online FSM ~ Control -10.394 5.545 .840 
     Info FSM ~ Control -14.092 2.221 .218 
Continued on next page 
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Table G1 continued 
ANCOVA Results Post-hoc Test 
 
Outcome Measure 




p-value Comparisons Confidence interval p-value 
Activity Card Sort 1.250 .043 .261 .294 Online FSM ~ Info FSM -.187 .112 1.000 
     Online FSM ~ Control -.093 .204 1.000 
     Info FSM ~ Control -.053 .238 .366 
Personal Wellbeing Index 4.395* .138 .735 .017 Online FSM ~ Info FSM -11.500 6.654 1.000 
     Online FSM ~ Control -1.155 16.224 .110 
     Info FSM ~ Control 1.191 18.725 .021* 
Note. FSM = Fatigue Self-management program; FIS= Fatigue Impact Scale. 






Table G2: Comparison of Online FSM, Info FSM and Control Groups on Primary Outcomes at Follow-up (Sensitivity Test) 
ANCOVA Results Post-hoc Test  
 
Outcome Measure 




p-value Comparisons Confidence interval p-value 
FIS: Overall 1.411 .049 .290 .252 Online FSM ~ Info FSM -.105 .166 1.000 
     Online FSM ~ Control -.187 .073 .846 
     Info FSM ~ Control -.220 .044 .321 
FIS: Physical Subscale 2.970 .097 .555 .060 Online FSM ~ Info FSM -2.502 6.951 .581 
     Online FSM ~ Control -6.962 2.221 .505 
     Info FSM ~ Control -9.243 .054 .054 
FIS: Cognitive Subscale 1.959 .066 .389 .151 Online FSM ~ Info FSM -5.587 4.969 .999 
     Online FSM ~ Control -8.769 1.393 .220 
     Info FSM ~ Control -8.591 1.833 .309 
FIS: Psychosocial Subscale 2.386 .080 .462 .101 Online FSM ~ Info FSM -7.599 12.833 .897 
     Online FSM ~ Control -15.549 3.836 .369 
     Info FSM ~ Control -18.394 1.448 .115 
Continued on next page 
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Table G2 continued 
ANCOVA Results Post-hoc Test  




p-value Comparisons Confidence interval p-value 
Activity Card Sort .516 .024 .157 .516 Online FSM ~ Info FSM -.194 .070 .584 
     Online FSM ~ Control -.158 .103 .937 
     Info FSM ~ Control -.094 .162 .887 
Personal Wellbeing Index .305 .011 .096 .738 Online FSM ~ Info FSM -7.097 10.073 .964 
     Online FSM ~ Control -5.614 10.823 .823 
     Info FSM ~ Control -7.175 9.409 .983 
Note. FSM = Fatigue Self-management program; FIS= Fatigue Impact Scale. 
a df =1; *p < .05. 
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Table G3: Comparison of Online FSM, Info FSM and Control Groups on Primary Outcomes at Post-test (Sensitivity Test) 
ANCOVA Results Post-hoc Test  




p-value Comparisons Confidence interval p-value 
Generalised Self-efficacy Scale 7.689* .215 .938 .001 Online FSM ~ Info FSM -2.638 2.712 1.000 
     Online FSM ~ Control .972 6.158 .004 
     Info FSM ~ Control .916 6.140 .005 
DASS: Depression Subscale .203 .007 .080 .817 Online FSM ~ Info FSM -4.578 5.897 1.000 
     Online FSM ~ Control -5.737 4.416 1.000 
     Info FSM ~ Control -6.434 3.794 1.000 
DASS: Anxiety Subscale .166 .006 .074 .848 Online FSM ~ Info FSM -3.881 2.413 1.000 
     Online FSM ~ Control -3.443 2.658 1.000 
     Info FSM ~ Control -2.732 3.414 1.000 
DASS: Stress Subscale .066 .002 .059 .936 Online FSM ~ Info FSM -5.646 4.306 1.000 
     Online FSM ~ Control -5.398 4.247 1.000 
     Info FSM ~ Control -4.764 4.953 1.000 
Continued on next page 
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Table G3 continued 
ANCOVA Results Post-hoc Test  




p-value Comparisons Confidence interval p-value 
SSI: Overall  .459 .016 .121 .634 Online FSM ~ Info FSM -3.923 1.870 1.000 
     Online FSM ~ Control -3.696 1.918 1.000 
     Info FSM ~ Control -2.690 2.966 1.000 
SSI: Social Interaction 1.248 .043 .261 .295 Online FSM ~ Info FSM -.799 1.261 1.000 
     Online FSM ~ Control -1.402 .587 .947 
     Info FSM ~ Control -1.657 .379 .381 
SSI: Satisfaction Subscale .649 .023 .154 .526 Online FSM ~ Info FSM -3.487 1.287 .781 
     Online FSM ~ Control -2.926 1.700 1.000 
     Info FSM ~ Control -1.821 2.794 1.000 
Note. FSM = Fatigue Self-management program; FIS= Fatigue Impact Scale. 






Table G4: Comparison of Online FSM, Info FSM and Control Groups on Primary Outcomes at Follow-up (Sensitivity Test) 
ANCOVA Results Post-hoc Test  




p-value Comparisons Confidence interval p-value 
Generalised Self-efficacy Scale 2.038 .068 .403 .140 Online FSM ~ Info FSM -3.767 2.607 1.000 
     Online FSM ~ Control -1.254 4.924 .445 
     Info FSM ~ Control -.697 5.527 .182 
DASS: Depression Subscale 1.323 .045 .274 .275 Online FSM ~ Info FSM -8.028 4.969 1.000 
     Online FSM ~ Control -10.391 2.206 .343 
     Info FSM ~ Control -8.908 3.782 .969 
DASS: Anxiety Subscale .323 .011 .099 .725 Online FSM ~ Info FSM -3.619 5.412 1.000 
     Online FSM ~ Control -4.907 3.846 1.000 
     Info FSM ~ Control -5.836 2.982 1.000 
DASS: Stress Subscale 2.180 .072 .427 .123 Online FSM ~ Info FSM -6.762 4.779 1.000 
     Online FSM ~ Control -10.071 1.116 .159 
     Info FSM ~ Control -9.121 2.148 .397 




Table G4 continued 
ANCOVA Results Post-hoc Test  




p-value Comparisons Confidence interval p-value 
SSI: Overall  2.091 .070 .412 .133 Online FSM ~ Info FSM -3.712 1.628 1.000 
     Online FSM ~ Control -1.473 3.702 .877 
     Info FSM ~ Control -.450 4.763 .138 
SSI: Social Interaction .489 .017 .126 .616 Online FSM ~ Info FSM -1.487 .732 1.000 
     Online FSM ~ Control -1.449 .694 1.000 
     Info FSM ~ Control -1.097 1.097 1.000 
SSI: Satisfaction Subscale 3.095 .100 .574 .053 Online FSM ~ Info FSM -2.613 1.510 1.000 
     Online FSM ~ Control -.614 3.381 .279 
     Info FSM ~ Control -.058 3.928 .060 
Note. FSM = Fatigue Self-management program; SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale. 




 Table G5: Testing Effect of Time on the Primary Outcome Measures in the Participants (Sensitivity Test) 

















FIS: Overall        
 Online FSM 7.899 (2, 38) .294 .938 .001 .272 .002 .074 
 Info FSM 12.331 (2,38) .394 .993 .000 .003 .004 .584 
 Control  1.146 (2,46) .047 .240 .327 1.00 .611 1.00 
FIS: Physical Subscale         
 Online FSM 7.803(2,38)** .291 .935 .001 .313 .001 .155 
 Info FSM 13.782(1.500,28.504)*** .420 .997 .000 .005 .002 .077 
 Control  3.595(2,46)* .135 .637 .035 .294 .044 1.000 
FIS: Cognitive Subscale         
 Online FSM 7.095(2,38)** .272 .910 .002 .202 .007 .162 
 Info FSM 7.266(2,38)** .277 .919 .002 .003 .028 1.000 
 Control  .704(2,46) .031 .121 .489 .833 1.000 .960 
FIS: Psychological Subscale        
 Online FSM 520.831(1.507,28.624)** .255 .883 .008 .383 .007 .081 
 Info FSM 1273.726(1.520,28.850)** .382 .991 .001 .003 .005 1.000 
 Control  45.597(2,46) .031 .142 .489 .833 1.000 1.000 
Continued on next page 
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Table G5 continued 

















Activity Participation         
 Online FSM a 3.852(1.507,28.662)* .169 .913 .044  .094 .007 1.000 
 Info FSM 7.28(2,38)** .277 .792 .002  .048 .009 1.000 
 Control a 4.565(1.386,31.875)* .166 .748 .029  1.000 .053 .002 
Personal Wellbeing Index         
 Online FSM 2.360(2,38) .110 .347 .108  .586 .175 1.000 
 Info FSM a 1.885(1.405,26.602) .090 .707 .179  .176 .189 1.000 
 Control  3.820(2,46)* .142 .666 .029  .320 .822 .053 
Note. FSM = Fatigue Self-management program. 





Table G6: Testing Effect of Time on the Secondary Outcome Measures Scores on the Participants (Sensitivity Test) 
 Results of Repeated Measures ANOVA Post-hoc test a Outcome 
Measure  
Group F 













Generalised Self-efficacy Scale       
 Online FSM 2.821(2,38) .129 .521 .072 .038 .665 1.000 
 Info FSM 4.421(2,38)* .189 .727 .019 .023 .059 1.000  
 Control .950(2,46) .040 .205 .394 .606 1.000 .825 
SSI: Overall       
  Online FSM 1.547(2,38) .075 .308 .226 .734 1.000 .310 
  Info FSM 2.133(2,38) .101 .410 .132 1.000 .092 .425 
  Control 1.345(2,46) .055 .276 .271 1.000 .634 .498 
SSI: Social Interaction Subscale     
  Online FSM 1.187(2,30) .073 .240 .319 1.000 .572 .698 
  Info FSM 1.970(2,38) .094 .382 .154 .635 1.000 .207 
  Control 1.389(2,38) .068 .280 .264 1.000 .137 .796 
SSI: Satisfaction Subscale     
  Online FSM .331(2,30) .022 .098 .721 1.000 1.000 1.000 
  Info FSM .142(2,38) .007 .070 .868 1.000 1.000 1.000 
  Control 1.559(2,38) .076 .310 .223 1.000 .528 .461 
Continued on next page 
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Table G6: continued 

















DASS: Depression Subscale     
  Online FSM .984(2,38) .049 .208 .383 1.000 .614 1.000 
  Info FSM .355(2,38) .018 .103 .703 1.000 1.000 1.000 
  Control a 1.256(1.495,34.391) .052 .225 .288 1.000 .684 1.000 
DASS: Anxiety Subscale     
  Online FSM .666(2,38) .034 .154 .520 .607 1.000 1.000 
  Info FSM .614(2,38) .031 .145 .546 1.000 .721 1.000 
  Control a .277(1.580,36.343) .012 .087 .707 1.000 1.000 1.000 
DASS: Stress Subscale     
  Online FSM 1.307(2,38) .664 .265 .282 1.000 .514 .806 
  Info FSM .964(2,38) .048 .205 .390 1.000 .336 1.000 
  Control a 1.228(1.608,36.990) .051 .229 .297 1.000 .567 .926 
Note. FSM = Fatigue Self-management program. 











PREDICTORS OF IMPROVEMENT 
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Table H1: Comparison of Participants with and without Positive Outcomes in the Personal Wellbeing Index (Continuous Variables) 
Group Mean  (SD) Numeric Variables 
Improved in PWI Improved in PWI 
t p-value 
Age 52.76 (10.58) 47.73 (11.66) 1.99* .049 








Fatigue Impact Scale 5.54  (.80) 5.70   (.94) -.83 .409 
FIS: Overall 72.56  (33.21) 79.00  (28.35) -.87 .386 
FIS: Physical Subscale 22.11 (8.14) 24.23 (7.40) -1.16 .251 
FIS: Cognitive Subscale 17.06 (9.25) 19.04 (8.76) -.94 .351 
FIS: Psychosocial Subscale 33.71 (17.26) 36.08 (19.94) -.61 .541 
Activity Card Sort .95 (.24) .8861 (.16) 1.22 .225 
Generalized Self-efficacy Scale 29.80 (4.34) 29.04 (4.05) .78 .440 
SSI: Overall 34.74 (4.54) 33.08 (5.23) 1.52 .133 
SSI: Social Interaction Subscale 8.38 (1.804) 8.35 (1.77) .08 .938 
SSI: Satisfaction Subscale 26.36 (3.79) 24.73 (4.27) 1.79 .076 
DASS: Depression Subscale 8.62 (7.80) 10.96 (10.88) -1.15 .252 













DASS: Stress Subscale 10.83 (7.68) 12.81 (9.41) -1.04 .301 




Table H1 continued 
Group Mean  (SD) Numeric Variables 
Improved in PWI Improved in PWI 
t p-value 
FIS: Overall -13.48  (21.23) -28.12 (33.68) 2.50* .014 
FIS: Physical Subscale -4.53 (5.98) -7.58 (8.98) 1.90 .061 
FIS: Cognitive Subscale -2.79 (6.12) -7.00 (9.08) 2.57* .012 
FIS: Psychosocial Subscale -6.17 (10.97) -13.39 (17.26) 2.39* .019 
Activity Card Sort .10 (.25) .17 (.17) -1.26 .212 
Generalized Self-efficacy Scale -.09 (3.65) 2.39 (4.22) -2.81** .006 
SSI: Overall -.65 (3.01) 2.50 (2.98) -4.53*** .000 
SSI: Social Interaction Subscale -.71 (2.35) 1.92 (2.54) -4.73*** .000 
SSI: Satisfaction Subscale .06 (1.322) .58 (1.42) -1.65 .102 
DASS: Depression Subscale 1.50 (8.11) -4.23 (7.46) 3.12** .002 



















DASS: Stress Subscale .39 (7.47) -3.77 (6.72) 2.47* .015 
*p < .05; **p< .01; *** p < .001. 
 
287  
Table H2: Comparison of Participants with and without Positive Outcomes in the Fatigue Impact Scale (Continuous Variables) 
Group Mean  (SD) Numeric Variables 
Not improved in FIS Improved in FIS 
t p-value 
Age 53.19 (10.49) 49.32 (11.44) 1.69 .094 








Fatigue Impact Scale 5.52 (.78) 5.654 (.91) -.76 .452 
Activity Card Sort .985 (.20) .871 (.23) 2.59* .011 
Personal Wellbeing Index 66.07 (16.77 58.93 (20.04) 1.86 .066 
Generalized Self-efficacy Scale 30.15 (4.13) 28.98 (4.35) 1.32 .189 
SSI: Overall 35.08 (4.78) 33.39 (4.66) 1.72 .089 
SSI: Social Interaction Subscale 8.54 (1.83) 8.18 (1.73) .97 .336 
SSI: Satisfaction Subscale 26.54 (4.05) 25.20 (3.82) 1.63 .108 
DASS: Depression Subscale 7.56 (7.59) 11.16 (9.66) -1.99* .049 













DASS: Stress Subscale 9.71 (7.10) 13.23 (8.98) -2.09* .039 




Table H2 continued 
Group Mean  (SD) Numeric Variables 
Not improved in FIS Improved in FIS 
t p-value 
Activity Card Sort .05 (.16) .19 (.28) -2.89* .005 
Personal Wellbeing Index -.63 (9.83) 6.69 (12.21) -3.18** .002 
Generalized Self-efficacy Scale -.98 (3.87) 2.34 (3.28) -4.41*** .000 
SSI: Overall -.54 (3.14) 1.09 (3.31) -2.43* .017 
SSI: Social Interaction Subscale -.77 (2.42) .91 (2.69) -3.15* .002 
SSI: Satisfaction Subscale .23 (1.40) .18 (1.33) .17 .869 
DASS: Depression Subscale 1.96 (6.96) -2.39 (9.11) 2.58* .011 


















DASS: Stress Subscale 1.71 (7.62) 3.50 (6.35) 3.55** .001 
*p < .05; **p< .01; *** p < .001. 
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Table H3: Comparison of Participants with and without Positive Outcomes in the Activity Card Sort (Continuous Variables) 
Group Mean  (SD) Numeric Variables 
Not improved in ACS Improved in ACS 
t p-value 
Age 52.00 (10.64) 50.31 (11.78) .18 .477 








Fatigue Impact Scale 5.57 (.90) 5.61 (.76) -.19 .853 
FIS: Overall 65.82 (31.09) 87.69 (28.75) -3.39** .001 
FIS: physical Subscale 20.84 (7.92) 25.61 (7.19) -2.92** .004 
FIS: Cognitive Subscale 15.45 (9.00) 21.00 (8.31) -2.97** .004 
FIS: Psychosocial Subscale 29.95 (16.15) 41.28 (15.01) -3.38** .001 
Personal Wellbeing Index 66.43 (17.35) 56.79 (19.32) 2.49* .015 
Generalized Self-efficacy Scale 30.55 (4.24) 28.08 (3.86) 2.82** .006 
SSI: Overall 34.82 (5.15) 33.42 (4.04) 1.38 .170 
SSI: Social Interaction Subscale 8.18 (2.00) 8.67 (1.35) -1.29 .202 
SSI: Satisfaction Subscale 26.64 (4.15) 24.75 (3.43) 2.28* .025 
DASS: Depression Subscale 7.50 (7.08) 12.06 (10.43) -2.50* .014 













DASS: Stress Subscale 9.63 (6.76) 14.14 (9.51) -2.66** .009 
Continued on next page 
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Table H3 continued 
Group Mean  (SD) Numeric Variables 
Not improved in ACS Improved in ACS 
t p-value 
FIS: Overall -11.66 (21.05) 26.89 (30.33) 2.84** .006 
FIS: Physical Subscale -4.23 (5.83) -7.19 (8.37) 2.00* .049 
FIS: Cognitive Subscale -2.55 (6.43) -6.20 (8.03) 2.40* .018 
FIS: Psychosocial Subscale -4.93 (10.79) -13.31 (15.40) 3.07** .003 
Personal Wellbeing Index .56 (11.17) 6.47 (11.41) -2.46* .016 
Generalized Self-efficacy Scale -.23 (3.42) 1.92 (4.40) 2.63* .010 
SSI: Overall .05 (3.30) .53 (3.35) -.67 .505 
SSI: Social Interaction Subscale -.16 (2.59) .33 (2.81) -.86 .390 
SSI: Satisfaction Subscale .21 (1.45) .19 (1.24) .07 .946 
DASS: Depression Subscale 1.00 (7.33) -1.86 (9.48) 1.63 .107 



















DASS: Stress Subscale .23 (7.13) -2.36 (7.82) 1.64 .105 
Note. ACS = Activity Card Sort; FIS= Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale. 




Table H4: Comparison of Participants With and Without Positive Outcomes in the Combined Outcome Index (Continuous Variables) 
Group Mean  (SD) Variables 
Not improved in COI Improved in COI 
t p-value 
Age 52.45 (10.82) 49.25 (11.41) 1.33 .188 








Fatigue Impact Scale 5.52 (.83) 5.700 (.87) -.94 .349 
Generalized Self-efficacy Scale 30.53 (4.07) 27.81 (4.08) 3.056** .003 
SSI: Overall 35.17 (4.91) 32.59 (4.07) 2.53* .013 
SSI: Social Interaction Subscale 8.42 (1.92) 8.28 (1.53) .35 .731 
SSI: Satisfaction Subscale 26.75 (3.99) 24.31 (3.50) 2.91** .005 
DASS: Depression Subscale 7.55 (7.19) 12.53 (10.55) -2.68** .009 














DASS: Stress Subscale 10.07 (6.97) 13.88 (9.76) -2.16* .033 
Continued on next page 
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Table H4 continued 
Group Mean  (SD) Variables 
Not improved in COI Improved in COI 
t p-value 
Generalized Self-efficacy Scale -.73 (3.60) 3.13 (3.34) -5.02*** .000 
SSI: Overall -.22 (3.20) 1.09 (3.39) -1.83 .070 
SSI: Social Interaction Subscale -.52 (2.45) 1.06 (2.81) -2.80** .006 
SSI: Satisfaction Subscale .30 (1.43) .03 (1.23) .90 .371 
DASS: Depression Subscale 1.43 (6.91) -3.03 (9.90) 2.53* .013 


















DASS: Stress Subscale .70 (7.12) -3.56 (7.43) 2.69** .008 
Note. COI = Combined Outcome Index; FIS= Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale. 
*p < .05; **p< .01; *** p < .001.
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Table H5: Comparison of Participants With and Without Positive Outcomes on the Personal Wellbeing Index and Fatigue Impact Scale (Categorical 
Variables) 
Personal Wellbeing Index  Fatigue Impact Scale  
Variables Not Improved 
Group 
Improved 





Gender        
Male 13 (19.7) 4 (15.4) .770  8 (16.7) 9 (20.5) .789 
Female 53 (80.3) 22 (84.6)   40 (83.3) 35 (79.5)  
Gross Income/week        
Less than $599  22 (34.9) 6 (25.0) .369  15 (32.6) 13 (31.7) .969 
Between $600 and $1999  31 (49.2) 13 (54.2)   23 (50.0) 21 (51.2)  
More than $2000 10 (15.9) 5 (20.8)   8 (17.4) 7 (17.1)  
Highest Education Level        
Secondary school or less 12 (21.4) 5 (23.8) .361  11 (25.6) 6 (17.6) .583 
Tertiary qualification 33 (58.9) 8 (38.1)   21 (48.8) 20 (58.8)  
Vocational qualification 11 (19.6) 8 (38.1)   11 (25.6) 8 (23.5)  





Table H5 continued 
Personal Wellbeing Index  Fatigue Impact Scale  
Variables Not Improved 
Group 
Improved 





Type of Intervention        
Face-to-face FSM 15  (22.7) 2  (7.7) .921  10 (20.8) 7 (15.9) .653 
Online FSM 14  (21.2) 13  (50.0)   13 (27.1) 14 (31.8)  
Info FSM 20  (30.3) 4  (15.4)   9 (18.8) 15 (34.1)  
Control 17  (25.8) 7  (26.9)   16 (33.3) 8 (18.2)  
Diagnosis        
Multiple Sclerosis 42 (77.8) 13 (68.4) .537  29 (76.3) 26 (74.3) 1.000 
Post-polio Syndrome or Parkinson 
Disease 
12 (22.2) 6 (31.6)   9 (23.7) 9 (25.7)  
Employment        
Employed 21 (31.8) 7 (73.1) .802  15 (31.3) 13 (29.5) .860 
Unemployed 45 (68.2) 19 (73.1)   33 (68.8) 31 (70.5)  
Note. FSM = Fatigue Self-management program.
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Table H6: Comparison of Participants With and Without Positive Outcomes on the Activity Card Sort and Combined Outcome Index (Categorical Variables) 
Activity Card Sort  Combined Outcome Index 
Variables Not Improved 
Group 
Improved 





Gender        
Male 9 (16.1) 8 (22.2) .583  11 (18.3) 6 (18.8) 1.000 
Female 47 (83.9) 28 (77.8)   49 (81.7) 26 (81.3)  
Gross Income/week        
Less than $599  16 (30.2) 12 (35.3) .353  19 (32.8) 9 (31.0) .583 
Between $600 and $1999  26 (49.1) 18 (52.9)   27 (46.6) 17 (58.6)  
More than $2000 11 (20.8) 4 (11.8)   12 (20.7) 3 (10.3)  
Highest Education Level        
Secondary school or less 7 (14.0) 10 (37.0) .348  10 (18.2) 7 (31.8) .875 
Tertiary qualification 32 (64.0) 9 (33.3)   34 (61.8) 7 (31.8)  
Vocational qualification 11 (22.0) 8 (29.6)   11 (20.0) 8 (36.4)  




Table H6 continued 
Activity Card Sort  Combined Outcome Index 
Variables Not Improved 
Group 
Improved 





Type of Intervention        
Face-to-face FSM 9 (16.1) 8 (22.2) .615  12 (20.0) 5 (15.6) .979 
Online FSM 18 (32.1) 9 (25.0)   16 (26.7) 11 (34.4)  
Info FSM 13 (23.2) 11 (30.6)   16 (26.7) 8 (25.0)  
Control 16 (28.6) 8 (22.2)   16 (26.7) 8 (25.0)  
Diagnosis        
Multiple Sclerosis 32 (72.7) 23 (79.3) .589  38 (79.2) 17 (68.0) .392 
Post-polio Syndrome or 
Parkinson Disease 
12 (27.3) 18 (24.7)   10 (20.8) 8 (32.0)  
Employment        
Employed 20 (35.7) 8 (22.2) .246  20 (33.3) 8 (25.0) .481 
Unemployed 36 (64.3) 28 (77.8)   40 (66.7) 24 (75.0)  
Note. FSM = Fatigue Self-management program.
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Table H7: Comparison of Less Active Participants With and Without Positive Outcomes on the 
Fatigue Impact Scale (Numerical Variables) 
Group Mean (SD) 
Variables Not improved in 
FIS 





Age 54.45 (8.43) 49.74 (14.03) 1.36 .18 








Fatigue Impact Scale 5.68 (.74) 5.78 (.90) -.41 .68 
 
Generalized Self-efficacy Scale 29.18 (3.92) 26.83 (3.86) 2.03 .048* 
SSI: Overall 32.86 (3.69) 31.30 (3.96) 1.36 .180 
SSI: Social Interaction 
Subscale 
8.36 (1.62) 7.57 (1.50) 1.72 .093 
SSI: Satisfaction Subscale 24.50 (3.11) 23.74 (3.58) .76 .452 
DASS: Depression Subscale 10.91 (8.52) 13.74 (11.20) -.95 .347 












DASS: Stress Subscale 12.82 (7.55) 16.48 (10.45) -1.34 .187 
 
Generalized Self-efficacy Scale -.95 (3.99) 3.17 (3.73) -3.59 .001**
SSI: Overall -1.64 (2.89) 1.22 (3.30) -3.08 .004**
SSI: Social Interaction 
Subscale 
-1.46 (2.40) .96 (2.72) -1.18 .243 
SSI: Satisfaction Subscale -.19 (1.18) .26 (1.32) -3.14 .003**
DASS: Depression Subscale 2.91 (8.01) -1.87 (10.95) 1.67 .103 



















DASS: Stress Subscale 1.91 (8.29) -4.49 (7.11) 2.74 .009**
Note. FIS= Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale. 





Table H8: Comparison of Less Active Participants With and Without Positive Outcomes on the 
Fatigue Impact Scale (Numerical Variables) 
Group Mean (SD) 
Variables Not improved in 
FIS 





Age 52.12 (12.02) 48.86 (8.05) 1.06 .293 








Fatigue Impact Scale 5.39 (.81) 5.52 (.92) -.51 .610 
 
Generalized Self-efficacy Scale 30.96 (4.19) 31.33 (3.62) -.32 .750 
SSI: Overall 36.96 (4.85) 35.67 (4.36) .95 .346 
SSI: Social Interaction 
Subscale 
8.69 (2.02) 8.86 (1.74) -.30 .769 
SSI: Satisfaction Subscale 28.27 (4.00) 26.81 (3.47) 1.32 .194 
DASS: Depression Subscale 4.73 (5.40) 8.33 (6.83) -2.02 .049 












DASS: Stress Subscale 7.08  (5.59) 9.67 (5.27) -1.6 .112 
 
Generalized Self-efficacy Scale -1.00 (3.85) 1.43 (22.50) -2.50 .016* 
SSI: Overall .38 (3.10) .65 (3.40) -.60 .553 
SSI: Social Interaction 
Subscale 
-1.95 (2.32) .86 (2.73) -1.43 .160 
SSI: Satisfaction Subscale .58 (1.50) .10 (1.37) 1.14 .262 
DASS: Depression Subscale 1.15 (5.97) -2.95 (6.78) 2.21 .032* 



















DASS: Stress Subscale 1.54 (7.16) -2.52 (5.38) 2.15 .037* 
Note. FIS= Fatigue Impact Scale; SSI = Social Support Index; DASS = Depression, Anxiety and Stress Scale. 
*p < .05; **p< .01; *** p < .001. 
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Table H9: Comparison of Participants With and Without Positive Outcomes on the Fatigue Impact Scale 
(Categorical Variables) 
Less active group  More active group 











Gender        
Male  4 (18.32) 4 (17.4) 1.00  4 (15.4) 5 (23.8) .486 
Female 18 (81.6) 19 (82.6)   22 (84.6) 16 (76.2)  
Gross Income/week        
Less than $599  9 (40.9) 7 (35.0) .728  6 (25) 6 (28.6) .964 
Between $600 and 
$1999  
11 (50.0) 11 (55.0)   12 (50) 10 (47.6)  
More than $2000 2 (9.1) 2 (10.0)   6 (25) 5 (23.8)  
Highest Education Level      
Secondary school or 
less 
7 (35.0) 3 (30.0) .501  4 (17.4) 3 (17.6) .750 
Tertiary qualification 6 (30.0) 8 (47.1)   15 (65.2) 12 (70.6)  
Vocational qualification 7 (35.0) 6 (35.3)   4 (17.4) 2 (11.8)  
Type of Intervention        
Face-to-face FSM 5 (22.7) 3 (13.0) .823  5 (19.2) 4 (19.0) .711 
Online FSM 5 (22.7) 9 (39.1)   8 (30.8) 5 (23.8)  
Info FSM 6 (27.3) 7 (30.4)   3 (11.5) 8 (38.1)  
Control 6 (27.3) 4 (17.4)   (38.5) 4 (19.0)  
Diagnosis        
Multiple Sclerosis 16 (72.7) 17 (73.9) 1.00  20 (76.9) 17 (81.0) 1.00 
Post-polio Syndrome or 
Parkinson Disease 
6 (27.3) 6 (26.1)   6 (23.1) 4 (19.0)  
Employment        
Employed 5 (22.7) 3 (13.0) .459  10 (38.5) 10 (47.6) .566 
Unemployed 17 (77.3) 20 (87.0)   16 (61.5) 11 (52.4)  
Note. FSM = Fatigue Self-management program. 
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